<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<ol style="list-style-type: decimal">
<li><p>MONDO classname (Label) [#subclasses][accuracy]</p></li>
<li><a href="html/MONDO_0000004.html">MONDO:0000004</a> (adrenal hypoplasia) [2][75.00%]</li>
<li><a href="html/MONDO_0000005.html">MONDO:0000005</a> (alopecia, isolated) [3][66.67%]</li>
<li><a href="html/MONDO_0000006.html">MONDO:0000006</a> (alopecia-mental retardation syndrome) [1][87.50%]</li>
<li><a href="html/MONDO_0000009.html">MONDO:0000009</a> (bleeding disorder, platelet-type) [5][65.00%]</li>
<li><a href="html/MONDO_0000013.html">MONDO:0000013</a> (choroidal dystrophy) [1][62.50%]</li>
<li><a href="html/MONDO_0000014.html">MONDO:0000014</a> (colorblindness, partial) [1][83.33%]</li>
<li><a href="html/MONDO_0000023.html">MONDO:0000023</a> (liver failure, infantile) [1][75.00%]</li>
<li><a href="html/MONDO_0000026.html">MONDO:0000026</a> (Fanconi renotubular syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0000028.html">MONDO:0000028</a> (epilepsy, Hot water) [1][66.67%]</li>
<li><a href="html/MONDO_0000032.html">MONDO:0000032</a> (febrile seizures, familial) [1][60.36%]</li>
<li><a href="html/MONDO_0000038.html">MONDO:0000038</a> (hyper-IgE recurrent infection syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0000044.html">MONDO:0000044</a> (hypophosphatemic rickets) [2][81.20%]</li>
<li><a href="html/MONDO_0000045.html">MONDO:0000045</a> (hypothyroidism, congenital, Nongoitrous) [4][68.69%]</li>
<li><a href="html/MONDO_0000050.html">MONDO:0000050</a> (isolated growth hormone deficiency) [1][55.36%]</li>
<li><a href="html/MONDO_0000064.html">MONDO:0000064</a> (microphthalmia, syndromic) [7][49.59%]</li>
<li><a href="html/MONDO_0000066.html">MONDO:0000066</a> (mitochondrial complex deficiency) [1][66.67%]</li>
<li><a href="html/MONDO_0000073.html">MONDO:0000073</a> (nail disorder, nonsyndromic congenital) [2][55.36%]</li>
<li><a href="html/MONDO_0000087.html">MONDO:0000087</a> (polymicrogyria) [4][58.30%]</li>
<li><a href="html/MONDO_0000088.html">MONDO:0000088</a> (precocious puberty) [2][75.00%]</li>
<li><a href="html/MONDO_0000090.html">MONDO:0000090</a> (progressive external ophthalmoplegia with mitochondrial DNA deletions) [1][91.67%]</li>
<li><a href="html/MONDO_0000105.html">MONDO:0000105</a> (anemia, nonspherocytic hemolytic) [1][75.00%]</li>
<li><a href="html/MONDO_0000110.html">MONDO:0000110</a> (bifid nose) [1][100.00%]</li>
<li><a href="html/MONDO_0000113.html">MONDO:0000113</a> (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome) [1][80.00%]</li>
<li><a href="html/MONDO_0000118.html">MONDO:0000118</a> (reticulate pigment disorder) [1][43.57%]</li>
<li><a href="html/MONDO_0000129.html">MONDO:0000129</a> (glutaric aciduria (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0000134.html">MONDO:0000134</a> (inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia) [1][62.50%]</li>
<li><a href="html/MONDO_0000137.html">MONDO:0000137</a> (leukoencephalopathy, megalencephalic) [1][62.50%]</li>
<li><a href="html/MONDO_0000148.html">MONDO:0000148</a> (pulmonary fibrosis and/or bone marrow failure, Telomere-related) [8][62.50%]</li>
<li><a href="html/MONDO_0000151.html">MONDO:0000151</a> (symphalangism) [1][66.67%]</li>
<li><a href="html/MONDO_0000152.html">MONDO:0000152</a> (thiamine-responsive dysfunction syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0000153.html">MONDO:0000153</a> (transposition of the great arteries) [1][52.02%]</li>
<li><a href="html/MONDO_0000167.html">MONDO:0000167</a> (Huntington disease and related disorders) [7][42.35%]</li>
<li><a href="html/MONDO_0000168.html">MONDO:0000168</a> (mental retardation, X-linked, nonsyndromic) [1][100.00%]</li>
<li><a href="html/MONDO_0000170.html">MONDO:0000170</a> (microphthalmia, isolated, with coloboma) [2][53.13%]</li>
<li><a href="html/MONDO_0000171.html">MONDO:0000171</a> (muscular dystrophy-dystroglycanopathy, type a) [2][66.67%]</li>
<li><a href="html/MONDO_0000172.html">MONDO:0000172</a> (muscular dystrophy-dystroglycanopathy, type b) [7][73.26%]</li>
<li><a href="html/MONDO_0000181.html">MONDO:0000181</a> (microcephaly and chorioretinopathy) [1][66.67%]</li>
<li><a href="html/MONDO_0000183.html">MONDO:0000183</a> (Hypertropic osteoarthropathy, primary) [1][73.84%]</li>
<li><a href="html/MONDO_0000190.html">MONDO:0000190</a> (ventricular fibrillation (disease)) [3][45.39%]</li>
<li><a href="html/MONDO_0000192.html">MONDO:0000192</a> (polyglucosan body myopathy) [1][66.67%]</li>
<li><a href="html/MONDO_0000199.html">MONDO:0000199</a> (Famailial adenomatous polyposis) [1][64.29%]</li>
<li><a href="html/MONDO_0000201.html">MONDO:0000201</a> (thyroid cancer, nonmedullary) [3][64.53%]</li>
<li><a href="html/MONDO_0000224.html">MONDO:0000224</a> (acquired carbohydrate metabolism disease) [22][57.50%]</li>
<li><a href="html/MONDO_0000226.html">MONDO:0000226</a> (mineral metabolism disease) [6][67.65%]</li>
<li><a href="html/MONDO_0000247.html">MONDO:0000247</a> (hemophagocytic lymphohistiocytosis) [4][63.64%]</li>
<li><a href="html/MONDO_0000256.html">MONDO:0000256</a> (systemic mycosis) [4][65.62%]</li>
<li><a href="html/MONDO_0000270.html">MONDO:0000270</a> (lower respiratory tract disease) [77][30.78%]</li>
<li><a href="html/MONDO_0000275.html">MONDO:0000275</a> (monogenic disease) [273][60.19%]</li>
<li><a href="html/MONDO_0000314.html">MONDO:0000314</a> (primary bacterial infectious disease) [14][15.67%]</li>
<li><a href="html/MONDO_0000350.html">MONDO:0000350</a> (Charcot-Marie-tooth disease intermediate type) [1][66.67%]</li>
<li><a href="html/MONDO_0000355.html">MONDO:0000355</a> (Ullrich congenital muscular dystrophy) [1][100.00%]</li>
<li><a href="html/MONDO_0000358.html">MONDO:0000358</a> (orofacial cleft) [2][35.92%]</li>
<li><a href="html/MONDO_0000359.html">MONDO:0000359</a> (spondylocostal dysostosis) [2][62.50%]</li>
<li><a href="html/MONDO_0000362.html">MONDO:0000362</a> (Sensenbrenner syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0000365.html">MONDO:0000365</a> (primary congenital glaucoma (disease)) [2][34.62%]</li>
<li><a href="html/MONDO_0000366.html">MONDO:0000366</a> (glycogen storage disease IX) [1][66.67%]</li>
<li><a href="html/MONDO_0000376.html">MONDO:0000376</a> (respiratory system cancer) [9][64.71%]</li>
<li><a href="html/MONDO_0000385.html">MONDO:0000385</a> (gastrointestinal system benign neoplasm) [3][55.36%]</li>
<li><a href="html/MONDO_0000390.html">MONDO:0000390</a> (vitelliform macular dystrophy) [1][100.00%]</li>
<li><a href="html/MONDO_0000396.html">MONDO:0000396</a> (spastic cerebral palsy) [1][75.00%]</li>
<li><a href="html/MONDO_0000402.html">MONDO:0000402</a> (small cell carcinoma) [1][50.00%]</li>
<li><a href="html/MONDO_0000403.html">MONDO:0000403</a> (organ system cancer) [223][48.25%]</li>
<li><a href="html/MONDO_0000404.html">MONDO:0000404</a> (cell type cancer) [84][42.06%]</li>
<li><a href="html/MONDO_0000405.html">MONDO:0000405</a> (anal canal cancer) [2][66.67%]</li>
<li><a href="html/MONDO_0000406.html">MONDO:0000406</a> (brown-Vialetto-van Laere syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0000411.html">MONDO:0000411</a> (electroclinical syndrome) [21][57.33%]</li>
<li><a href="html/MONDO_0000412.html">MONDO:0000412</a> (neonatal period electroclinical syndrome) [5][64.71%]</li>
<li><a href="html/MONDO_0000413.html">MONDO:0000413</a> (infancy electroclinical syndrome) [5][59.93%]</li>
<li><a href="html/MONDO_0000414.html">MONDO:0000414</a> (childhood electroclinical syndrome) [4][40.36%]</li>
<li><a href="html/MONDO_0000415.html">MONDO:0000415</a> (adolescence-adult electroclinical syndrome) [5][66.22%]</li>
<li><a href="html/MONDO_0000416.html">MONDO:0000416</a> (variable age at onset electroclinical syndrome) [5][66.67%]</li>
<li><a href="html/MONDO_0000421.html">MONDO:0000421</a> (serine deficiency) [3][66.67%]</li>
<li><a href="html/MONDO_0000422.html">MONDO:0000422</a> (glycogen metabolism disorder) [5][31.78%]</li>
<li><a href="html/MONDO_0000424.html">MONDO:0000424</a> (vitamin B12 deficiency (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0000425.html">MONDO:0000425</a> (X-linked disease) [55][47.00%]</li>
<li><a href="html/MONDO_0000426.html">MONDO:0000426</a> (autosomal dominant disease) [106][49.77%]</li>
<li><a href="html/MONDO_0000429.html">MONDO:0000429</a> (autosomal genetic disease) [193][58.05%]</li>
<li><a href="html/MONDO_0000432.html">MONDO:0000432</a> (lymphoplasmacytic lymphoma) [1][83.33%]</li>
<li><a href="html/MONDO_0000437.html">MONDO:0000437</a> (cerebellar ataxia) [33][50.29%]</li>
<li><a href="html/MONDO_0000447.html">MONDO:0000447</a> (polycystic liver disease (disease)) [1][83.33%]</li>
<li><a href="html/MONDO_0000453.html">MONDO:0000453</a> (short QT syndrome) [1][100.00%]</li>
<li><a href="html/MONDO_0000469.html">MONDO:0000469</a> (sinoatrial node disease) [2][80.00%]</li>
<li><a href="html/MONDO_0000473.html">MONDO:0000473</a> (artery disease) [34][36.05%]</li>
<li><a href="html/MONDO_0000476.html">MONDO:0000476</a> (generalized dystonia) [1][66.67%]</li>
<li><a href="html/MONDO_0000490.html">MONDO:0000490</a> (glomerulosclerosis) [1][81.25%]</li>
<li><a href="html/MONDO_0000507.html">MONDO:0000507</a> (inclusion body myopathy with Paget disease of bone and frontotemporal dementia) [1][62.50%]</li>
<li><a href="html/MONDO_0000508.html">MONDO:0000508</a> (syndromic intellectual disability) [133][54.73%]</li>
<li><a href="html/MONDO_0000509.html">MONDO:0000509</a> (non-syndromic intellectual disability) [10][58.36%]</li>
<li><a href="html/MONDO_0000510.html">MONDO:0000510</a> (synucleinopathy) [9][60.94%]</li>
<li><a href="html/MONDO_0000528.html">MONDO:0000528</a> (large intestine adenocarcinoma) [2][75.00%]</li>
<li><a href="html/MONDO_0000557.html">MONDO:0000557</a> (hereditary ataxia) [41][48.89%]</li>
<li><a href="html/MONDO_0000564.html">MONDO:0000564</a> (cerebellar ataxia, mental retardation and dysequlibrium syndrome) [1][80.00%]</li>
<li><a href="html/MONDO_0000569.html">MONDO:0000569</a> (autoimmune disease of endocrine system) [6][28.94%]</li>
<li><a href="html/MONDO_0000586.html">MONDO:0000586</a> (autoimmune disease of exocrine system) [1][57.49%]</li>
<li><a href="html/MONDO_0000588.html">MONDO:0000588</a> (autoimmune disease of gastrointestinal tract) [11][39.40%]</li>
<li><a href="html/MONDO_0000589.html">MONDO:0000589</a> (autoimmune disease of musculoskeletal system) [11][26.58%]</li>
<li><a href="html/MONDO_0000590.html">MONDO:0000590</a> (autoimmune disease of peripheral nervous system) [2][64.29%]</li>
<li><a href="html/MONDO_0000591.html">MONDO:0000591</a> (intrinsic cardiomyopathy) [70][57.71%]</li>
<li><a href="html/MONDO_0000592.html">MONDO:0000592</a> (specific developmental disorder) [148][56.95%]</li>
<li><a href="html/MONDO_0000594.html">MONDO:0000594</a> (pervasive developmental disorder) [9][63.10%]</li>
<li><a href="html/MONDO_0000601.html">MONDO:0000601</a> (autoimmune disease of urogenital tract) [1][57.49%]</li>
<li><a href="html/MONDO_0000603.html">MONDO:0000603</a> (autoimmune disease of cardiovascular system) [1][83.33%]</li>
<li><a href="html/MONDO_0000605.html">MONDO:0000605</a> (hypersensitivity reaction disease) [58][34.52%]</li>
<li><a href="html/MONDO_0000612.html">MONDO:0000612</a> (lymphatic system cancer) [2][83.33%]</li>
<li><a href="html/MONDO_0000620.html">MONDO:0000620</a> (breast benign neoplasm) [1][75.00%]</li>
<li><a href="html/MONDO_0000621.html">MONDO:0000621</a> (immune system cancer) [54][52.30%]</li>
<li><a href="html/MONDO_0000622.html">MONDO:0000622</a> (cell type benign neoplasm) [17][37.02%]</li>
<li><a href="html/MONDO_0000623.html">MONDO:0000623</a> (organ system benign neoplasm) [33][34.29%]</li>
<li><a href="html/MONDO_0000624.html">MONDO:0000624</a> (female reproductive organ benign neoplasm) [1][100.00%]</li>
<li><a href="html/MONDO_0000627.html">MONDO:0000627</a> (endocrine organ benign neoplasm) [8][62.50%]</li>
<li><a href="html/MONDO_0000628.html">MONDO:0000628</a> (central nervous system organ benign neoplasm) [1][100.00%]</li>
<li><a href="html/MONDO_0000632.html">MONDO:0000632</a> (uterine benign neoplasm) [1][100.00%]</li>
<li><a href="html/MONDO_0000633.html">MONDO:0000633</a> (sensory organ benign neoplasm) [1][62.50%]</li>
<li><a href="html/MONDO_0000634.html">MONDO:0000634</a> (thoracic benign neoplasm) [1][75.00%]</li>
<li><a href="html/MONDO_0000636.html">MONDO:0000636</a> (musculoskeletal system benign neoplasm) [1][66.67%]</li>
<li><a href="html/MONDO_0000637.html">MONDO:0000637</a> (musculoskeletal system cancer) [36][36.72%]</li>
<li><a href="html/MONDO_0000648.html">MONDO:0000648</a> (nervous system benign neoplasm) [13][50.15%]</li>
<li><a href="html/MONDO_0000649.html">MONDO:0000649</a> (sensory system cancer) [4][54.76%]</li>
<li><a href="html/MONDO_0000651.html">MONDO:0000651</a> (thoracic disease) [207][44.02%]</li>
<li><a href="html/MONDO_0000652.html">MONDO:0000652</a> (integumentary system benign neoplasm) [10][49.19%]</li>
<li><a href="html/MONDO_0000653.html">MONDO:0000653</a> (integumentary system cancer) [19][26.70%]</li>
<li><a href="html/MONDO_0000654.html">MONDO:0000654</a> (connective tissue benign neoplasm) [1][66.67%]</li>
<li><a href="html/MONDO_0000688.html">MONDO:0000688</a> (organic acidemia) [17][53.63%]</li>
<li><a href="html/MONDO_0000698.html">MONDO:0000698</a> (gamma-amino butyric acid metabolism disorder) [1][75.00%]</li>
<li><a href="html/MONDO_0000700.html">MONDO:0000700</a> (familial hemiplegic migraine) [2][90.00%]</li>
<li><a href="html/MONDO_0000720.html">MONDO:0000720</a> (basal ganglia calcification) [1][83.33%]</li>
<li><a href="html/MONDO_0000721.html">MONDO:0000721</a> (xanthinuria) [1][66.67%]</li>
<li><a href="html/MONDO_0000728.html">MONDO:0000728</a> (ptosis (disease)) [1][62.50%]</li>
<li><a href="html/MONDO_0000732.html">MONDO:0000732</a> (combined oxidative phosphorylation deficiency) [1][70.00%]</li>
<li><a href="html/MONDO_0000733.html">MONDO:0000733</a> (cornea plana) [1][74.16%]</li>
<li><a href="html/MONDO_0000736.html">MONDO:0000736</a> (dyschromatosis universalis hereditaria) [1][62.50%]</li>
<li><a href="html/MONDO_0000738.html">MONDO:0000738</a> (syndromic X-linked intellectual disability) [6][62.50%]</li>
<li><a href="html/MONDO_0000761.html">MONDO:0000761</a> (chromosomal deletion syndrome) [5][30.89%]</li>
<li><a href="html/MONDO_0000762.html">MONDO:0000762</a> (chromosomal duplication syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0000766.html">MONDO:0000766</a> (corneal endothelial dystrophy) [2][58.76%]</li>
<li><a href="html/MONDO_0000820.html">MONDO:0000820</a> (cerebral cavernous malformation) [1][75.00%]</li>
<li><a href="html/MONDO_0000823.html">MONDO:0000823</a> (familial temporal lobe epilepsy 3) [1][62.50%]</li>
<li><a href="html/MONDO_0000828.html">MONDO:0000828</a> (juvenile-onset Parkinson disease) [4][63.16%]</li>
<li><a href="html/MONDO_0000833.html">MONDO:0000833</a> (bone remodeling disease) [17][56.96%]</li>
<li><a href="html/MONDO_0000835.html">MONDO:0000835</a> (ischemic bone disease) [9][69.23%]</li>
<li><a href="html/MONDO_0000837.html">MONDO:0000837</a> (bone resorption disease) [1][61.79%]</li>
<li><a href="html/MONDO_0000838.html">MONDO:0000838</a> (chromosomal disease) [11][39.96%]</li>
<li><a href="html/MONDO_0000839.html">MONDO:0000839</a> (physical disorder) [74][42.26%]</li>
<li><a href="html/MONDO_0000841.html">MONDO:0000841</a> (metaphyseal dysplasia) [1][100.00%]</li>
<li><a href="html/MONDO_0000844.html">MONDO:0000844</a> (spondyloepimetaphyseal dysplasia) [4][62.50%]</li>
<li><a href="html/MONDO_0000863.html">MONDO:0000863</a> (myopathy, lactic acidosis, and sideroblastic anemia) [1][75.00%]</li>
<li><a href="html/MONDO_0000865.html">MONDO:0000865</a> (congenital fiber-type disproportion) [1][83.33%]</li>
<li><a href="html/MONDO_0000869.html">MONDO:0000869</a> (congenital fibrosis of the extraocular muscles) [1][71.43%]</li>
<li><a href="html/MONDO_0000903.html">MONDO:0000903</a> (myoclonus-dystonia syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0000942.html">MONDO:0000942</a> (corneal disease) [23][49.21%]</li>
<li><a href="html/MONDO_0000984.html">MONDO:0000984</a> (thalassemia) [3][83.79%]</li>
<li><a href="html/MONDO_0000992.html">MONDO:0000992</a> (heart conduction disease) [21][63.93%]</li>
<li><a href="html/MONDO_0000995.html">MONDO:0000995</a> (familial periodic paralysis) [2][64.29%]</li>
<li><a href="html/MONDO_0001018.html">MONDO:0001018</a> (lymphoblastic leukemia) [5][41.27%]</li>
<li><a href="html/MONDO_0001029.html">MONDO:0001029</a> (Klippel-Feil syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0001056.html">MONDO:0001056</a> (stomach cancer) [4][62.50%]</li>
<li><a href="html/MONDO_0001070.html">MONDO:0001070</a> (adrenoleukodystrophy) [2][70.00%]</li>
<li><a href="html/MONDO_0001071.html">MONDO:0001071</a> (intellectual disability) [143][57.89%]</li>
<li><a href="html/MONDO_0001083.html">MONDO:0001083</a> (Fanconi syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0001149.html">MONDO:0001149</a> (microcephaly (disease)) [5][60.61%]</li>
<li><a href="html/MONDO_0001150.html">MONDO:0001150</a> (hydrocephalus) [3][65.00%]</li>
<li><a href="html/MONDO_0001165.html">MONDO:0001165</a> (tongue disease) [1][100.00%]</li>
<li><a href="html/MONDO_0001166.html">MONDO:0001166</a> (nephritis) [2][77.78%]</li>
<li><a href="html/MONDO_0001170.html">MONDO:0001170</a> (hemiplegia) [1][83.33%]</li>
<li><a href="html/MONDO_0001176.html">MONDO:0001176</a> (lens disease) [48][58.17%]</li>
<li><a href="html/MONDO_0001187.html">MONDO:0001187</a> (urinary bladder cancer) [1][100.00%]</li>
<li><a href="html/MONDO_0001189.html">MONDO:0001189</a> (esophageal carcinoma) [1][75.00%]</li>
<li><a href="html/MONDO_0001220.html">MONDO:0001220</a> (hypoparathyroidism) [15][60.47%]</li>
<li><a href="html/MONDO_0001223.html">MONDO:0001223</a> (parathyroid gland disease) [24][59.59%]</li>
<li><a href="html/MONDO_0001245.html">MONDO:0001245</a> (microcytic anemia) [1][100.00%]</li>
<li><a href="html/MONDO_0001273.html">MONDO:0001273</a> (megacolon) [1][48.87%]</li>
<li><a href="html/MONDO_0001292.html">MONDO:0001292</a> (autonomic nervous system disease) [4][64.29%]</li>
<li><a href="html/MONDO_0001314.html">MONDO:0001314</a> (chondrocalcinosis) [1][72.36%]</li>
<li><a href="html/MONDO_0001336.html">MONDO:0001336</a> (familial hyperlipidemia) [4][67.26%]</li>
<li><a href="html/MONDO_0001340.html">MONDO:0001340</a> (heart cancer) [6][65.00%]</li>
<li><a href="html/MONDO_0001343.html">MONDO:0001343</a> (impaired renal function disease) [1][83.33%]</li>
<li><a href="html/MONDO_0001346.html">MONDO:0001346</a> (distal muscular dystrophy) [1][66.67%]</li>
<li><a href="html/MONDO_0001358.html">MONDO:0001358</a> (bronchial disease) [3][66.67%]</li>
<li><a href="html/MONDO_0001406.html">MONDO:0001406</a> (peripheral nervous system neoplasm) [6][38.54%]</li>
<li><a href="html/MONDO_0001409.html">MONDO:0001409</a> (esophagitis (disease)) [1][83.33%]</li>
<li><a href="html/MONDO_0001411.html">MONDO:0001411</a> (synostosis) [13][57.81%]</li>
<li><a href="html/MONDO_0001436.html">MONDO:0001436</a> (hemosiderosis) [1][66.67%]</li>
<li><a href="html/MONDO_0001437.html">MONDO:0001437</a> (pulmonary alveolar proteinosis) [2][75.00%]</li>
<li><a href="html/MONDO_0001475.html">MONDO:0001475</a> (neutropenia) [2][68.18%]</li>
<li><a href="html/MONDO_0001476.html">MONDO:0001476</a> (coloboma) [5][67.72%]</li>
<li><a href="html/MONDO_0001493.html">MONDO:0001493</a> (chronic pulmonary heart disease) [2][75.00%]</li>
<li><a href="html/MONDO_0001516.html">MONDO:0001516</a> (spinal muscular atrophy) [1][75.00%]</li>
<li><a href="html/MONDO_0001531.html">MONDO:0001531</a> (blood coagulation disease) [65][53.56%]</li>
<li><a href="html/MONDO_0001545.html">MONDO:0001545</a> (von willebrand's disease) [1][18.92%]</li>
<li><a href="html/MONDO_0001549.html">MONDO:0001549</a> (hemolytic-uremic syndrome) [4][66.67%]</li>
<li><a href="html/MONDO_0001566.html">MONDO:0001566</a> (hypercalcemia (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0001574.html">MONDO:0001574</a> (capillary disease) [1][100.00%]</li>
<li><a href="html/MONDO_0001584.html">MONDO:0001584</a> (ocular motility disease) [4][63.16%]</li>
<li><a href="html/MONDO_0001595.html">MONDO:0001595</a> (choreatic disease) [1][66.67%]</li>
<li><a href="html/MONDO_0001609.html">MONDO:0001609</a> (agranulocytosis) [2][68.18%]</li>
<li><a href="html/MONDO_0001627.html">MONDO:0001627</a> (dementia) [84][52.15%]</li>
<li><a href="html/MONDO_0001639.html">MONDO:0001639</a> (deficiency anemia) [13][60.11%]</li>
<li><a href="html/MONDO_0001657.html">MONDO:0001657</a> (brain cancer) [8][60.47%]</li>
<li><a href="html/MONDO_0001697.html">MONDO:0001697</a> (reading disorder) [1][71.43%]</li>
<li><a href="html/MONDO_0001703.html">MONDO:0001703</a> (color blindness) [2][70.00%]</li>
<li><a href="html/MONDO_0001713.html">MONDO:0001713</a> (congenital hypoplastic anemia) [2][75.00%]</li>
<li><a href="html/MONDO_0001741.html">MONDO:0001741</a> (hyperparathyroidism) [7][77.27%]</li>
<li><a href="html/MONDO_0001751.html">MONDO:0001751</a> (cholestasis) [4][79.17%]</li>
<li><a href="html/MONDO_0001823.html">MONDO:0001823</a> (sick sinus syndrome) [1][80.00%]</li>
<li><a href="html/MONDO_0001834.html">MONDO:0001834</a> (visual pathway disease) [1][100.00%]</li>
<li><a href="html/MONDO_0001898.html">MONDO:0001898</a> (choroid disease) [3][62.50%]</li>
<li><a href="html/MONDO_0001909.html">MONDO:0001909</a> (renal tubular acidosis) [1][83.33%]</li>
<li><a href="html/MONDO_0001926.html">MONDO:0001926</a> (ureteral disease) [3][53.54%]</li>
<li><a href="html/MONDO_0001937.html">MONDO:0001937</a> (leopard syndrome) [1][87.50%]</li>
<li><a href="html/MONDO_0001941.html">MONDO:0001941</a> (blindness) [2][70.00%]</li>
<li><a href="html/MONDO_0001967.html">MONDO:0001967</a> (gonadal dysgenesis) [5][80.43%]</li>
<li><a href="html/MONDO_0001968.html">MONDO:0001968</a> (46 XY gonadal dysgenesis) [1][66.67%]</li>
<li><a href="html/MONDO_0001982.html">MONDO:0001982</a> (Niemann-Pick disease) [1][66.67%]</li>
<li><a href="html/MONDO_0001999.html">MONDO:0001999</a> (primary pulmonary hypertension) [1][75.00%]</li>
<li><a href="html/MONDO_0002001.html">MONDO:0002001</a> (disease of cellular proliferation) [263][49.67%]</li>
<li><a href="html/MONDO_0002007.html">MONDO:0002007</a> (VACTERL association) [1][66.67%]</li>
<li><a href="html/MONDO_0002012.html">MONDO:0002012</a> (methylmalonic acidemia) [3][64.29%]</li>
<li><a href="html/MONDO_0002021.html">MONDO:0002021</a> (gingival disease) [1][70.00%]</li>
<li><a href="html/MONDO_0002022.html">MONDO:0002022</a> (eye and adnexa disease) [457][63.13%]</li>
<li><a href="html/MONDO_0002025.html">MONDO:0002025</a> (disease of mental health) [246][59.66%]</li>
<li><a href="html/MONDO_0002026.html">MONDO:0002026</a> (candidiasis) [1][70.83%]</li>
<li><a href="html/MONDO_0002038.html">MONDO:0002038</a> (head and neck carcinoma) [1][42.68%]</li>
<li><a href="html/MONDO_0002039.html">MONDO:0002039</a> (cognitive disorder) [240][59.60%]</li>
<li><a href="html/MONDO_0002041.html">MONDO:0002041</a> (fungal infectious disease) [5][64.71%]</li>
<li><a href="html/MONDO_0002049.html">MONDO:0002049</a> (thrombocytopenia) [1][75.00%]</li>
<li><a href="html/MONDO_0002051.html">MONDO:0002051</a> (integumentary system disease) [340][62.58%]</li>
<li><a href="html/MONDO_0002070.html">MONDO:0002070</a> (ventricular septal defect (disease)) [2][60.82%]</li>
<li><a href="html/MONDO_0002071.html">MONDO:0002071</a> (supratentorial cancer) [1][83.33%]</li>
<li><a href="html/MONDO_0002078.html">MONDO:0002078</a> (heart septal defect) [6][57.56%]</li>
<li><a href="html/MONDO_0002081.html">MONDO:0002081</a> (musculoskeletal system disease) [482][60.35%]</li>
<li><a href="html/MONDO_0002082.html">MONDO:0002082</a> (endocrine gland cancer) [31][54.10%]</li>
<li><a href="html/MONDO_0002100.html">MONDO:0002100</a> (cardiovascular cancer) [7][63.64%]</li>
<li><a href="html/MONDO_0002108.html">MONDO:0002108</a> (thyroid cancer) [8][73.35%]</li>
<li><a href="html/MONDO_0002109.html">MONDO:0002109</a> (pituitary cancer) [1][100.00%]</li>
<li><a href="html/MONDO_0002118.html">MONDO:0002118</a> (urinary system disease) [198][55.84%]</li>
<li><a href="html/MONDO_0002123.html">MONDO:0002123</a> (calcinosis) [2][62.50%]</li>
<li><a href="html/MONDO_0002129.html">MONDO:0002129</a> (bone cancer) [4][35.35%]</li>
<li><a href="html/MONDO_0002135.html">MONDO:0002135</a> (optic nerve disease) [6][58.80%]</li>
<li><a href="html/MONDO_0002145.html">MONDO:0002145</a> (sex differentiation disease) [1][75.00%]</li>
<li><a href="html/MONDO_0002146.html">MONDO:0002146</a> (hypogonadism) [7][58.78%]</li>
<li><a href="html/MONDO_0002173.html">MONDO:0002173</a> (neuroma) [2][62.50%]</li>
<li><a href="html/MONDO_0002175.html">MONDO:0002175</a> (degeneration of macula and posterior pole) [3][55.40%]</li>
<li><a href="html/MONDO_0002176.html">MONDO:0002176</a> (connective tissue cancer) [13][41.67%]</li>
<li><a href="html/MONDO_0002181.html">MONDO:0002181</a> (exostosis) [1][87.50%]</li>
<li><a href="html/MONDO_0002182.html">MONDO:0002182</a> (communication disorder) [2][66.67%]</li>
<li><a href="html/MONDO_0002185.html">MONDO:0002185</a> (hyperostosis) [4][64.29%]</li>
<li><a href="html/MONDO_0002211.html">MONDO:0002211</a> (b cell deficiency) [10][73.15%]</li>
<li><a href="html/MONDO_0002220.html">MONDO:0002220</a> (teeth hard tissue disease) [6][70.07%]</li>
<li><a href="html/MONDO_0002228.html">MONDO:0002228</a> (malignant ovarian surface epithelial-stromal neoplasm) [2][75.00%]</li>
<li><a href="html/MONDO_0002229.html">MONDO:0002229</a> (ovary epithelial cancer) [2][75.00%]</li>
<li><a href="html/MONDO_0002236.html">MONDO:0002236</a> (ocular cancer) [4][54.76%]</li>
<li><a href="html/MONDO_0002243.html">MONDO:0002243</a> (hemorrhagic disease) [12][65.52%]</li>
<li><a href="html/MONDO_0002245.html">MONDO:0002245</a> (blood platelet disease) [12][65.52%]</li>
<li><a href="html/MONDO_0002249.html">MONDO:0002249</a> (thrombocytosis) [4][75.38%]</li>
<li><a href="html/MONDO_0002254.html">MONDO:0002254</a> (syndromic disease) [131][56.47%]</li>
<li><a href="html/MONDO_0002259.html">MONDO:0002259</a> (gonadal disease) [9][59.07%]</li>
<li><a href="html/MONDO_0002260.html">MONDO:0002260</a> (hidradenitis) [1][83.33%]</li>
<li><a href="html/MONDO_0002263.html">MONDO:0002263</a> (female reproductive system disease) [26][36.87%]</li>
<li><a href="html/MONDO_0002267.html">MONDO:0002267</a> (obstructive lung disease) [2][100.00%]</li>
<li><a href="html/MONDO_0002279.html">MONDO:0002279</a> (iron metabolism disease) [1][66.67%]</li>
<li><a href="html/MONDO_0002280.html">MONDO:0002280</a> (anemia (disease)) [78][52.62%]</li>
<li><a href="html/MONDO_0002281.html">MONDO:0002281</a> (macrocytic anemia (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0002289.html">MONDO:0002289</a> (iris disease) [4][72.22%]</li>
<li><a href="html/MONDO_0002305.html">MONDO:0002305</a> (thrombophilia) [1][75.00%]</li>
<li><a href="html/MONDO_0002311.html">MONDO:0002311</a> (retinal vascular disease) [2][77.27%]</li>
<li><a href="html/MONDO_0002312.html">MONDO:0002312</a> (opportunistic mycosis) [3][66.67%]</li>
<li><a href="html/MONDO_0002316.html">MONDO:0002316</a> (motor peripheral neuropathy) [1][75.00%]</li>
<li><a href="html/MONDO_0002320.html">MONDO:0002320</a> (congenital nervous system abnormality) [30][56.18%]</li>
<li><a href="html/MONDO_0002331.html">MONDO:0002331</a> (nephrosis) [4][62.50%]</li>
<li><a href="html/MONDO_0002332.html">MONDO:0002332</a> (splenic disease) [1][66.67%]</li>
<li><a href="html/MONDO_0002334.html">MONDO:0002334</a> (hematologic cancer) [52][52.84%]</li>
<li><a href="html/MONDO_0002356.html">MONDO:0002356</a> (pancreas disease) [10][36.32%]</li>
<li><a href="html/MONDO_0002363.html">MONDO:0002363</a> (papilloma) [1][83.33%]</li>
<li><a href="html/MONDO_0002366.html">MONDO:0002366</a> (autonomic nervous system neoplasm) [2][42.39%]</li>
<li><a href="html/MONDO_0002367.html">MONDO:0002367</a> (kidney cancer) [7][44.25%]</li>
<li><a href="html/MONDO_0002403.html">MONDO:0002403</a> (synovium cancer) [1][75.00%]</li>
<li><a href="html/MONDO_0002406.html">MONDO:0002406</a> (dermatitis) [5][42.00%]</li>
<li><a href="html/MONDO_0002407.html">MONDO:0002407</a> (capillary hemangioma) [1][100.00%]</li>
<li><a href="html/MONDO_0002408.html">MONDO:0002408</a> (bilirubin metabolic disorder) [1][75.00%]</li>
<li><a href="html/MONDO_0002409.html">MONDO:0002409</a> (auditory system disease) [12][45.45%]</li>
<li><a href="html/MONDO_0002412.html">MONDO:0002412</a> (glycogen storage disease) [5][31.78%]</li>
<li><a href="html/MONDO_0002422.html">MONDO:0002422</a> (adamantinoma) [1][60.36%]</li>
<li><a href="html/MONDO_0002427.html">MONDO:0002427</a> (cerebellar disease) [34][50.70%]</li>
<li><a href="html/MONDO_0002428.html">MONDO:0002428</a> (parasitic protozoa infectious disease) [3][55.36%]</li>
<li><a href="html/MONDO_0002429.html">MONDO:0002429</a> (idiopathic interstitial pneumonia) [8][51.97%]</li>
<li><a href="html/MONDO_0002441.html">MONDO:0002441</a> (Jervell-Lange Nielsen syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0002442.html">MONDO:0002442</a> (long QT syndrome) [4][78.95%]</li>
<li><a href="html/MONDO_0002456.html">MONDO:0002456</a> (cervix carcinoma) [2][75.00%]</li>
<li><a href="html/MONDO_0002457.html">MONDO:0002457</a> (Treacher Collins syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0002459.html">MONDO:0002459</a> (hypersensitivity reaction type IV disease) [3][66.67%]</li>
<li><a href="html/MONDO_0002462.html">MONDO:0002462</a> (glomerulonephritis (disease)) [2][77.78%]</li>
<li><a href="html/MONDO_0002466.html">MONDO:0002466</a> (eye carcinoma) [3][56.15%]</li>
<li><a href="html/MONDO_0002467.html">MONDO:0002467</a> (inner ear disease) [4][71.43%]</li>
<li><a href="html/MONDO_0002468.html">MONDO:0002468</a> (hyperimmunoglobulin syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0002507.html">MONDO:0002507</a> (gingival overgrowth) [1][70.00%]</li>
<li><a href="html/MONDO_0002510.html">MONDO:0002510</a> (germ cell and embryonal cancer) [2][66.67%]</li>
<li><a href="html/MONDO_0002513.html">MONDO:0002513</a> (kidney benign neoplasm) [1][100.00%]</li>
<li><a href="html/MONDO_0002515.html">MONDO:0002515</a> (hepatobiliary disease) [55][48.26%]</li>
<li><a href="html/MONDO_0002516.html">MONDO:0002516</a> (gastrointestinal system cancer) [22][42.16%]</li>
<li><a href="html/MONDO_0002520.html">MONDO:0002520</a> (acute porphyria) [3][62.50%]</li>
<li><a href="html/MONDO_0002525.html">MONDO:0002525</a> (lipid metabolism disorder) [28][55.71%]</li>
<li><a href="html/MONDO_0002531.html">MONDO:0002531</a> (skin benign neoplasm) [2][62.50%]</li>
<li><a href="html/MONDO_0002545.html">MONDO:0002545</a> (spinal cord disease) [2][66.67%]</li>
<li><a href="html/MONDO_0002546.html">MONDO:0002546</a> (neurilemmoma) [2][62.50%]</li>
<li><a href="html/MONDO_0002547.html">MONDO:0002547</a> (peripheral nerve sheath neoplasm) [4][62.50%]</li>
<li><a href="html/MONDO_0002557.html">MONDO:0002557</a> (neurilemmomatosis) [1][62.50%]</li>
<li><a href="html/MONDO_0002561.html">MONDO:0002561</a> (lysosomal storage disease) [48][48.99%]</li>
<li><a href="html/MONDO_0002586.html">MONDO:0002586</a> (thymus cancer) [2][83.33%]</li>
<li><a href="html/MONDO_0002597.html">MONDO:0002597</a> (notochordal cancer) [1][75.00%]</li>
<li><a href="html/MONDO_0002602.html">MONDO:0002602</a> (central nervous system disease) [409][60.78%]</li>
<li><a href="html/MONDO_0002608.html">MONDO:0002608</a> (gangliosidosis GM2) [2][78.57%]</li>
<li><a href="html/MONDO_0002612.html">MONDO:0002612</a> (frontal lobe epilepsy) [1][66.67%]</li>
<li><a href="html/MONDO_0002614.html">MONDO:0002614</a> (bone inflammation disease) [9][55.42%]</li>
<li><a href="html/MONDO_0002616.html">MONDO:0002616</a> (mesenchymal cell neoplasm) [21][41.99%]</li>
<li><a href="html/MONDO_0002635.html">MONDO:0002635</a> (periodontal disease) [4][62.50%]</li>
<li><a href="html/MONDO_0002637.html">MONDO:0002637</a> (histiocytosis) [3][72.22%]</li>
<li><a href="html/MONDO_0002643.html">MONDO:0002643</a> (vestibular disease) [2][62.50%]</li>
<li><a href="html/MONDO_0002656.html">MONDO:0002656</a> (skin carcinoma) [4][46.21%]</li>
<li><a href="html/MONDO_0002657.html">MONDO:0002657</a> (breast disease) [14][37.54%]</li>
<li><a href="html/MONDO_0002659.html">MONDO:0002659</a> (uveal cancer) [1][62.50%]</li>
<li><a href="html/MONDO_0002661.html">MONDO:0002661</a> (uveal disease) [22][32.05%]</li>
<li><a href="html/MONDO_0002663.html">MONDO:0002663</a> (systemic mastocytosis) [2][100.00%]</li>
<li><a href="html/MONDO_0002681.html">MONDO:0002681</a> (choroid plexus cancer) [1][83.33%]</li>
<li><a href="html/MONDO_0002682.html">MONDO:0002682</a> (cerebral ventricle cancer) [1][83.33%]</li>
<li><a href="html/MONDO_0002691.html">MONDO:0002691</a> (liver cancer) [3][70.00%]</li>
<li><a href="html/MONDO_0002714.html">MONDO:0002714</a> (central nervous system cancer) [11][56.55%]</li>
<li><a href="html/MONDO_0002723.html">MONDO:0002723</a> (cutaneous mastocytosis (disease)) [1][100.00%]</li>
<li><a href="html/MONDO_0002724.html">MONDO:0002724</a> (mast cell neoplasm) [1][100.00%]</li>
<li><a href="html/MONDO_0002731.html">MONDO:0002731</a> (cerebrum cancer) [1][83.33%]</li>
<li><a href="html/MONDO_0002771.html">MONDO:0002771</a> (pulmonary fibrosis) [8][62.50%]</li>
<li><a href="html/MONDO_0002813.html">MONDO:0002813</a> (lipomatous cancer) [3][66.67%]</li>
<li><a href="html/MONDO_0002816.html">MONDO:0002816</a> (adrenal cortex disease) [16][60.67%]</li>
<li><a href="html/MONDO_0002817.html">MONDO:0002817</a> (adrenal gland cancer) [3][75.00%]</li>
<li><a href="html/MONDO_0002827.html">MONDO:0002827</a> (urinary system cancer) [12][24.48%]</li>
<li><a href="html/MONDO_0002847.html">MONDO:0002847</a> (skeletal muscle cancer) [3][66.67%]</li>
<li><a href="html/MONDO_0002869.html">MONDO:0002869</a> (heart valve disease) [4][64.29%]</li>
<li><a href="html/MONDO_0002872.html">MONDO:0002872</a> (trophoblastic neoplasm) [2][66.67%]</li>
<li><a href="html/MONDO_0002884.html">MONDO:0002884</a> (nail disease) [2][55.36%]</li>
<li><a href="html/MONDO_0002887.html">MONDO:0002887</a> (bile duct disease) [9][67.50%]</li>
<li><a href="html/MONDO_0002895.html">MONDO:0002895</a> (dentinogenesis imperfecta) [1][66.67%]</li>
<li><a href="html/MONDO_0002898.html">MONDO:0002898</a> (skin cancer) [5][26.10%]</li>
<li><a href="html/MONDO_0002903.html">MONDO:0002903</a> (articulation disorder) [1][22.93%]</li>
<li><a href="html/MONDO_0002906.html">MONDO:0002906</a> (scleroderma) [2][83.33%]</li>
<li><a href="html/MONDO_0002908.html">MONDO:0002908</a> (glucose metabolism disease) [21][58.16%]</li>
<li><a href="html/MONDO_0002917.html">MONDO:0002917</a> (hair disease) [12][55.82%]</li>
<li><a href="html/MONDO_0002921.html">MONDO:0002921</a> (congenital structural myopathy) [11][68.00%]</li>
<li><a href="html/MONDO_0002924.html">MONDO:0002924</a> (smooth muscle cancer) [2][62.50%]</li>
<li><a href="html/MONDO_0002932.html">MONDO:0002932</a> (conjunctival disease) [15][60.83%]</li>
<li><a href="html/MONDO_0002933.html">MONDO:0002933</a> (osteosclerosis) [8][72.00%]</li>
<li><a href="html/MONDO_0002964.html">MONDO:0002964</a> (non-Langerhans-cell histiocytosis) [2][83.33%]</li>
<li><a href="html/MONDO_0002977.html">MONDO:0002977</a> (autoimmune disease of the nervous system) [7][42.15%]</li>
<li><a href="html/MONDO_0002986.html">MONDO:0002986</a> (neuromuscular disease) [34][50.33%]</li>
<li><a href="html/MONDO_0003004.html">MONDO:0003004</a> (macular degeneration) [6][67.50%]</li>
<li><a href="html/MONDO_0003006.html">MONDO:0003006</a> (Bartter disease) [1][66.67%]</li>
<li><a href="html/MONDO_0003008.html">MONDO:0003008</a> (hereditary renal cell carcinoma) [1][66.67%]</li>
<li><a href="html/MONDO_0003020.html">MONDO:0003020</a> (orofaciodigital syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0003037.html">MONDO:0003037</a> (hypotrichosis) [8][63.64%]</li>
<li><a href="html/MONDO_0003059.html">MONDO:0003059</a> (bile duct cancer) [2][66.67%]</li>
<li><a href="html/MONDO_0003060.html">MONDO:0003060</a> (biliary tract cancer) [2][66.67%]</li>
<li><a href="html/MONDO_0003072.html">MONDO:0003072</a> (retinal cancer) [1][85.36%]</li>
<li><a href="html/MONDO_0003107.html">MONDO:0003107</a> (infratentorial cancer) [1][55.36%]</li>
<li><a href="html/MONDO_0003110.html">MONDO:0003110</a> (skin hemangioma) [2][62.50%]</li>
<li><a href="html/MONDO_0003122.html">MONDO:0003122</a> (striatonigral degeneration) [1][62.50%]</li>
<li><a href="html/MONDO_0003150.html">MONDO:0003150</a> (male reproductive system disease) [67][48.18%]</li>
<li><a href="html/MONDO_0003151.html">MONDO:0003151</a> (movement disease) [27][38.64%]</li>
<li><a href="html/MONDO_0003193.html">MONDO:0003193</a> (bile duct adenocarcinoma) [1][81.62%]</li>
<li><a href="html/MONDO_0003225.html">MONDO:0003225</a> (bone marrow disease) [32][48.12%]</li>
<li><a href="html/MONDO_0003240.html">MONDO:0003240</a> (thyroid gland disease) [37][61.04%]</li>
<li><a href="html/MONDO_0003241.html">MONDO:0003241</a> (central nervous system hemangioma) [1][75.00%]</li>
<li><a href="html/MONDO_0003249.html">MONDO:0003249</a> (pineal gland cancer) [1][100.00%]</li>
<li><a href="html/MONDO_0003274.html">MONDO:0003274</a> (thoracic cancer) [18][30.60%]</li>
<li><a href="html/MONDO_0003381.html">MONDO:0003381</a> (pituitary gland disease) [11][64.41%]</li>
<li><a href="html/MONDO_0003393.html">MONDO:0003393</a> (thymus gland disease) [3][83.33%]</li>
<li><a href="html/MONDO_0003406.html">MONDO:0003406</a> (sleep disorder) [6][62.50%]</li>
<li><a href="html/MONDO_0003409.html">MONDO:0003409</a> (colonic disease) [2][45.53%]</li>
<li><a href="html/MONDO_0003429.html">MONDO:0003429</a> (functioning pituitary adenoma) [3][71.43%]</li>
<li><a href="html/MONDO_0003432.html">MONDO:0003432</a> (strabismus) [1][70.00%]</li>
<li><a href="html/MONDO_0003441.html">MONDO:0003441</a> (dystonia (disease)) [20][41.62%]</li>
<li><a href="html/MONDO_0003569.html">MONDO:0003569</a> (cranial nerve neuropathy) [11][48.95%]</li>
<li><a href="html/MONDO_0003576.html">MONDO:0003576</a> (large intestine cancer) [4][48.69%]</li>
<li><a href="html/MONDO_0003606.html">MONDO:0003606</a> (adrenal medulla cancer) [1][100.00%]</li>
<li><a href="html/MONDO_0003608.html">MONDO:0003608</a> (optic atrophy) [4][55.11%]</li>
<li><a href="html/MONDO_0003615.html">MONDO:0003615</a> (nerve compression syndrome) [1][76.73%]</li>
<li><a href="html/MONDO_0003620.html">MONDO:0003620</a> (peripheral nervous system disease) [136][44.06%]</li>
<li><a href="html/MONDO_0003634.html">MONDO:0003634</a> (proteinuria) [1][66.67%]</li>
<li><a href="html/MONDO_0003656.html">MONDO:0003656</a> (hemoglobinuria) [1][66.67%]</li>
<li><a href="html/MONDO_0003664.html">MONDO:0003664</a> (hemolytic anemia) [41][55.80%]</li>
<li><a href="html/MONDO_0003689.html">MONDO:0003689</a> (congenital hemolytic anemia) [17][58.46%]</li>
<li><a href="html/MONDO_0003749.html">MONDO:0003749</a> (esophageal disease) [4][66.67%]</li>
<li><a href="html/MONDO_0003757.html">MONDO:0003757</a> (paraplegia) [16][55.11%]</li>
<li><a href="html/MONDO_0003767.html">MONDO:0003767</a> (mitral valve disease) [2][75.00%]</li>
<li><a href="html/MONDO_0003778.html">MONDO:0003778</a> (primary immunodeficiency disease) [30][64.98%]</li>
<li><a href="html/MONDO_0003785.html">MONDO:0003785</a> (leukopenia) [2][68.18%]</li>
<li><a href="html/MONDO_0003803.html">MONDO:0003803</a> (aortic valve disease) [2][66.67%]</li>
<li><a href="html/MONDO_0003833.html">MONDO:0003833</a> (severe combined immunodeficiency (disease)) [4][55.80%]</li>
<li><a href="html/MONDO_0003847.html">MONDO:0003847</a> (genetic disease) [2273][77.33%]</li>
<li><a href="html/MONDO_0003900.html">MONDO:0003900</a> (connective tissue disease) [341][61.71%]</li>
<li><a href="html/MONDO_0003914.html">MONDO:0003914</a> (purine-pyrimidine metabolic disorder) [3][66.67%]</li>
<li><a href="html/MONDO_0003916.html">MONDO:0003916</a> (overnutrition) [15][52.85%]</li>
<li><a href="html/MONDO_0003917.html">MONDO:0003917</a> (heart lymphoma) [1][100.00%]</li>
<li><a href="html/MONDO_0003939.html">MONDO:0003939</a> (muscle tissue disease) [90][58.62%]</li>
<li><a href="html/MONDO_0003996.html">MONDO:0003996</a> (basal ganglia disease) [9][62.11%]</li>
<li><a href="html/MONDO_0004018.html">MONDO:0004018</a> (liver carcinoma) [3][70.00%]</li>
<li><a href="html/MONDO_0004038.html">MONDO:0004038</a> (dental enamel hypoplasia) [4][77.57%]</li>
<li><a href="html/MONDO_0004068.html">MONDO:0004068</a> (disease of anatomical entity) [2855][77.36%]</li>
<li><a href="html/MONDO_0004069.html">MONDO:0004069</a> (mitochondrial metabolism disease) [13][55.77%]</li>
<li><a href="html/MONDO_0004095.html">MONDO:0004095</a> (b-cell lymphoma) [8][41.36%]</li>
<li><a href="html/MONDO_0004139.html">MONDO:0004139</a> (normocytic anemia) [42][57.95%]</li>
<li><a href="html/MONDO_0004180.html">MONDO:0004180</a> (urinary system benign neoplasm) [4][17.72%]</li>
<li><a href="html/MONDO_0004298.html">MONDO:0004298</a> (stomach disease) [7][41.12%]</li>
<li><a href="html/MONDO_0004335.html">MONDO:0004335</a> (gastrointestinal system disease) [153][41.46%]</li>
<li><a href="html/MONDO_0004338.html">MONDO:0004338</a> (retinal cell cancer) [1][85.36%]</li>
<li><a href="html/MONDO_0004425.html">MONDO:0004425</a> (hyperthyroidism) [5][65.36%]</li>
<li><a href="html/MONDO_0004580.html">MONDO:0004580</a> (retinal degeneration) [9][65.22%]</li>
<li><a href="html/MONDO_0004588.html">MONDO:0004588</a> (night blindness) [1][86.63%]</li>
<li><a href="html/MONDO_0004589.html">MONDO:0004589</a> (hereditary retinal dystrophy) [1][66.67%]</li>
<li><a href="html/MONDO_0004590.html">MONDO:0004590</a> (fundus dystrophy) [2][45.53%]</li>
<li><a href="html/MONDO_0004596.html">MONDO:0004596</a> (cor pulmonale) [2][75.00%]</li>
<li><a href="html/MONDO_0004600.html">MONDO:0004600</a> (monocytic leukemia) [1][75.00%]</li>
<li><a href="html/MONDO_0004603.html">MONDO:0004603</a> (collagen disease) [11][66.67%]</li>
<li><a href="html/MONDO_0004634.html">MONDO:0004634</a> (vein disease) [1][64.43%]</li>
<li><a href="html/MONDO_0004643.html">MONDO:0004643</a> (myeloid leukemia) [3][52.05%]</li>
<li><a href="html/MONDO_0004664.html">MONDO:0004664</a> (parasitic helminthiasis infectious disease) [2][21.04%]</li>
<li><a href="html/MONDO_0004670.html">MONDO:0004670</a> (lupus erythematosus) [4][15.08%]</li>
<li><a href="html/MONDO_0004674.html">MONDO:0004674</a> (chorioretinitis (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0004676.html">MONDO:0004676</a> (progressive myoclonus epilepsy) [1][62.50%]</li>
<li><a href="html/MONDO_0004681.html">MONDO:0004681</a> (learning disability) [1][71.43%]</li>
<li><a href="html/MONDO_0004688.html">MONDO:0004688</a> (sideroblastic anemia) [3][41.67%]</li>
<li><a href="html/MONDO_0004689.html">MONDO:0004689</a> (metal metabolism disorder) [13][44.06%]</li>
<li><a href="html/MONDO_0004711.html">MONDO:0004711</a> (amyloidosis (disease)) [6][65.00%]</li>
<li><a href="html/MONDO_0004730.html">MONDO:0004730</a> (speech disorder) [1][22.93%]</li>
<li><a href="html/MONDO_0004736.html">MONDO:0004736</a> (amino acid metabolic disorder) [35][53.06%]</li>
<li><a href="html/MONDO_0004737.html">MONDO:0004737</a> (homocystinuria (disease)) [2][70.00%]</li>
<li><a href="html/MONDO_0004738.html">MONDO:0004738</a> (histidine metabolism disease) [1][75.00%]</li>
<li><a href="html/MONDO_0004739.html">MONDO:0004739</a> (urea cycle disorder) [5][62.50%]</li>
<li><a href="html/MONDO_0004748.html">MONDO:0004748</a> (lip disease) [4][64.29%]</li>
<li><a href="html/MONDO_0004750.html">MONDO:0004750</a> (language disorder) [1][80.00%]</li>
<li><a href="html/MONDO_0004782.html">MONDO:0004782</a> (diabetes insipidus) [1][75.00%]</li>
<li><a href="html/MONDO_0004789.html">MONDO:0004789</a> (cholangitis) [3][70.00%]</li>
<li><a href="html/MONDO_0004796.html">MONDO:0004796</a> (meningitis (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0004805.html">MONDO:0004805</a> (leukocyte disease) [18][55.08%]</li>
<li><a href="html/MONDO_0004814.html">MONDO:0004814</a> (vascular skin disease) [5][67.36%]</li>
<li><a href="html/MONDO_0004822.html">MONDO:0004822</a> (bronchiectasis) [1][87.50%]</li>
<li><a href="html/MONDO_0004843.html">MONDO:0004843</a> (pathologic nystagmus) [1][60.16%]</li>
<li><a href="html/MONDO_0004860.html">MONDO:0004860</a> (vitreous disease) [1][66.67%]</li>
<li><a href="html/MONDO_0004867.html">MONDO:0004867</a> (upper respiratory tract disease) [3][22.85%]</li>
<li><a href="html/MONDO_0004868.html">MONDO:0004868</a> (biliary tract disease) [15][50.36%]</li>
<li><a href="html/MONDO_0004883.html">MONDO:0004883</a> (hereditary choroidal atrophy) [1][65.81%]</li>
<li><a href="html/MONDO_0004884.html">MONDO:0004884</a> (eye degenerative disease) [62][52.68%]</li>
<li><a href="html/MONDO_0004885.html">MONDO:0004885</a> (choroidal sclerosis) [2][62.50%]</li>
<li><a href="html/MONDO_0004891.html">MONDO:0004891</a> (hyperopia) [1][70.00%]</li>
<li><a href="html/MONDO_0004892.html">MONDO:0004892</a> (refractive error) [2][66.67%]</li>
<li><a href="html/MONDO_0004900.html">MONDO:0004900</a> (peripheral vertigo) [2][62.50%]</li>
<li><a href="html/MONDO_0004907.html">MONDO:0004907</a> (alopecia) [6][69.37%]</li>
<li><a href="html/MONDO_0004908.html">MONDO:0004908</a> (galactosemia) [1][83.33%]</li>
<li><a href="html/MONDO_0004910.html">MONDO:0004910</a> (mitral valve prolapse (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0004933.html">MONDO:0004933</a> (hypoplastic left heart syndrome) [1][83.33%]</li>
<li><a href="html/MONDO_0004949.html">MONDO:0004949</a> (neoplasm of mature b-cells) [6][37.47%]</li>
<li><a href="html/MONDO_0004950.html">MONDO:0004950</a> (gastric carcinoma) [3][62.50%]</li>
<li><a href="html/MONDO_0004952.html">MONDO:0004952</a> (Hodgkins lymphoma) [1][62.50%]</li>
<li><a href="html/MONDO_0004959.html">MONDO:0004959</a> (plasma cell neoplasm) [3][70.00%]</li>
<li><a href="html/MONDO_0004967.html">MONDO:0004967</a> (acute lymphoblastic leukemia (disease)) [3][34.32%]</li>
<li><a href="html/MONDO_0004970.html">MONDO:0004970</a> (adenocarcinoma) [12][36.84%]</li>
<li><a href="html/MONDO_0004972.html">MONDO:0004972</a> (adenoma) [7][65.38%]</li>
<li><a href="html/MONDO_0004975.html">MONDO:0004975</a> (Alzheimers disease) [2][68.75%]</li>
<li><a href="html/MONDO_0004976.html">MONDO:0004976</a> (amyotrophic lateral sclerosis) [5][75.85%]</li>
<li><a href="html/MONDO_0004978.html">MONDO:0004978</a> (aortic stenosis) [1][66.67%]</li>
<li><a href="html/MONDO_0004982.html">MONDO:0004982</a> (pancreatitis) [1][100.00%]</li>
<li><a href="html/MONDO_0004983.html">MONDO:0004983</a> (azoospermia) [1][75.00%]</li>
<li><a href="html/MONDO_0004987.html">MONDO:0004987</a> (bladder tumor) [2][100.00%]</li>
<li><a href="html/MONDO_0004992.html">MONDO:0004992</a> (cancer) [235][48.10%]</li>
<li><a href="html/MONDO_0004993.html">MONDO:0004993</a> (carcinoma) [50][41.66%]</li>
<li><a href="html/MONDO_0004994.html">MONDO:0004994</a> (cardiomyopathy) [70][57.71%]</li>
<li><a href="html/MONDO_0004995.html">MONDO:0004995</a> (cardiovascular disease) [236][51.85%]</li>
<li><a href="html/MONDO_0005002.html">MONDO:0005002</a> (chronic obstructive pulmonary disease) [1][100.00%]</li>
<li><a href="html/MONDO_0005009.html">MONDO:0005009</a> (congestive heart failure) [2][75.00%]</li>
<li><a href="html/MONDO_0005012.html">MONDO:0005012</a> (cutaneous melanoma (disease)) [2][56.94%]</li>
<li><a href="html/MONDO_0005015.html">MONDO:0005015</a> (diabetes mellitus (disease)) [20][56.96%]</li>
<li><a href="html/MONDO_0005020.html">MONDO:0005020</a> (digestive system disease) [91][38.32%]</li>
<li><a href="html/MONDO_0005021.html">MONDO:0005021</a> (dilated cardiomyopathy) [24][31.29%]</li>
<li><a href="html/MONDO_0005024.html">MONDO:0005024</a> (emphysema) [1][100.00%]</li>
<li><a href="html/MONDO_0005027.html">MONDO:0005027</a> (epilepsy) [182][58.10%]</li>
<li><a href="html/MONDO_0005029.html">MONDO:0005029</a> (essential thrombocythemia) [4][75.38%]</li>
<li><a href="html/MONDO_0005039.html">MONDO:0005039</a> (reproductive system disease) [121][45.56%]</li>
<li><a href="html/MONDO_0005040.html">MONDO:0005040</a> (germ cell tumor) [5][17.81%]</li>
<li><a href="html/MONDO_0005041.html">MONDO:0005041</a> (glaucoma (disease)) [4][55.51%]</li>
<li><a href="html/MONDO_0005042.html">MONDO:0005042</a> (head disease) [6][38.04%]</li>
<li><a href="html/MONDO_0005043.html">MONDO:0005043</a> (hyperplasia) [1][100.00%]</li>
<li><a href="html/MONDO_0005044.html">MONDO:0005044</a> (hypertension) [20][54.40%]</li>
<li><a href="html/MONDO_0005045.html">MONDO:0005045</a> (hypertrophic cardiomyopathy) [26][44.09%]</li>
<li><a href="html/MONDO_0005046.html">MONDO:0005046</a> (immune system disease) [257][50.44%]</li>
<li><a href="html/MONDO_0005047.html">MONDO:0005047</a> (infertility) [87][51.68%]</li>
<li><a href="html/MONDO_0005058.html">MONDO:0005058</a> (leiomyosarcoma) [1][66.67%]</li>
<li><a href="html/MONDO_0005059.html">MONDO:0005059</a> (leukemia (disease)) [9][55.80%]</li>
<li><a href="html/MONDO_0005060.html">MONDO:0005060</a> (liposarcoma) [2][66.67%]</li>
<li><a href="html/MONDO_0005062.html">MONDO:0005062</a> (lymphoma) [32][43.47%]</li>
<li><a href="html/MONDO_0005065.html">MONDO:0005065</a> (mesothelioma) [1][75.00%]</li>
<li><a href="html/MONDO_0005066.html">MONDO:0005066</a> (metabolic disease) [441][52.74%]</li>
<li><a href="html/MONDO_0005070.html">MONDO:0005070</a> (neoplasm (disease)) [270][50.01%]</li>
<li><a href="html/MONDO_0005071.html">MONDO:0005071</a> (nervous system disease) [1284][65.37%]</li>
<li><a href="html/MONDO_0005072.html">MONDO:0005072</a> (neuroblastoma) [1][85.36%]</li>
<li><a href="html/MONDO_0005073.html">MONDO:0005073</a> (nevus) [7][63.16%]</li>
<li><a href="html/MONDO_0005075.html">MONDO:0005075</a> (papillary thyroid carcinoma (disease)) [3][64.53%]</li>
<li><a href="html/MONDO_0005076.html">MONDO:0005076</a> (periodontitis) [2][66.67%]</li>
<li><a href="html/MONDO_0005083.html">MONDO:0005083</a> (psoriasis) [2][62.50%]</li>
<li><a href="html/MONDO_0005084.html">MONDO:0005084</a> (mental or behavioural disorder) [161][58.46%]</li>
<li><a href="html/MONDO_0005086.html">MONDO:0005086</a> (renal cell carcinoma (disease)) [3][43.39%]</li>
<li><a href="html/MONDO_0005087.html">MONDO:0005087</a> (respiratory system disease) [122][36.30%]</li>
<li><a href="html/MONDO_0005089.html">MONDO:0005089</a> (sarcoma) [15][48.75%]</li>
<li><a href="html/MONDO_0005093.html">MONDO:0005093</a> (skin disease) [330][62.55%]</li>
<li><a href="html/MONDO_0005096.html">MONDO:0005096</a> (squamous cell carcinoma) [3][55.36%]</li>
<li><a href="html/MONDO_0005098.html">MONDO:0005098</a> (stroke) [5][63.64%]</li>
<li><a href="html/MONDO_0005100.html">MONDO:0005100</a> (systemic scleroderma) [1][83.33%]</li>
<li><a href="html/MONDO_0005105.html">MONDO:0005105</a> (melanoma (disease)) [4][56.96%]</li>
<li><a href="html/MONDO_0005108.html">MONDO:0005108</a> (viral disease) [11][20.60%]</li>
<li><a href="html/MONDO_0005113.html">MONDO:0005113</a> (bacterial disease) [8][21.85%]</li>
<li><a href="html/MONDO_0005115.html">MONDO:0005115</a> (temporal lobe epilepsy) [4][68.18%]</li>
<li><a href="html/MONDO_0005128.html">MONDO:0005128</a> (sensory system disease) [475][61.49%]</li>
<li><a href="html/MONDO_0005129.html">MONDO:0005129</a> (cataract (disease)) [47][58.17%]</li>
<li><a href="html/MONDO_0005135.html">MONDO:0005135</a> (parasitic infection) [7][16.44%]</li>
<li><a href="html/MONDO_0005137.html">MONDO:0005137</a> (nutritional disorder) [16][46.79%]</li>
<li><a href="html/MONDO_0005138.html">MONDO:0005138</a> (lung carcinoma) [3][66.67%]</li>
<li><a href="html/MONDO_0005147.html">MONDO:0005147</a> (type i diabetes mellitus) [2][70.00%]</li>
<li><a href="html/MONDO_0005149.html">MONDO:0005149</a> (pulmonary hypertension) [7][62.50%]</li>
<li><a href="html/MONDO_0005150.html">MONDO:0005150</a> (age-related macular degeneration) [2][66.67%]</li>
<li><a href="html/MONDO_0005151.html">MONDO:0005151</a> (endocrine system disease) [364][58.46%]</li>
<li><a href="html/MONDO_0005152.html">MONDO:0005152</a> (hypopituitarism) [4][66.78%]</li>
<li><a href="html/MONDO_0005154.html">MONDO:0005154</a> (liver disease) [53][48.19%]</li>
<li><a href="html/MONDO_0005155.html">MONDO:0005155</a> (cirrhosis of liver) [2][30.90%]</li>
<li><a href="html/MONDO_0005157.html">MONDO:0005157</a> (lymphoid neoplasm) [51][53.03%]</li>
<li><a href="html/MONDO_0005160.html">MONDO:0005160</a> (aortic aneurysm (disease)) [4][63.13%]</li>
<li><a href="html/MONDO_0005165.html">MONDO:0005165</a> (benign neoplasm) [36][35.15%]</li>
<li><a href="html/MONDO_0005167.html">MONDO:0005167</a> (fibroma) [1][100.00%]</li>
<li><a href="html/MONDO_0005168.html">MONDO:0005168</a> (neoplasm of immature b and T cells) [4][66.67%]</li>
<li><a href="html/MONDO_0005170.html">MONDO:0005170</a> (myeloid neoplasm) [19][46.69%]</li>
<li><a href="html/MONDO_0005171.html">MONDO:0005171</a> (chronic myeloproliferative disorder) [7][58.30%]</li>
<li><a href="html/MONDO_0005172.html">MONDO:0005172</a> (skeletal system disease) [463][59.87%]</li>
<li><a href="html/MONDO_0005180.html">MONDO:0005180</a> (Parkinson's disease) [5][60.06%]</li>
<li><a href="html/MONDO_0005181.html">MONDO:0005181</a> (progressive external ophthalmoplegia) [2][83.33%]</li>
<li><a href="html/MONDO_0005185.html">MONDO:0005185</a> (chronic childhood arthritis) [4][66.67%]</li>
<li><a href="html/MONDO_0005197.html">MONDO:0005197</a> (thymus neoplasm) [2][83.33%]</li>
<li><a href="html/MONDO_0005201.html">MONDO:0005201</a> (restrictive cardiomyopathy) [14][35.26%]</li>
<li><a href="html/MONDO_0005206.html">MONDO:0005206</a> (renal carcinoma) [4][41.01%]</li>
<li><a href="html/MONDO_0005212.html">MONDO:0005212</a> (rhabdomyosarcoma (disease)) [2][70.00%]</li>
<li><a href="html/MONDO_0005218.html">MONDO:0005218</a> (muscular disease) [91][58.30%]</li>
<li><a href="html/MONDO_0005233.html">MONDO:0005233</a> (non-small cell lung carcinoma (disease)) [1][100.00%]</li>
<li><a href="html/MONDO_0005240.html">MONDO:0005240</a> (kidney disease) [32][46.34%]</li>
<li><a href="html/MONDO_0005244.html">MONDO:0005244</a> (peripheral neuropathy) [131][43.84%]</li>
<li><a href="html/MONDO_0005249.html">MONDO:0005249</a> (pneumonia) [8][51.97%]</li>
<li><a href="html/MONDO_0005252.html">MONDO:0005252</a> (heart failure) [2][75.00%]</li>
<li><a href="html/MONDO_0005258.html">MONDO:0005258</a> (autism spectrum disorder) [8][63.10%]</li>
<li><a href="html/MONDO_0005265.html">MONDO:0005265</a> (inflammatory bowel disease) [8][63.16%]</li>
<li><a href="html/MONDO_0005267.html">MONDO:0005267</a> (heart disease) [118][58.42%]</li>
<li><a href="html/MONDO_0005271.html">MONDO:0005271</a> (allergic disease) [13][40.36%]</li>
<li><a href="html/MONDO_0005275.html">MONDO:0005275</a> (lung disease) [73][30.92%]</li>
<li><a href="html/MONDO_0005277.html">MONDO:0005277</a> (migraine disorder) [4][76.89%]</li>
<li><a href="html/MONDO_0005282.html">MONDO:0005282</a> (cutaneous lupus erythematosus) [3][45.00%]</li>
<li><a href="html/MONDO_0005283.html">MONDO:0005283</a> (retinopathy) [19][51.78%]</li>
<li><a href="html/MONDO_0005292.html">MONDO:0005292</a> (colitis (disease)) [2][75.00%]</li>
<li><a href="html/MONDO_0005296.html">MONDO:0005296</a> (sleep apnea (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0005308.html">MONDO:0005308</a> (ciliopathy) [5][57.01%]</li>
<li><a href="html/MONDO_0005328.html">MONDO:0005328</a> (eye disease) [457][63.13%]</li>
<li><a href="html/MONDO_0005332.html">MONDO:0005332</a> (growth hormone-secreting pituitary adenoma) [3][71.43%]</li>
<li><a href="html/MONDO_0005335.html">MONDO:0005335</a> (colorectal neoplasm) [2][38.61%]</li>
<li><a href="html/MONDO_0005336.html">MONDO:0005336</a> (myopathy) [77][61.06%]</li>
<li><a href="html/MONDO_0005338.html">MONDO:0005338</a> (open-angle glaucoma) [1][33.00%]</li>
<li><a href="html/MONDO_0005340.html">MONDO:0005340</a> (alopecia areata) [3][66.67%]</li>
<li><a href="html/MONDO_0005357.html">MONDO:0005357</a> (Creutzfeldt Jacob disease) [1][83.33%]</li>
<li><a href="html/MONDO_0005364.html">MONDO:0005364</a> (Graves disease) [1][100.00%]</li>
<li><a href="html/MONDO_0005372.html">MONDO:0005372</a> (male infertility) [61][51.60%]</li>
<li><a href="html/MONDO_0005374.html">MONDO:0005374</a> (myeloproliferative disorder) [19][46.69%]</li>
<li><a href="html/MONDO_0005377.html">MONDO:0005377</a> (nephrotic syndrome) [3][41.37%]</li>
<li><a href="html/MONDO_0005380.html">MONDO:0005380</a> (osteonecrosis) [8][66.67%]</li>
<li><a href="html/MONDO_0005381.html">MONDO:0005381</a> (bone disease) [319][61.92%]</li>
<li><a href="html/MONDO_0005384.html">MONDO:0005384</a> (partial epilepsy) [6][56.96%]</li>
<li><a href="html/MONDO_0005385.html">MONDO:0005385</a> (vascular disease) [65][36.93%]</li>
<li><a href="html/MONDO_0005395.html">MONDO:0005395</a> (movement disorder) [87][43.67%]</li>
<li><a href="html/MONDO_0005396.html">MONDO:0005396</a> (thoracic aortic aneurysm) [1][69.37%]</li>
<li><a href="html/MONDO_0005397.html">MONDO:0005397</a> (goiter (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0005420.html">MONDO:0005420</a> (hypothyroidism) [20][64.71%]</li>
<li><a href="html/MONDO_0005429.html">MONDO:0005429</a> (prion disease) [3][70.00%]</li>
<li><a href="html/MONDO_0005439.html">MONDO:0005439</a> (familial hypercholesterolemia) [2][77.80%]</li>
<li><a href="html/MONDO_0005451.html">MONDO:0005451</a> (eating disorder) [1][75.00%]</li>
<li><a href="html/MONDO_0005453.html">MONDO:0005453</a> (congenital heart disease) [10][59.66%]</li>
<li><a href="html/MONDO_0005472.html">MONDO:0005472</a> (congenital heart malformation) [2][83.33%]</li>
<li><a href="html/MONDO_0005475.html">MONDO:0005475</a> (migraine with aura) [3][87.31%]</li>
<li><a href="html/MONDO_0005485.html">MONDO:0005485</a> (psychosis (disease)) [1][100.00%]</li>
<li><a href="html/MONDO_0005492.html">MONDO:0005492</a> (urticaria) [4][90.00%]</li>
<li><a href="html/MONDO_0005495.html">MONDO:0005495</a> (adrenal gland disease) [17][60.29%]</li>
<li><a href="html/MONDO_0005496.html">MONDO:0005496</a> (bile duct carcinoma) [2][66.67%]</li>
<li><a href="html/MONDO_0005497.html">MONDO:0005497</a> (bone development disease) [163][57.95%]</li>
<li><a href="html/MONDO_0005498.html">MONDO:0005498</a> (botulism) [2][100.00%]</li>
<li><a href="html/MONDO_0005499.html">MONDO:0005499</a> (brain glioma) [2][75.00%]</li>
<li><a href="html/MONDO_0005500.html">MONDO:0005500</a> (congenital disorder of glycosylation type I) [1][66.67%]</li>
<li><a href="html/MONDO_0005503.html">MONDO:0005503</a> (developmental disorder of mental health) [153][59.15%]</li>
<li><a href="html/MONDO_0005514.html">MONDO:0005514</a> (microphthalmia (disease)) [7][49.59%]</li>
<li><a href="html/MONDO_0005515.html">MONDO:0005515</a> (oral cavity cancer) [3][66.67%]</li>
<li><a href="html/MONDO_0005516.html">MONDO:0005516</a> (osteochondrodysplasia) [33][55.78%]</li>
<li><a href="html/MONDO_0005517.html">MONDO:0005517</a> (pharynx cancer) [1][62.50%]</li>
<li><a href="html/MONDO_0005520.html">MONDO:0005520</a> (rickets (disease)) [3][69.06%]</li>
<li><a href="html/MONDO_0005523.html">MONDO:0005523</a> (steroid inherited metabolic disorder) [7][78.12%]</li>
<li><a href="html/MONDO_0005528.html">MONDO:0005528</a> (vitamin metabolic disorder) [1][66.67%]</li>
<li><a href="html/MONDO_0005550.html">MONDO:0005550</a> (infectious disease) [58][24.82%]</li>
<li><a href="html/MONDO_0005554.html">MONDO:0005554</a> (rheumatic disease) [11][26.58%]</li>
<li><a href="html/MONDO_0005557.html">MONDO:0005557</a> (calcium metabolic disease) [5][64.29%]</li>
<li><a href="html/MONDO_0005558.html">MONDO:0005558</a> (ovarian disease) [2][69.10%]</li>
<li><a href="html/MONDO_0005559.html">MONDO:0005559</a> (neurodegenerative disease) [151][51.05%]</li>
<li><a href="html/MONDO_0005560.html">MONDO:0005560</a> (brain disease) [400][60.73%]</li>
<li><a href="html/MONDO_0005561.html">MONDO:0005561</a> (aortic disease) [5][63.13%]</li>
<li><a href="html/MONDO_0005564.html">MONDO:0005564</a> (embryonal neoplasm) [6][37.59%]</li>
<li><a href="html/MONDO_0005565.html">MONDO:0005565</a> (blastoma) [2][75.00%]</li>
<li><a href="html/MONDO_0005570.html">MONDO:0005570</a> (hematological system disease) [211][57.06%]</li>
<li><a href="html/MONDO_0005571.html">MONDO:0005571</a> (polycythemia) [4][66.67%]</li>
<li><a href="html/MONDO_0005574.html">MONDO:0005574</a> (tauopathy) [3][70.00%]</li>
<li><a href="html/MONDO_0005575.html">MONDO:0005575</a> (colorectal cancer) [1][100.00%]</li>
<li><a href="html/MONDO_0005578.html">MONDO:0005578</a> (arthritis) [8][56.15%]</li>
<li><a href="html/MONDO_0005579.html">MONDO:0005579</a> (generalised epilepsy) [6][62.50%]</li>
<li><a href="html/MONDO_0005584.html">MONDO:0005584</a> (congenital left-sided heart lesions) [1][83.33%]</li>
<li><a href="html/MONDO_0005586.html">MONDO:0005586</a> (head and neck neoplasia) [1][42.68%]</li>
<li><a href="html/MONDO_0005587.html">MONDO:0005587</a> (non-Hodgkins lymphoma) [8][41.36%]</li>
<li><a href="html/MONDO_0005593.html">MONDO:0005593</a> (chronic periodontitis) [1][75.00%]</li>
<li><a href="html/MONDO_0005618.html">MONDO:0005618</a> (anxiety disorder) [3][21.71%]</li>
<li><a href="html/MONDO_0005620.html">MONDO:0005620</a> (cerebral amyloid angiopathy) [1][76.89%]</li>
<li><a href="html/MONDO_0005623.html">MONDO:0005623</a> (autoimmune thyroid disease) [3][57.49%]</li>
<li><a href="html/MONDO_0005627.html">MONDO:0005627</a> (head and neck malignant neoplasia) [1][42.68%]</li>
<li><a href="html/MONDO_0005728.html">MONDO:0005728</a> (diaphragm disease) [1][84.72%]</li>
<li><a href="html/MONDO_0005803.html">MONDO:0005803</a> (hyperinsulinemic hypoglycemia (disease)) [2][75.00%]</li>
<li><a href="html/MONDO_0005814.html">MONDO:0005814</a> (intestinal cancer) [5][47.86%]</li>
<li><a href="html/MONDO_0005833.html">MONDO:0005833</a> (lymphatic system disease) [22][39.85%]</li>
<li><a href="html/MONDO_0005864.html">MONDO:0005864</a> (muscle cancer) [5][58.30%]</li>
<li><a href="html/MONDO_0005872.html">MONDO:0005872</a> (nervous system cancer) [60][33.06%]</li>
<li><a href="html/MONDO_0005910.html">MONDO:0005910</a> (phagocyte bactericidal dysfunction) [1][81.25%]</li>
<li><a href="html/MONDO_0005933.html">MONDO:0005933</a> (pulmonary blastoma) [1][66.67%]</li>
<li><a href="html/MONDO_0006007.html">MONDO:0006007</a> (vesicoureteral reflux (disease)) [2][47.29%]</li>
<li><a href="html/MONDO_0006025.html">MONDO:0006025</a> (autosomal recessive disease) [84][54.86%]</li>
<li><a href="html/MONDO_0006026.html">MONDO:0006026</a> (bladder disease) [6][50.74%]</li>
<li><a href="html/MONDO_0006130.html">MONDO:0006130</a> (central nervous system neoplasm) [17][53.08%]</li>
<li><a href="html/MONDO_0006311.html">MONDO:0006311</a> (myelodysplastic/myeloproliferative neoplasm) [2][66.67%]</li>
<li><a href="html/MONDO_0006325.html">MONDO:0006325</a> (ocular melanoma) [2][64.29%]</li>
<li><a href="html/MONDO_0006373.html">MONDO:0006373</a> (pituitary gland adenoma) [3][71.43%]</li>
<li><a href="html/MONDO_0006496.html">MONDO:0006496</a> (palsy) [1][75.00%]</li>
<li><a href="html/MONDO_0006497.html">MONDO:0006497</a> (cerebral palsy) [1][75.00%]</li>
<li><a href="html/MONDO_0006500.html">MONDO:0006500</a> (hemangioma) [6][63.64%]</li>
<li><a href="html/MONDO_0006501.html">MONDO:0006501</a> (inflammatory skin disease) [4][25.14%]</li>
<li><a href="html/MONDO_0006503.html">MONDO:0006503</a> (Isaacs syndrome) [2][75.00%]</li>
<li><a href="html/MONDO_0006504.html">MONDO:0006504</a> (acquired metabolic disease) [49][47.83%]</li>
<li><a href="html/MONDO_0006506.html">MONDO:0006506</a> (congenital nonspherocytic hemolytic anemia) [1][75.00%]</li>
<li><a href="html/MONDO_0006507.html">MONDO:0006507</a> (hemochromatosis) [2][70.00%]</li>
<li><a href="html/MONDO_0006508.html">MONDO:0006508</a> (infantile epileptic encephalopathy) [1][62.50%]</li>
<li><a href="html/MONDO_0006510.html">MONDO:0006510</a> (renal tubular transport disease) [10][58.82%]</li>
<li><a href="html/MONDO_0006529.html">MONDO:0006529</a> (bullous skin disease) [1][75.00%]</li>
<li><a href="html/MONDO_0006541.html">MONDO:0006541</a> (epidermolysis bullosa) [6][63.50%]</li>
<li><a href="html/MONDO_0006543.html">MONDO:0006543</a> (epidermolysis bullosa dystrophica) [1][100.00%]</li>
<li><a href="html/MONDO_0006552.html">MONDO:0006552</a> (folliculitis) [1][75.00%]</li>
<li><a href="html/MONDO_0006566.html">MONDO:0006566</a> (keratosis) [34][58.39%]</li>
<li><a href="html/MONDO_0006573.html">MONDO:0006573</a> (lipodystrophy (disease)) [4][76.83%]</li>
<li><a href="html/MONDO_0006574.html">MONDO:0006574</a> (lipomatosis) [1][75.00%]</li>
<li><a href="html/MONDO_0006590.html">MONDO:0006590</a> (palmoplantar keratosis) [28][63.90%]</li>
<li><a href="html/MONDO_0006594.html">MONDO:0006594</a> (pemphigus) [1][75.00%]</li>
<li><a href="html/MONDO_0006600.html">MONDO:0006600</a> (pigmentation disease) [4][47.86%]</li>
<li><a href="html/MONDO_0006602.html">MONDO:0006602</a> (porokeratosis (disease)) [2][85.00%]</li>
<li><a href="html/MONDO_0006615.html">MONDO:0006615</a> (sweat gland disease) [2][75.00%]</li>
<li><a href="html/MONDO_0006617.html">MONDO:0006617</a> (vesiculobullous skin disease) [6][63.50%]</li>
<li><a href="html/MONDO_0006639.html">MONDO:0006639</a> (adrenal cortex carcinoma) [2][70.00%]</li>
<li><a href="html/MONDO_0006640.html">MONDO:0006640</a> (adrenal gland hyperfunction) [13][62.50%]</li>
<li><a href="html/MONDO_0006693.html">MONDO:0006693</a> (cerebral arterial disease) [2][65.00%]</li>
<li><a href="html/MONDO_0006744.html">MONDO:0006744</a> (endolymphatic hydrops) [1][60.36%]</li>
<li><a href="html/MONDO_0006788.html">MONDO:0006788</a> (hydrophthalmos) [2][34.62%]</li>
<li><a href="html/MONDO_0006793.html">MONDO:0006793</a> (hyperpituitarism) [1][83.33%]</li>
<li><a href="html/MONDO_0006808.html">MONDO:0006808</a> (intracranial arterial disease) [2][65.00%]</li>
<li><a href="html/MONDO_0006816.html">MONDO:0006816</a> (joint disease) [1][100.00%]</li>
<li><a href="html/MONDO_0006834.html">MONDO:0006834</a> (lip cancer) [3][66.67%]</li>
<li><a href="html/MONDO_0006858.html">MONDO:0006858</a> (mouth disease) [18][50.69%]</li>
<li><a href="html/MONDO_0006949.html">MONDO:0006949</a> (retinal drusen) [1][66.67%]</li>
<li><a href="html/MONDO_0006999.html">MONDO:0006999</a> (tooth disease) [13][58.79%]</li>
<li><a href="html/MONDO_0007052.html">MONDO:0007052</a> (growth hormone secreting pituitary adenoma) [2][70.00%]</li>
<li><a href="html/MONDO_0007082.html">MONDO:0007082</a> (alopecia areata 1) [2][66.67%]</li>
<li><a href="html/MONDO_0007088.html">MONDO:0007088</a> (Alzheimer disease type 1) [1][68.75%]</li>
<li><a href="html/MONDO_0007108.html">MONDO:0007108</a> (anal canal carcinoma) [1][100.00%]</li>
<li><a href="html/MONDO_0007160.html">MONDO:0007160</a> (Stickler syndrome type 1) [1][62.50%]</li>
<li><a href="html/MONDO_0007179.html">MONDO:0007179</a> (hypersensitivity reaction type II disease) [41][33.62%]</li>
<li><a href="html/MONDO_0007254.html">MONDO:0007254</a> (breast cancer) [3][58.30%]</li>
<li><a href="html/MONDO_0007256.html">MONDO:0007256</a> (hepatocellular carcinoma) [1][75.00%]</li>
<li><a href="html/MONDO_0007263.html">MONDO:0007263</a> (cardiac rhythm disease) [18][62.71%]</li>
<li><a href="html/MONDO_0007264.html">MONDO:0007264</a> (sudden cardiac arrest) [1][66.67%]</li>
<li><a href="html/MONDO_0007294.html">MONDO:0007294</a> (central core myopathy) [2][64.29%]</li>
<li><a href="html/MONDO_0007481.html">MONDO:0007481</a> (Leri-Weill dyschondrosteosis) [1][75.00%]</li>
<li><a href="html/MONDO_0007571.html">MONDO:0007571</a> (primary erythermalgia) [1][66.67%]</li>
<li><a href="html/MONDO_0007576.html">MONDO:0007576</a> (esophageal cancer) [1][75.00%]</li>
<li><a href="html/MONDO_0007667.html">MONDO:0007667</a> (Subependymoma) [2][70.00%]</li>
<li><a href="html/MONDO_0007750.html">MONDO:0007750</a> (hypercholesterolemia, familial) [1][75.00%]</li>
<li><a href="html/MONDO_0007803.html">MONDO:0007803</a> (multiple system atrophy) [2][43.57%]</li>
<li><a href="html/MONDO_0007827.html">MONDO:0007827</a> (inclusion body myositis) [2][70.00%]</li>
<li><a href="html/MONDO_0007864.html">MONDO:0007864</a> (Klippel-Trenaunay syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0007950.html">MONDO:0007950</a> (mastocytosis) [7][62.50%]</li>
<li><a href="html/MONDO_0007963.html">MONDO:0007963</a> (CMM1) [1][58.30%]</li>
<li><a href="html/MONDO_0008054.html">MONDO:0008054</a> (myositis) [3][64.29%]</li>
<li><a href="html/MONDO_0008170.html">MONDO:0008170</a> (ovarian cancer) [9][53.18%]</li>
<li><a href="html/MONDO_0008266.html">MONDO:0008266</a> (polydactyly, postaxial, type A1) [1][75.00%]</li>
<li><a href="html/MONDO_0008345.html">MONDO:0008345</a> (idiopathic pulmonary fibrosis) [7][62.50%]</li>
<li><a href="html/MONDO_0008360.html">MONDO:0008360</a> (radioulnar synostosis (disease)) [1][75.00%]</li>
<li><a href="html/MONDO_0008383.html">MONDO:0008383</a> (rheumatoid arthritis) [4][66.67%]</li>
<li><a href="html/MONDO_0008537.html">MONDO:0008537</a> (telecanthus) [2][70.00%]</li>
<li><a href="html/MONDO_0008552.html">MONDO:0008552</a> (platelet-type bleeding disorder 16) [1][75.00%]</li>
<li><a href="html/MONDO_0008554.html">MONDO:0008554</a> (thrombocythemia 1) [1][83.71%]</li>
<li><a href="html/MONDO_0008567.html">MONDO:0008567</a> (thyroid cancer, nonmedullary, 1) [2][64.53%]</li>
<li><a href="html/MONDO_0008596.html">MONDO:0008596</a> (trichorhinophalangeal syndrome type i) [1][66.67%]</li>
<li><a href="html/MONDO_0008653.html">MONDO:0008653</a> (VUR1) [1][47.29%]</li>
<li><a href="html/MONDO_0008675.html">MONDO:0008675</a> (Freeman-Sheldon syndrome) [1][100.00%]</li>
<li><a href="html/MONDO_0008730.html">MONDO:0008730</a> (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency) [1][64.14%]</li>
<li><a href="html/MONDO_0008903.html">MONDO:0008903</a> (lung cancer) [6][64.29%]</li>
<li><a href="html/MONDO_0009010.html">MONDO:0009010</a> (double outlet right ventricle) [1][75.00%]</li>
<li><a href="html/MONDO_0009043.html">MONDO:0009043</a> (generalized resistance to thyroid hormone) [3][82.27%]</li>
<li><a href="html/MONDO_0009276.html">MONDO:0009276</a> (Bernard-Soulier syndrome) [1][100.00%]</li>
<li><a href="html/MONDO_0009277.html">MONDO:0009277</a> (buphthalmos) [1][33.00%]</li>
<li><a href="html/MONDO_0009292.html">MONDO:0009292</a> (glycogen storage disease IV) [1][75.00%]</li>
<li><a href="html/MONDO_0009299.html">MONDO:0009299</a> (46 XX gonadal dysgenesis) [1][80.00%]</li>
<li><a href="html/MONDO_0009364.html">MONDO:0009364</a> (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1) [1][100.00%]</li>
<li><a href="html/MONDO_0009441.html">MONDO:0009441</a> (autosomal recessive congenital ichthyosis 1) [2][75.00%]</li>
<li><a href="html/MONDO_0009459.html">MONDO:0009459</a> (channelopathy-associated congenital insensitivity to pain) [1][70.00%]</li>
<li><a href="html/MONDO_0009509.html">MONDO:0009509</a> (Landau-Kleffner syndrome) [1][83.33%]</li>
<li><a href="html/MONDO_0009563.html">MONDO:0009563</a> (maple syrup urine disease) [1][83.33%]</li>
<li><a href="html/MONDO_0009637.html">MONDO:0009637</a> (mitochondrial myopathy) [6][66.67%]</li>
<li><a href="html/MONDO_0009693.html">MONDO:0009693</a> (multiple myeloma) [1][100.00%]</li>
<li><a href="html/MONDO_0009696.html">MONDO:0009696</a> (juvenile myoclonic epilepsy) [4][60.35%]</li>
<li><a href="html/MONDO_0009723.html">MONDO:0009723</a> (Leigh syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0009861.html">MONDO:0009861</a> (phenylketonuria) [1][90.00%]</li>
<li><a href="html/MONDO_0009958.html">MONDO:0009958</a> (Refsum disease) [1][66.67%]</li>
<li><a href="html/MONDO_0010108.html">MONDO:0010108</a> (testicular germ cell tumor) [1][75.00%]</li>
<li><a href="html/MONDO_0010239.html">MONDO:0010239</a> (lissencephaly type 1 due to doublecortin gene mutation) [1][65.82%]</li>
<li><a href="html/MONDO_0010261.html">MONDO:0010261</a> (microphthalmia, syndromic 2) [1][66.67%]</li>
<li><a href="html/MONDO_0010401.html">MONDO:0010401</a> (X-linked myopathy with postural muscle atrophy) [1][62.50%]</li>
<li><a href="html/MONDO_0010481.html">MONDO:0010481</a> (angioedema) [4][85.71%]</li>
<li><a href="html/MONDO_0010584.html">MONDO:0010584</a> (dyskeratosis congenita, X-linked) [1][67.86%]</li>
<li><a href="html/MONDO_0010613.html">MONDO:0010613</a> (glycerol kinase deficiency) [1][100.00%]</li>
<li><a href="html/MONDO_0010622.html">MONDO:0010622</a> (X-linked ichthyosis) [1][83.33%]</li>
<li><a href="html/MONDO_0010726.html">MONDO:0010726</a> (Rett syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0010795.html">MONDO:0010795</a> (oncocytoma) [1][100.00%]</li>
<li><a href="html/MONDO_0011010.html">MONDO:0011010</a> (Matthew-wood syndrome) [1][52.37%]</li>
<li><a href="html/MONDO_0011057.html">MONDO:0011057</a> (cerebrovascular disorder) [4][64.29%]</li>
<li><a href="html/MONDO_0011060.html">MONDO:0011060</a> (early-onset non-syndromic cataract) [4][42.72%]</li>
<li><a href="html/MONDO_0011101.html">MONDO:0011101</a> (peroxisome biogenesis disorder 1B) [1][62.50%]</li>
<li><a href="html/MONDO_0011118.html">MONDO:0011118</a> (acute myeloid leukemia) [1][75.00%]</li>
<li><a href="html/MONDO_0011119.html">MONDO:0011119</a> (iridogoniodysgenesis syndrome) [7][70.67%]</li>
<li><a href="html/MONDO_0011122.html">MONDO:0011122</a> (obesity (disease)) [14][53.89%]</li>
<li><a href="html/MONDO_0011173.html">MONDO:0011173</a> (thrombocythemia 2) [1][83.71%]</li>
<li><a href="html/MONDO_0011198.html">MONDO:0011198</a> (spondyloepimetaphyseal dysplasia, Missouri type) [1][66.67%]</li>
<li><a href="html/MONDO_0011233.html">MONDO:0011233</a> (Axenfeld-Rieger syndrome type 3) [1][62.50%]</li>
<li><a href="html/MONDO_0011348.html">MONDO:0011348</a> (non-syndromic polydactyly) [14][47.12%]</li>
<li><a href="html/MONDO_0011380.html">MONDO:0011380</a> (leukoencephalopathy with vanishing white matter) [1][66.67%]</li>
<li><a href="html/MONDO_0011394.html">MONDO:0011394</a> (keratosis pilaris) [1][75.00%]</li>
<li><a href="html/MONDO_0011429.html">MONDO:0011429</a> (juvenile rheumatoid arthritis) [3][83.33%]</li>
<li><a href="html/MONDO_0011512.html">MONDO:0011512</a> (Brooke-Spiegler syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0011622.html">MONDO:0011622</a> (nephrolithiasis, Uric acid, susceptibility to) [1][75.00%]</li>
<li><a href="html/MONDO_0011643.html">MONDO:0011643</a> (permanent neonatal diabetes mellitus) [1][75.00%]</li>
<li><a href="html/MONDO_0011688.html">MONDO:0011688</a> (muscular dystrophy-dystroglycanopathy type B5) [2][78.32%]</li>
<li><a href="html/MONDO_0011830.html">MONDO:0011830</a> (lissencephaly due to LIS1 mutation) [1][65.82%]</li>
<li><a href="html/MONDO_0011842.html">MONDO:0011842</a> (Grn-related frontotemporal lobar degeneration with Tdp43 inclusions) [2][70.00%]</li>
<li><a href="html/MONDO_0011851.html">MONDO:0011851</a> (migraine with or without aura, susceptibility to, 6) [1][90.00%]</li>
<li><a href="html/MONDO_0012026.html">MONDO:0012026</a> (myotonia, potassium-aggravated) [1][66.67%]</li>
<li><a href="html/MONDO_0012163.html">MONDO:0012163</a> (severe combined immunodeficiency, autosomal recessive, T cell-negative, b cell-positive, Nk cell-positive) [1][70.00%]</li>
<li><a href="html/MONDO_0012197.html">MONDO:0012197</a> (aplastic anemia) [5][47.86%]</li>
<li><a href="html/MONDO_0012212.html">MONDO:0012212</a> (Loeys-Dietz syndrome 1) [1][69.37%]</li>
<li><a href="html/MONDO_0012400.html">MONDO:0012400</a> (cortical dysplasia-focal epilepsy syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0012413.html">MONDO:0012413</a> (syndromic microphthalmia type 5) [1][62.50%]</li>
<li><a href="html/MONDO_0012427.html">MONDO:0012427</a> (Loeys-Dietz syndrome 2) [1][69.37%]</li>
<li><a href="html/MONDO_0012580.html">MONDO:0012580</a> (hereditary pulmonary alveolar proteinosis) [1][62.50%]</li>
<li><a href="html/MONDO_0012627.html">MONDO:0012627</a> (epilepsy, idiopathic generalized, susceptibility to, 13) [1][66.67%]</li>
<li><a href="html/MONDO_0013015.html">MONDO:0013015</a> (Brugada syndrome 5) [1][66.67%]</li>
<li><a href="html/MONDO_0013093.html">MONDO:0013093</a> (glioma susceptibility 3) [1][83.33%]</li>
<li><a href="html/MONDO_0013103.html">MONDO:0013103</a> (epilepsy, idiopathic generalized, susceptibility to, 10) [1][70.00%]</li>
<li><a href="html/MONDO_0013159.html">MONDO:0013159</a> (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1) [1][78.93%]</li>
<li><a href="html/MONDO_0013160.html">MONDO:0013160</a> (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2) [1][78.93%]</li>
<li><a href="html/MONDO_0013624.html">MONDO:0013624</a> (mental retardation, autosomal recessive 15) [2][66.67%]</li>
<li><a href="html/MONDO_0013626.html">MONDO:0013626</a> (psoriasis 14, pustular) [1][66.67%]</li>
<li><a href="html/MONDO_0013648.html">MONDO:0013648</a> (familial progressive hyperpigmentation) [1][66.67%]</li>
<li><a href="html/MONDO_0013794.html">MONDO:0013794</a> (thrombocythemia 3) [1][83.71%]</li>
<li><a href="html/MONDO_0013878.html">MONDO:0013878</a> (pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1) [6][62.50%]</li>
<li><a href="html/MONDO_0013879.html">MONDO:0013879</a> (pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2) [6][62.50%]</li>
<li><a href="html/MONDO_0014100.html">MONDO:0014100</a> (dilated cardiomyopathy 1KK) [1][57.49%]</li>
<li><a href="html/MONDO_0014141.html">MONDO:0014141</a> (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14) [1][78.93%]</li>
<li><a href="html/MONDO_0014231.html">MONDO:0014231</a> (juvenile onset Parkinson disease 19A) [2][57.22%]</li>
<li><a href="html/MONDO_0014284.html">MONDO:0014284</a> (short-rib thoracic dysplasia 10 with or without polydactyly) [1][66.67%]</li>
<li><a href="html/MONDO_0014373.html">MONDO:0014373</a> (nephrotic syndrome, type 10) [1][75.00%]</li>
<li><a href="html/MONDO_0014452.html">MONDO:0014452</a> (familial dysfibrinogenemia) [1][62.50%]</li>
<li><a href="html/MONDO_0014695.html">MONDO:0014695</a> (glioma susceptibility 9) [1][66.67%]</li>
<li><a href="html/MONDO_0014883.html">MONDO:0014883</a> (hypertrophic cardiomyopathy 26) [1][57.49%]</li>
<li><a href="html/MONDO_0015027.html">MONDO:0015027</a> (familial isolated hyperparathyroidism) [1][83.33%]</li>
<li><a href="html/MONDO_0015052.html">MONDO:0015052</a> (primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies) [2][75.00%]</li>
<li><a href="html/MONDO_0015059.html">MONDO:0015059</a> (progressive non-fluent aphasia) [1][66.67%]</li>
<li><a href="html/MONDO_0015074.html">MONDO:0015074</a> (thyroid tumor) [8][73.35%]</li>
<li><a href="html/MONDO_0015075.html">MONDO:0015075</a> (thyroid carcinoma (disease)) [7][75.23%]</li>
<li><a href="html/MONDO_0015076.html">MONDO:0015076</a> (rare parathyroid tumor) [4][62.50%]</li>
<li><a href="html/MONDO_0015077.html">MONDO:0015077</a> (adrenal/paraganglial tumor) [5][66.67%]</li>
<li><a href="html/MONDO_0015078.html">MONDO:0015078</a> (Gastroenteropancreatic endocrine tumor) [3][66.67%]</li>
<li><a href="html/MONDO_0015079.html">MONDO:0015079</a> (multiple polyglandular tumor) [3][77.78%]</li>
<li><a href="html/MONDO_0015080.html">MONDO:0015080</a> (thymic tumor) [4][80.00%]</li>
<li><a href="html/MONDO_0015083.html">MONDO:0015083</a> (nuclear oculomotor paralysis) [1][70.00%]</li>
<li><a href="html/MONDO_0015087.html">MONDO:0015087</a> (autosomal dominant complex spastic paraplegia) [1][75.00%]</li>
<li><a href="html/MONDO_0015089.html">MONDO:0015089</a> (autosomal recessive complex spastic paraplegia) [2][66.67%]</li>
<li><a href="html/MONDO_0015104.html">MONDO:0015104</a> (porphyria cutanea tarda) [1][75.00%]</li>
<li><a href="html/MONDO_0015106.html">MONDO:0015106</a> (rare urogenital disease) [71][44.74%]</li>
<li><a href="html/MONDO_0015107.html">MONDO:0015107</a> (rare genetic eye disease) [416][63.27%]</li>
<li><a href="html/MONDO_0015108.html">MONDO:0015108</a> (rare non-syndromic intellectual disability) [9][59.09%]</li>
<li><a href="html/MONDO_0015110.html">MONDO:0015110</a> (genetic cardiac rhythm disease) [12][63.89%]</li>
<li><a href="html/MONDO_0015111.html">MONDO:0015111</a> (rare gastroesophageal disease) [7][62.50%]</li>
<li><a href="html/MONDO_0015112.html">MONDO:0015112</a> (rare pancreatic disease) [8][62.50%]</li>
<li><a href="html/MONDO_0015113.html">MONDO:0015113</a> (rare vascular liver disease) [1][83.33%]</li>
<li><a href="html/MONDO_0015114.html">MONDO:0015114</a> (rare parenchymal liver disease) [2][70.00%]</li>
<li><a href="html/MONDO_0015115.html">MONDO:0015115</a> (rare metabolic liver disease) [24][45.51%]</li>
<li><a href="html/MONDO_0015116.html">MONDO:0015116</a> (rare biliary tract disease) [12][59.64%]</li>
<li><a href="html/MONDO_0015117.html">MONDO:0015117</a> (rare hepatic and biliary tract tumor) [9][62.50%]</li>
<li><a href="html/MONDO_0015118.html">MONDO:0015118</a> (rare pulmonary disease) [73][32.48%]</li>
<li><a href="html/MONDO_0015119.html">MONDO:0015119</a> (rare bronchopulmonary tumor) [4][62.50%]</li>
<li><a href="html/MONDO_0015120.html">MONDO:0015120</a> (rare acquired eye disease) [20][27.89%]</li>
<li><a href="html/MONDO_0015121.html">MONDO:0015121</a> (rare eye tumor) [2][57.49%]</li>
<li><a href="html/MONDO_0015122.html">MONDO:0015122</a> (rare diabetes mellitus) [17][56.25%]</li>
<li><a href="html/MONDO_0015123.html">MONDO:0015123</a> (rare dyslipidemia) [24][51.19%]</li>
<li><a href="html/MONDO_0015124.html">MONDO:0015124</a> (rare adrenal disease) [39][61.22%]</li>
<li><a href="html/MONDO_0015125.html">MONDO:0015125</a> (rare thyroid disease) [31][59.53%]</li>
<li><a href="html/MONDO_0015126.html">MONDO:0015126</a> (polyendocrinopathy) [6][67.86%]</li>
<li><a href="html/MONDO_0015127.html">MONDO:0015127</a> (pituitary deficiency) [52][45.18%]</li>
<li><a href="html/MONDO_0015128.html">MONDO:0015128</a> (primary adrenal insufficiency) [15][52.24%]</li>
<li><a href="html/MONDO_0015129.html">MONDO:0015129</a> (chronic primary adrenal insufficiency) [13][61.08%]</li>
<li><a href="html/MONDO_0015130.html">MONDO:0015130</a> (acquired chronic primary adrenal insufficiency) [1][66.67%]</li>
<li><a href="html/MONDO_0015131.html">MONDO:0015131</a> (combined T cell and b cell immunodeficiency) [11][41.14%]</li>
<li><a href="html/MONDO_0015132.html">MONDO:0015132</a> (immunodeficiency predominantly affecting antibody production) [13][71.84%]</li>
<li><a href="html/MONDO_0015133.html">MONDO:0015133</a> (quantitative and/or qualitative congenital phagocyte defect) [9][53.26%]</li>
<li><a href="html/MONDO_0015134.html">MONDO:0015134</a> (constitutional neutropenia) [3][66.67%]</li>
<li><a href="html/MONDO_0015135.html">MONDO:0015135</a> (primary immunodeficiency due to a defect in innate immunity) [33][41.61%]</li>
<li><a href="html/MONDO_0015136.html">MONDO:0015136</a> (immunodeficiency due to a complement cascade protein anomaly) [4][81.25%]</li>
<li><a href="html/MONDO_0015137.html">MONDO:0015137</a> (periodic fever syndrome) [6][65.00%]</li>
<li><a href="html/MONDO_0015138.html">MONDO:0015138</a> (primary immunodeficiency) [96][53.44%]</li>
<li><a href="html/MONDO_0015139.html">MONDO:0015139</a> (rare epilepsy) [176][56.88%]</li>
<li><a href="html/MONDO_0015141.html">MONDO:0015141</a> (Medullar disease) [3][62.50%]</li>
<li><a href="html/MONDO_0015142.html">MONDO:0015142</a> (rare ataxia) [42][48.53%]</li>
<li><a href="html/MONDO_0015143.html">MONDO:0015143</a> (rare movement disorder) [86][43.76%]</li>
<li><a href="html/MONDO_0015144.html">MONDO:0015144</a> (brain inflammatory disease) [13][18.35%]</li>
<li><a href="html/MONDO_0015145.html">MONDO:0015145</a> (Neurovascular malformation) [4][66.67%]</li>
<li><a href="html/MONDO_0015146.html">MONDO:0015146</a> (classic lissencephaly) [3][57.49%]</li>
<li><a href="html/MONDO_0015147.html">MONDO:0015147</a> (other syndrome with lissencephaly as a major feature) [2][62.50%]</li>
<li><a href="html/MONDO_0015148.html">MONDO:0015148</a> (lissencephaly type 3) [1][100.00%]</li>
<li><a href="html/MONDO_0015150.html">MONDO:0015150</a> (complex hereditary spastic paraplegia) [6][68.18%]</li>
<li><a href="html/MONDO_0015157.html">MONDO:0015157</a> (human herpesvirus 8-related disorder) [3][62.50%]</li>
<li><a href="html/MONDO_0015159.html">MONDO:0015159</a> (multiple congenital anomalies/dysmorphic syndrome-intellectual disability) [56][51.01%]</li>
<li><a href="html/MONDO_0015160.html">MONDO:0015160</a> (multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome) [23][52.20%]</li>
<li><a href="html/MONDO_0015161.html">MONDO:0015161</a> (multiple congenital anomalies/dysmorphic syndrome without intellectual disability) [26][50.62%]</li>
<li><a href="html/MONDO_0015162.html">MONDO:0015162</a> (rare syndromic intellectual disability) [131][54.75%]</li>
<li><a href="html/MONDO_0015163.html">MONDO:0015163</a> (primary glomerular disease) [12][40.73%]</li>
<li><a href="html/MONDO_0015167.html">MONDO:0015167</a> (amniotic bands) [1][66.67%]</li>
<li><a href="html/MONDO_0015168.html">MONDO:0015168</a> (arthrogryposis multiplex congenita) [3][72.22%]</li>
<li><a href="html/MONDO_0015178.html">MONDO:0015178</a> (congenital intestinal transport defect) [1][66.67%]</li>
<li><a href="html/MONDO_0015181.html">MONDO:0015181</a> (congenital intestinal disease due to an enzymatic defect) [1][75.00%]</li>
<li><a href="html/MONDO_0015183.html">MONDO:0015183</a> (short bowel syndrome) [2][75.00%]</li>
<li><a href="html/MONDO_0015184.html">MONDO:0015184</a> (rare disease involving intestinal motility) [5][53.32%]</li>
<li><a href="html/MONDO_0015185.html">MONDO:0015185</a> (intestinal polyposis syndrome) [9][63.64%]</li>
<li><a href="html/MONDO_0015187.html">MONDO:0015187</a> (rare inflammatory bowel disease) [3][66.67%]</li>
<li><a href="html/MONDO_0015188.html">MONDO:0015188</a> (metabolic disease with intestinal involvement) [8][62.50%]</li>
<li><a href="html/MONDO_0015193.html">MONDO:0015193</a> (hydrops fetalis (disease)) [1][62.50%]</li>
<li><a href="html/MONDO_0015194.html">MONDO:0015194</a> (sideroblastic anemia) [5][56.94%]</li>
<li><a href="html/MONDO_0015207.html">MONDO:0015207</a> (non-syndromic esophageal malformation) [3][62.50%]</li>
<li><a href="html/MONDO_0015208.html">MONDO:0015208</a> (syndromic esophageal malformation) [2][64.29%]</li>
<li><a href="html/MONDO_0015210.html">MONDO:0015210</a> (syndromic gastroduodenal malformation) [1][66.67%]</li>
<li><a href="html/MONDO_0015211.html">MONDO:0015211</a> (non-syndromic intestinal malformation) [1][83.33%]</li>
<li><a href="html/MONDO_0015212.html">MONDO:0015212</a> (syndromic intestinal malformation) [2][62.50%]</li>
<li><a href="html/MONDO_0015213.html">MONDO:0015213</a> (non-syndromic visceral malformation) [1][62.50%]</li>
<li><a href="html/MONDO_0015214.html">MONDO:0015214</a> (syndromic visceral malformation) [4][65.79%]</li>
<li><a href="html/MONDO_0015215.html">MONDO:0015215</a> (non-syndromic diaphragmatic or abdominal wall malformation) [3][59.01%]</li>
<li><a href="html/MONDO_0015216.html">MONDO:0015216</a> (syndromic diaphragmatic or abdominal wall malformation) [13][61.08%]</li>
<li><a href="html/MONDO_0015217.html">MONDO:0015217</a> (non-syndromic developmental defect of the eye) [42][51.77%]</li>
<li><a href="html/MONDO_0015218.html">MONDO:0015218</a> (syndromic developmental defect of the eye) [19][51.13%]</li>
<li><a href="html/MONDO_0015219.html">MONDO:0015219</a> (non-syndromic central nervous system malformation) [65][44.51%]</li>
<li><a href="html/MONDO_0015220.html">MONDO:0015220</a> (syndrome with a central nervous system malformation as major feature) [44][50.52%]</li>
<li><a href="html/MONDO_0015221.html">MONDO:0015221</a> (non-syndromic respiratory or mediastinal malformation) [8][39.61%]</li>
<li><a href="html/MONDO_0015222.html">MONDO:0015222</a> (syndromic respiratory or mediastinal malformation) [5][62.50%]</li>
<li><a href="html/MONDO_0015223.html">MONDO:0015223</a> (rare anemia) [72][50.20%]</li>
<li><a href="html/MONDO_0015225.html">MONDO:0015225</a> (arthrogryposis syndrome) [15][60.68%]</li>
<li><a href="html/MONDO_0015226.html">MONDO:0015226</a> (syndrome with limb malformations as a major feature) [58][55.30%]</li>
<li><a href="html/MONDO_0015227.html">MONDO:0015227</a> (non-syndromic limb malformation) [73][30.13%]</li>
<li><a href="html/MONDO_0015231.html">MONDO:0015231</a> (Bartter syndrome) [3][62.50%]</li>
<li><a href="html/MONDO_0015240.html">MONDO:0015240</a> (Digitotalar dysmorphism) [1][100.00%]</li>
<li><a href="html/MONDO_0015244.html">MONDO:0015244</a> (autosomal recessive cerebellar ataxia) [23][51.63%]</li>
<li><a href="html/MONDO_0015245.html">MONDO:0015245</a> (rare intestinal disease) [53][44.61%]</li>
<li><a href="html/MONDO_0015246.html">MONDO:0015246</a> (syndromic anorectal malformation) [17][50.83%]</li>
<li><a href="html/MONDO_0015262.html">MONDO:0015262</a> (brachyolmia) [2][70.00%]</li>
<li><a href="html/MONDO_0015263.html">MONDO:0015263</a> (Brugada syndrome) [2][64.29%]</li>
<li><a href="html/MONDO_0015286.html">MONDO:0015286</a> (congenital disorder of glycosylation) [41][41.38%]</li>
<li><a href="html/MONDO_0015301.html">MONDO:0015301</a> (primary cutaneous amyloidosis) [1][66.67%]</li>
<li><a href="html/MONDO_0015318.html">MONDO:0015318</a> (Pierre robin syndrome associated with collagen disease) [4][65.00%]</li>
<li><a href="html/MONDO_0015319.html">MONDO:0015319</a> (rare disease with Pierre robin syndrome) [16][46.91%]</li>
<li><a href="html/MONDO_0015320.html">MONDO:0015320</a> (Pierre robin syndrome associated with a chromosomal anomaly) [3][62.50%]</li>
<li><a href="html/MONDO_0015321.html">MONDO:0015321</a> (Pierre robin syndrome associated with branchial archs anomalies) [1][62.50%]</li>
<li><a href="html/MONDO_0015322.html">MONDO:0015322</a> (Pierre robin syndrome associated with bone disease) [1][75.00%]</li>
<li><a href="html/MONDO_0015323.html">MONDO:0015323</a> (Teratogenic Pierre robin syndrome) [2][66.67%]</li>
<li><a href="html/MONDO_0015327.html">MONDO:0015327</a> (developmental anomaly of metabolic origin) [100][47.41%]</li>
<li><a href="html/MONDO_0015328.html">MONDO:0015328</a> (rare bone development disorder) [255][62.99%]</li>
<li><a href="html/MONDO_0015329.html">MONDO:0015329</a> (malformation syndrome with short stature) [12][52.22%]</li>
<li><a href="html/MONDO_0015330.html">MONDO:0015330</a> (overgrowth/obesity syndrome) [27][41.23%]</li>
<li><a href="html/MONDO_0015331.html">MONDO:0015331</a> (malformation syndrome with skin/mucosae involvement) [60][58.44%]</li>
<li><a href="html/MONDO_0015332.html">MONDO:0015332</a> (rare developmental defect with connective tissue involvement) [18][59.05%]</li>
<li><a href="html/MONDO_0015333.html">MONDO:0015333</a> (progeroid syndrome) [7][67.15%]</li>
<li><a href="html/MONDO_0015334.html">MONDO:0015334</a> (branchial arch or oral-acral syndrome) [12][51.88%]</li>
<li><a href="html/MONDO_0015335.html">MONDO:0015335</a> (orofacial clefting syndrome) [6][64.58%]</li>
<li><a href="html/MONDO_0015336.html">MONDO:0015336</a> (malformation syndrome with odontal and/or periodontal component) [6][63.33%]</li>
<li><a href="html/MONDO_0015337.html">MONDO:0015337</a> (isolated craniosynostosis) [1][66.67%]</li>
<li><a href="html/MONDO_0015338.html">MONDO:0015338</a> (syndromic craniosynostosis) [7][67.50%]</li>
<li><a href="html/MONDO_0015356.html">MONDO:0015356</a> (inherited cancer-predisposing syndrome) [55][49.41%]</li>
<li><a href="html/MONDO_0015358.html">MONDO:0015358</a> (hereditary motor and sensory neuropathy) [21][46.56%]</li>
<li><a href="html/MONDO_0015359.html">MONDO:0015359</a> (autosomal dominant hereditary demyelinating motor and sensory neuropathy) [2][66.67%]</li>
<li><a href="html/MONDO_0015360.html">MONDO:0015360</a> (autosomal dominant hereditary axonal motor and sensory neuropathy) [5][63.33%]</li>
<li><a href="html/MONDO_0015362.html">MONDO:0015362</a> (autosomal dominant distal hereditary motor neuropathy) [3][63.64%]</li>
<li><a href="html/MONDO_0015363.html">MONDO:0015363</a> (autosomal recessive distal hereditary motor neuropathy) [1][75.00%]</li>
<li><a href="html/MONDO_0015364.html">MONDO:0015364</a> (hereditary sensory and autonomic neuropathy) [9][36.83%]</li>
<li><a href="html/MONDO_0015365.html">MONDO:0015365</a> (autosomal dominant hereditary sensory and autonomic neuropathy) [4][65.38%]</li>
<li><a href="html/MONDO_0015366.html">MONDO:0015366</a> (autosomal recessive hereditary sensory and autonomic neuropathy) [2][66.67%]</li>
<li><a href="html/MONDO_0015368.html">MONDO:0015368</a> (Neuro-ophthalmological disease) [77][50.84%]</li>
<li><a href="html/MONDO_0015369.html">MONDO:0015369</a> (Joubert syndrome and related disorders) [5][61.07%]</li>
<li><a href="html/MONDO_0015375.html">MONDO:0015375</a> (orofaciodigital syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0015397.html">MONDO:0015397</a> (Oculo-auriculo-vertebral spectrum) [1][70.00%]</li>
<li><a href="html/MONDO_0015411.html">MONDO:0015411</a> (facial cleft) [6][71.43%]</li>
<li><a href="html/MONDO_0015412.html">MONDO:0015412</a> (median facial cleft) [2][100.00%]</li>
<li><a href="html/MONDO_0015427.html">MONDO:0015427</a> (paroxysmal dyskinesia) [2][75.00%]</li>
<li><a href="html/MONDO_0015448.html">MONDO:0015448</a> (isolated CoQ-cytochrome c reductase deficiency) [1][66.67%]</li>
<li><a href="html/MONDO_0015461.html">MONDO:0015461</a> (short rib-polydactyly syndrome) [5][64.29%]</li>
<li><a href="html/MONDO_0015465.html">MONDO:0015465</a> (craniometaphyseal dysplasia) [1][75.00%]</li>
<li><a href="html/MONDO_0015469.html">MONDO:0015469</a> (craniosynostosis) [11][54.62%]</li>
<li><a href="html/MONDO_0015475.html">MONDO:0015475</a> (rare head and neck malformation) [75][46.18%]</li>
<li><a href="html/MONDO_0015482.html">MONDO:0015482</a> (otomandibular dysplasia) [8][63.16%]</li>
<li><a href="html/MONDO_0015483.html">MONDO:0015483</a> (mandibulofacial dysostosis) [3][62.50%]</li>
<li><a href="html/MONDO_0015485.html">MONDO:0015485</a> (primary glaucoma) [3][62.50%]</li>
<li><a href="html/MONDO_0015486.html">MONDO:0015486</a> (keratoconus (disease)) [3][75.00%]</li>
<li><a href="html/MONDO_0015488.html">MONDO:0015488</a> (predominantly large-vessel vasculitis) [1][75.00%]</li>
<li><a href="html/MONDO_0015489.html">MONDO:0015489</a> (predominantly medium-vessel vasculitis) [3][62.50%]</li>
<li><a href="html/MONDO_0015490.html">MONDO:0015490</a> (predominantly small-vessel vasculitis) [3][75.00%]</li>
<li><a href="html/MONDO_0015491.html">MONDO:0015491</a> (immune complex mediated vasculitis) [1][100.00%]</li>
<li><a href="html/MONDO_0015494.html">MONDO:0015494</a> (isolated dystonia) [3][70.00%]</li>
<li><a href="html/MONDO_0015495.html">MONDO:0015495</a> (otomandibular dysplasia associated with monogenic syndromes) [1][83.33%]</li>
<li><a href="html/MONDO_0015496.html">MONDO:0015496</a> (macroglossia) [2][80.00%]</li>
<li><a href="html/MONDO_0015497.html">MONDO:0015497</a> (Hypoglossia/aglossia) [4][66.67%]</li>
<li><a href="html/MONDO_0015498.html">MONDO:0015498</a> (oromandibular-limb anomalies syndrome) [3][68.75%]</li>
<li><a href="html/MONDO_0015499.html">MONDO:0015499</a> (paralytic facial malformation) [1][66.67%]</li>
<li><a href="html/MONDO_0015501.html">MONDO:0015501</a> (syndrome or malformation associated with head and neck malformations) [34][46.46%]</li>
<li><a href="html/MONDO_0015502.html">MONDO:0015502</a> (Pinnae and external auditory canal anomaly) [2][43.15%]</li>
<li><a href="html/MONDO_0015503.html">MONDO:0015503</a> (nose and cavum anomaly) [5][66.67%]</li>
<li><a href="html/MONDO_0015504.html">MONDO:0015504</a> (larynx anomaly) [2][66.67%]</li>
<li><a href="html/MONDO_0015506.html">MONDO:0015506</a> (rare syndrome with cardiac malformations) [7][53.32%]</li>
<li><a href="html/MONDO_0015507.html">MONDO:0015507</a> (rare genetic hepatic disease) [36][44.59%]</li>
<li><a href="html/MONDO_0015508.html">MONDO:0015508</a> (genetic parenchymatous liver disease) [2][70.00%]</li>
<li><a href="html/MONDO_0015509.html">MONDO:0015509</a> (genetic biliary tract disease) [7][68.42%]</li>
<li><a href="html/MONDO_0015510.html">MONDO:0015510</a> (rare genetic respiratory disease) [45][44.86%]</li>
<li><a href="html/MONDO_0015511.html">MONDO:0015511</a> (rare genetic urogenital disease) [42][42.62%]</li>
<li><a href="html/MONDO_0015512.html">MONDO:0015512</a> (genetic hypertension) [9][58.33%]</li>
<li><a href="html/MONDO_0015513.html">MONDO:0015513</a> (rare genetic endocrine disease) [265][54.83%]</li>
<li><a href="html/MONDO_0015514.html">MONDO:0015514</a> (genetic endocrine growth disease) [56][50.83%]</li>
<li><a href="html/MONDO_0015517.html">MONDO:0015517</a> (common variable immunodeficiency) [1][68.69%]</li>
<li><a href="html/MONDO_0015518.html">MONDO:0015518</a> (infantile bilateral striatal necrosis) [1][62.50%]</li>
<li><a href="html/MONDO_0015540.html">MONDO:0015540</a> (hemophagocytic syndrome) [5][62.50%]</li>
<li><a href="html/MONDO_0015541.html">MONDO:0015541</a> (primary hemophagocytic lymphohistiocytosis) [3][65.00%]</li>
<li><a href="html/MONDO_0015547.html">MONDO:0015547</a> (genetic dementia) [75][52.20%]</li>
<li><a href="html/MONDO_0015548.html">MONDO:0015548</a> (Huntington disease-like syndrome) [5][58.30%]</li>
<li><a href="html/MONDO_0015549.html">MONDO:0015549</a> (rare genetic hematologic disease) [109][54.83%]</li>
<li><a href="html/MONDO_0015564.html">MONDO:0015564</a> (Castleman disease) [1][75.00%]</li>
<li><a href="html/MONDO_0015572.html">MONDO:0015572</a> (non-syndromic cerebral malformation due to abnormal neuronal migration) [12][39.59%]</li>
<li><a href="html/MONDO_0015574.html">MONDO:0015574</a> (chronic cutaneous lupus erythematosus) [1][66.67%]</li>
<li><a href="html/MONDO_0015576.html">MONDO:0015576</a> (rare viral disease) [9][22.77%]</li>
<li><a href="html/MONDO_0015577.html">MONDO:0015577</a> (rare parasitic disease) [7][16.44%]</li>
<li><a href="html/MONDO_0015578.html">MONDO:0015578</a> (rare mycosis) [3][66.67%]</li>
<li><a href="html/MONDO_0015581.html">MONDO:0015581</a> (bile acid synthesis defect with cholestasis and malabsorption) [2][62.50%]</li>
<li><a href="html/MONDO_0015582.html">MONDO:0015582</a> (rare disorder related with pregnancy, childbirth and puerperium) [5][68.42%]</li>
<li><a href="html/MONDO_0015603.html">MONDO:0015603</a> (rare odontal or periodontal disorder) [11][59.33%]</li>
<li><a href="html/MONDO_0015610.html">MONDO:0015610</a> (rare acquired aplastic anemia) [9][37.38%]</li>
<li><a href="html/MONDO_0015612.html">MONDO:0015612</a> (Dent disease) [1][75.00%]</li>
<li><a href="html/MONDO_0015613.html">MONDO:0015613</a> (dentin dysplasia) [1][66.67%]</li>
<li><a href="html/MONDO_0015615.html">MONDO:0015615</a> (rare genetic gastroenterological disease) [42][47.24%]</li>
<li><a href="html/MONDO_0015616.html">MONDO:0015616</a> (genetic intestinal disease) [35][46.37%]</li>
<li><a href="html/MONDO_0015618.html">MONDO:0015618</a> (genetic pancreatic disease) [4][31.29%]</li>
<li><a href="html/MONDO_0015619.html">MONDO:0015619</a> (non-syndromic urogenital tract malformation) [21][39.94%]</li>
<li><a href="html/MONDO_0015620.html">MONDO:0015620</a> (syndromic urogenital tract malformation) [5][65.00%]</li>
<li><a href="html/MONDO_0015621.html">MONDO:0015621</a> (rare abdominal surgical disease) [65][44.34%]</li>
<li><a href="html/MONDO_0015624.html">MONDO:0015624</a> (Diazoxide-sensitive diffuse hyperinsulinism) [1][66.67%]</li>
<li><a href="html/MONDO_0015626.html">MONDO:0015626</a> (Charcot-Marie-tooth disease) [21][46.98%]</li>
<li><a href="html/MONDO_0015642.html">MONDO:0015642</a> (benign partial infantile seizures) [4][65.38%]</li>
<li><a href="html/MONDO_0015650.html">MONDO:0015650</a> (epilepsy syndrome) [52][53.90%]</li>
<li><a href="html/MONDO_0015651.html">MONDO:0015651</a> (neurocutaneous syndrome with epilepsy) [5][67.36%]</li>
<li><a href="html/MONDO_0015652.html">MONDO:0015652</a> (chromosomal anomaly with epilepsy as a major feature) [2][75.00%]</li>
<li><a href="html/MONDO_0015653.html">MONDO:0015653</a> (monogenic disease with epilepsy) [27][46.34%]</li>
<li><a href="html/MONDO_0015654.html">MONDO:0015654</a> (idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes) [15][57.56%]</li>
<li><a href="html/MONDO_0015655.html">MONDO:0015655</a> (cerebral malformation with epilepsy) [37][48.63%]</li>
<li><a href="html/MONDO_0015656.html">MONDO:0015656</a> (metabolic diseases with epilepsy) [60][52.04%]</li>
<li><a href="html/MONDO_0015659.html">MONDO:0015659</a> (infectious disease with epilepsy) [3][66.67%]</li>
<li><a href="html/MONDO_0015667.html">MONDO:0015667</a> (unclassified acute myeloid leukemia) [4][41.37%]</li>
<li><a href="html/MONDO_0015668.html">MONDO:0015668</a> (hereditary dentin defect) [4][60.82%]</li>
<li><a href="html/MONDO_0015669.html">MONDO:0015669</a> (rare disease with dentinogenesis imperfecta) [2][66.67%]</li>
<li><a href="html/MONDO_0015670.html">MONDO:0015670</a> (cardiomyopathy) [66][59.23%]</li>
<li><a href="html/MONDO_0015673.html">MONDO:0015673</a> (rare cardiac tumor) [1][62.50%]</li>
<li><a href="html/MONDO_0015680.html">MONDO:0015680</a> (rare pervasive developmental disorder) [5][63.64%]</li>
<li><a href="html/MONDO_0015707.html">MONDO:0015707</a> (DNA repair defect other than combined T-cell and b-cell immunodeficiencies) [2][62.50%]</li>
<li><a href="html/MONDO_0015708.html">MONDO:0015708</a> (Immuno-osseous dysplasia) [1][66.67%]</li>
<li><a href="html/MONDO_0015709.html">MONDO:0015709</a> (immunodeficiency syndrome with autoimmunity) [1][87.50%]</li>
<li><a href="html/MONDO_0015710.html">MONDO:0015710</a> (immune dysregulation disease with immunodeficiency) [16][35.47%]</li>
<li><a href="html/MONDO_0015735.html">MONDO:0015735</a> (severe congenital nemaline myopathy) [1][66.67%]</li>
<li><a href="html/MONDO_0015736.html">MONDO:0015736</a> (intermediate nemaline myopathy) [2][70.00%]</li>
<li><a href="html/MONDO_0015737.html">MONDO:0015737</a> (Typical nemaline myopathy) [2][70.00%]</li>
<li><a href="html/MONDO_0015738.html">MONDO:0015738</a> (childhood-onset nemaline myopathy) [3][75.00%]</li>
<li><a href="html/MONDO_0015756.html">MONDO:0015756</a> (myeloid hemopathy) [28][46.56%]</li>
<li><a href="html/MONDO_0015757.html">MONDO:0015757</a> (lymphoid hemopathy) [45][30.58%]</li>
<li><a href="html/MONDO_0015759.html">MONDO:0015759</a> (b-cell non-Hodgkin lymphoma) [11][31.50%]</li>
<li><a href="html/MONDO_0015765.html">MONDO:0015765</a> (congenital myopathy with cores) [3][66.67%]</li>
<li><a href="html/MONDO_0015770.html">MONDO:0015770</a> (congenital hypogonadotropic hypogonadism) [10][55.11%]</li>
<li><a href="html/MONDO_0015775.html">MONDO:0015775</a> (non-rhizomelic chondrodysplasia punctata) [2][64.29%]</li>
<li><a href="html/MONDO_0015780.html">MONDO:0015780</a> (dyskeratosis congenita) [2][83.79%]</li>
<li><a href="html/MONDO_0015789.html">MONDO:0015789</a> (non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations) [2][64.73%]</li>
<li><a href="html/MONDO_0015790.html">MONDO:0015790</a> (central diabetes insipidus) [1][75.00%]</li>
<li><a href="html/MONDO_0015802.html">MONDO:0015802</a> (autosomal dominant non-syndromic intellectual disability) [3][66.67%]</li>
<li><a href="html/MONDO_0015823.html">MONDO:0015823</a> (primary immunodeficiency due to a defect in adaptive immunity) [61][59.28%]</li>
<li><a href="html/MONDO_0015827.html">MONDO:0015827</a> (distal renal tubular acidosis (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0015828.html">MONDO:0015828</a> (uterovaginal malformation) [11][27.42%]</li>
<li><a href="html/MONDO_0015829.html">MONDO:0015829</a> (non-syndromic uterovaginal malformation) [8][39.02%]</li>
<li><a href="html/MONDO_0015830.html">MONDO:0015830</a> (partial bilateral aplasia of the mullerian ducts) [1][66.67%]</li>
<li><a href="html/MONDO_0015846.html">MONDO:0015846</a> (syndromic uterovaginal malformation) [1][100.00%]</li>
<li><a href="html/MONDO_0015851.html">MONDO:0015851</a> (rare breast malformation) [6][47.29%]</li>
<li><a href="html/MONDO_0015853.html">MONDO:0015853</a> (deficient breast volume or number) [3][57.49%]</li>
<li><a href="html/MONDO_0015860.html">MONDO:0015860</a> (anomaly of puberty or/and menstrual cycle) [26][51.76%]</li>
<li><a href="html/MONDO_0015868.html">MONDO:0015868</a> (rare breast tumor) [6][55.80%]</li>
<li><a href="html/MONDO_0015870.html">MONDO:0015870</a> (rare malignant breast tumor) [4][58.30%]</li>
<li><a href="html/MONDO_0015878.html">MONDO:0015878</a> (rare disease with autism) [2][80.00%]</li>
<li><a href="html/MONDO_0015879.html">MONDO:0015879</a> (non-syndromic diaphragmatic or thoracic malformation) [2][78.05%]</li>
<li><a href="html/MONDO_0015880.html">MONDO:0015880</a> (syndromic diaphragmatic or thoracic malformation) [12][61.37%]</li>
<li><a href="html/MONDO_0015881.html">MONDO:0015881</a> (rare gastroesophageal tumor) [5][38.26%]</li>
<li><a href="html/MONDO_0015885.html">MONDO:0015885</a> (rare insulin-resistance syndrome) [2][64.29%]</li>
<li><a href="html/MONDO_0015886.html">MONDO:0015886</a> (rare diabetes mellitus type 1) [1][75.00%]</li>
<li><a href="html/MONDO_0015887.html">MONDO:0015887</a> (rare diabetes mellitus type 2) [4][75.37%]</li>
<li><a href="html/MONDO_0015888.html">MONDO:0015888</a> (other rare diabetes mellitus) [1][100.00%]</li>
<li><a href="html/MONDO_0015889.html">MONDO:0015889</a> (rare hypothalamic or pituitary disease) [54][46.32%]</li>
<li><a href="html/MONDO_0015890.html">MONDO:0015890</a> (rare disorder with hypogonadotropic hypogonadism) [5][66.67%]</li>
<li><a href="html/MONDO_0015891.html">MONDO:0015891</a> (hypogonadotropic hypogonadism associated with other endocrinopathies) [3][58.30%]</li>
<li><a href="html/MONDO_0015893.html">MONDO:0015893</a> (rare hypothyroidism) [18][65.15%]</li>
<li><a href="html/MONDO_0015894.html">MONDO:0015894</a> (rare hyperthyroidism) [4][68.69%]</li>
<li><a href="html/MONDO_0015895.html">MONDO:0015895</a> (syndrome with hypoparathyroidism) [5][56.21%]</li>
<li><a href="html/MONDO_0015896.html">MONDO:0015896</a> (rare hypoparathyroidism) [14][60.93%]</li>
<li><a href="html/MONDO_0015897.html">MONDO:0015897</a> (rare hyperparathyroidism) [5][83.33%]</li>
<li><a href="html/MONDO_0015898.html">MONDO:0015898</a> (adrenogenital syndrome) [6][80.00%]</li>
<li><a href="html/MONDO_0015900.html">MONDO:0015900</a> (rare hypoaldosteronism) [2][70.00%]</li>
<li><a href="html/MONDO_0015901.html">MONDO:0015901</a> (rare hyperlipidemia) [7][71.88%]</li>
<li><a href="html/MONDO_0015902.html">MONDO:0015902</a> (major hypertriglyceridemia) [1][70.00%]</li>
<li><a href="html/MONDO_0015903.html">MONDO:0015903</a> (hyperalphalipoproteinemia) [1][66.67%]</li>
<li><a href="html/MONDO_0015904.html">MONDO:0015904</a> (rare hypolipidemia) [3][70.00%]</li>
<li><a href="html/MONDO_0015905.html">MONDO:0015905</a> (rare syndromic dyslipidemia) [1][100.00%]</li>
<li><a href="html/MONDO_0015906.html">MONDO:0015906</a> (rare disorder with hypergonadotropic hypogonadism) [3][62.50%]</li>
<li><a href="html/MONDO_0015909.html">MONDO:0015909</a> (aplastic anemia) [15][68.18%]</li>
<li><a href="html/MONDO_0015910.html">MONDO:0015910</a> (rare constitutional hemolytic anemia) [17][56.66%]</li>
<li><a href="html/MONDO_0015911.html">MONDO:0015911</a> (rare acquired hemolytic anemia) [4][66.67%]</li>
<li><a href="html/MONDO_0015913.html">MONDO:0015913</a> (rare thrombotic disease of hematologic origin) [15][64.29%]</li>
<li><a href="html/MONDO_0015914.html">MONDO:0015914</a> (primary orthostatic hypotension) [6][58.92%]</li>
<li><a href="html/MONDO_0015915.html">MONDO:0015915</a> (cerebellar malformation) [8][52.13%]</li>
<li><a href="html/MONDO_0015916.html">MONDO:0015916</a> (rare neuroinflammatory or neuroimmunological disease) [22][19.52%]</li>
<li><a href="html/MONDO_0015918.html">MONDO:0015918</a> (rare neurodegenerative disease) [142][51.75%]</li>
<li><a href="html/MONDO_0015919.html">MONDO:0015919</a> (syndromic neurometabolic disease with non-X-linked intellectual disability) [8][73.52%]</li>
<li><a href="html/MONDO_0015920.html">MONDO:0015920</a> (syndromic neurometabolic disease with X-linked intellectual disability) [6][50.43%]</li>
<li><a href="html/MONDO_0015921.html">MONDO:0015921</a> (ARX-related epileptic encephalopathy) [6][62.50%]</li>
<li><a href="html/MONDO_0015922.html">MONDO:0015922</a> (channelopathy with epilepsy) [18][51.94%]</li>
<li><a href="html/MONDO_0015923.html">MONDO:0015923</a> (acquired peripheral neuropathy) [26][20.16%]</li>
<li><a href="html/MONDO_0015924.html">MONDO:0015924</a> (pulmonary arterial hypertension) [3][68.75%]</li>
<li><a href="html/MONDO_0015925.html">MONDO:0015925</a> (interstitial lung disease) [62][30.41%]</li>
<li><a href="html/MONDO_0015929.html">MONDO:0015929</a> (thoracic malformation) [10][56.67%]</li>
<li><a href="html/MONDO_0015930.html">MONDO:0015930</a> (respiratory malformation) [7][43.99%]</li>
<li><a href="html/MONDO_0015933.html">MONDO:0015933</a> (non-syndromic urogenital tract malformation of male) [2][62.50%]</li>
<li><a href="html/MONDO_0015934.html">MONDO:0015934</a> (non-syndromic urogenital tract malformation of male and female) [5][48.69%]</li>
<li><a href="html/MONDO_0015936.html">MONDO:0015936</a> (tumor of endocrine glands) [41][61.32%]</li>
<li><a href="html/MONDO_0015937.html">MONDO:0015937</a> (rare inflammatory eye disease) [17][35.89%]</li>
<li><a href="html/MONDO_0015938.html">MONDO:0015938</a> (rare systemic disease) [47][42.92%]</li>
<li><a href="html/MONDO_0015939.html">MONDO:0015939</a> (systemic autoimmune disease) [13][52.03%]</li>
<li><a href="html/MONDO_0015940.html">MONDO:0015940</a> (rare rheumatologic disease) [37][33.36%]</li>
<li><a href="html/MONDO_0015945.html">MONDO:0015945</a> (polymalformative genetic syndrome with increased risk of developing cancer) [23][49.84%]</li>
<li><a href="html/MONDO_0015946.html">MONDO:0015946</a> (genetic epidermal disorder) [80][59.99%]</li>
<li><a href="html/MONDO_0015947.html">MONDO:0015947</a> (inherited ichthyosis) [29][67.83%]</li>
<li><a href="html/MONDO_0015948.html">MONDO:0015948</a> (genetic skin vascular disorder) [6][62.50%]</li>
<li><a href="html/MONDO_0015949.html">MONDO:0015949</a> (genetic subcutaneous tissue disorder) [8][76.82%]</li>
<li><a href="html/MONDO_0015950.html">MONDO:0015950</a> (genetic skin tumor) [11][45.03%]</li>
<li><a href="html/MONDO_0015951.html">MONDO:0015951</a> (genetic photodermatosis) [12][62.50%]</li>
<li><a href="html/MONDO_0015952.html">MONDO:0015952</a> (genetic neurodegenerative disease) [95][49.26%]</li>
<li><a href="html/MONDO_0015953.html">MONDO:0015953</a> (genetic central nervous system and retinal vascular disease) [24][46.34%]</li>
<li><a href="html/MONDO_0015954.html">MONDO:0015954</a> (rare genetic headache) [1][90.00%]</li>
<li><a href="html/MONDO_0015955.html">MONDO:0015955</a> (rare genetic epilepsy) [155][58.11%]</li>
<li><a href="html/MONDO_0015956.html">MONDO:0015956</a> (rare hereditary ataxia) [39][49.07%]</li>
<li><a href="html/MONDO_0015957.html">MONDO:0015957</a> (rare genetic movement disorder) [71][44.91%]</li>
<li><a href="html/MONDO_0015958.html">MONDO:0015958</a> (rare genetic bone disease) [288][62.44%]</li>
<li><a href="html/MONDO_0015959.html">MONDO:0015959</a> (genetic bone tumor) [3][68.75%]</li>
<li><a href="html/MONDO_0015960.html">MONDO:0015960</a> (rare genetic developmental defect during embryogenesis) [743][64.74%]</li>
<li><a href="html/MONDO_0015961.html">MONDO:0015961</a> (genetic head and neck malformation) [56][45.57%]</li>
<li><a href="html/MONDO_0015962.html">MONDO:0015962</a> (genetic renal tubular disease) [39][49.82%]</li>
<li><a href="html/MONDO_0015963.html">MONDO:0015963</a> (genetic renal tumor) [2][86.16%]</li>
<li><a href="html/MONDO_0015964.html">MONDO:0015964</a> (rare genetic palpebral, lacrimal system and conjunctival disease) [111][45.23%]</li>
<li><a href="html/MONDO_0015965.html">MONDO:0015965</a> (rare genetic refraction anomaly) [13][46.37%]</li>
<li><a href="html/MONDO_0015966.html">MONDO:0015966</a> (genetic eye tumor) [1][85.36%]</li>
<li><a href="html/MONDO_0015967.html">MONDO:0015967</a> (rare genetic diabetes mellitus) [13][63.10%]</li>
<li><a href="html/MONDO_0015968.html">MONDO:0015968</a> (rare genetic hypothalamic or pituitary disease) [55][44.24%]</li>
<li><a href="html/MONDO_0015969.html">MONDO:0015969</a> (rare genetic thyroid disease) [24][62.39%]</li>
<li><a href="html/MONDO_0015970.html">MONDO:0015970</a> (rare genetic parathyroid disease and phosphocalcic metabolism disorder) [28][61.46%]</li>
<li><a href="html/MONDO_0015971.html">MONDO:0015971</a> (rare genetic adrenal disease) [20][54.44%]</li>
<li><a href="html/MONDO_0015972.html">MONDO:0015972</a> (rare constitutional anemia) [61][49.85%]</li>
<li><a href="html/MONDO_0015973.html">MONDO:0015973</a> (rare genetic coagulation disorder) [42][56.66%]</li>
<li><a href="html/MONDO_0015974.html">MONDO:0015974</a> (severe combined immunodeficiency (disease)) [5][58.30%]</li>
<li><a href="html/MONDO_0015977.html">MONDO:0015977</a> (agammaglobulinemia) [7][74.60%]</li>
<li><a href="html/MONDO_0015978.html">MONDO:0015978</a> (functional neutrophil defect) [2][70.83%]</li>
<li><a href="html/MONDO_0015979.html">MONDO:0015979</a> (genetic susceptibility to infections due to particular pathogens) [8][56.60%]</li>
<li><a href="html/MONDO_0015980.html">MONDO:0015980</a> (rare genetic gynecological and obstetrical diseases) [46][45.43%]</li>
<li><a href="html/MONDO_0015981.html">MONDO:0015981</a> (genetic gynecological tumor) [2][66.67%]</li>
<li><a href="html/MONDO_0015982.html">MONDO:0015982</a> (rare genetic intellectual disability) [136][57.82%]</li>
<li><a href="html/MONDO_0015983.html">MONDO:0015983</a> (rare genetic syndromic intellectual disability) [128][54.82%]</li>
<li><a href="html/MONDO_0015984.html">MONDO:0015984</a> (rare genetic immune disease) [164][54.48%]</li>
<li><a href="html/MONDO_0015991.html">MONDO:0015991</a> (citrullinemia) [3][70.00%]</li>
<li><a href="html/MONDO_0016001.html">MONDO:0016001</a> (2-hydroxyglutaric aciduria) [1][83.33%]</li>
<li><a href="html/MONDO_0016006.html">MONDO:0016006</a> (Cockayne syndrome) [1][68.75%]</li>
<li><a href="html/MONDO_0016021.html">MONDO:0016021</a> (early infantile epileptic encephalopathy) [3][63.64%]</li>
<li><a href="html/MONDO_0016023.html">MONDO:0016023</a> (ocular coloboma) [1][47.86%]</li>
<li><a href="html/MONDO_0016034.html">MONDO:0016034</a> (cleft lip with or without cleft palate) [3][42.65%]</li>
<li><a href="html/MONDO_0016046.html">MONDO:0016046</a> (familial clubfoot with or without associated lower limb anomalies) [1][62.50%]</li>
<li><a href="html/MONDO_0016054.html">MONDO:0016054</a> (cerebral malformation) [30][41.28%]</li>
<li><a href="html/MONDO_0016055.html">MONDO:0016055</a> (syndrome with corpus callosum agenesis /dysgenesis as a major feature) [4][71.43%]</li>
<li><a href="html/MONDO_0016056.html">MONDO:0016056</a> (isolated congenital microcephaly) [2][58.14%]</li>
<li><a href="html/MONDO_0016058.html">MONDO:0016058</a> (paroxysmal dystonia) [3][71.43%]</li>
<li><a href="html/MONDO_0016060.html">MONDO:0016060</a> (Laryngotracheoesophageal cleft) [1][75.00%]</li>
<li><a href="html/MONDO_0016063.html">MONDO:0016063</a> (Cowden disease) [1][75.00%]</li>
<li><a href="html/MONDO_0016064.html">MONDO:0016064</a> (cleft palate) [1][75.00%]</li>
<li><a href="html/MONDO_0016072.html">MONDO:0016072</a> (anomaly of puberty or/and menstrual cycle of genetic origin) [23][51.89%]</li>
<li><a href="html/MONDO_0016073.html">MONDO:0016073</a> (syndromic microphthalmia) [8][55.42%]</li>
<li><a href="html/MONDO_0016088.html">MONDO:0016088</a> (hypoxanthine-guanine phosphoribosyltransferase deficiency) [1][83.33%]</li>
<li><a href="html/MONDO_0016105.html">MONDO:0016105</a> (acquired skeletal muscle disease) [13][33.50%]</li>
<li><a href="html/MONDO_0016106.html">MONDO:0016106</a> (progressive muscular dystrophy) [16][45.14%]</li>
<li><a href="html/MONDO_0016108.html">MONDO:0016108</a> (autosomal dominant distal myopathy) [1][75.00%]</li>
<li><a href="html/MONDO_0016109.html">MONDO:0016109</a> (autosomal recessive distal myopathy) [2][66.67%]</li>
<li><a href="html/MONDO_0016110.html">MONDO:0016110</a> (non-dystrophic myopathy) [51][49.60%]</li>
<li><a href="html/MONDO_0016112.html">MONDO:0016112</a> (inclusion myopathy) [3][66.67%]</li>
<li><a href="html/MONDO_0016113.html">MONDO:0016113</a> (bulbospinal muscular atrophy) [7][38.29%]</li>
<li><a href="html/MONDO_0016114.html">MONDO:0016114</a> (bulbospinal muscular atrophy of childhood) [1][62.50%]</li>
<li><a href="html/MONDO_0016117.html">MONDO:0016117</a> (muscular lipidosis) [12][58.14%]</li>
<li><a href="html/MONDO_0016118.html">MONDO:0016118</a> (muscular glycogenosis) [3][24.28%]</li>
<li><a href="html/MONDO_0016120.html">MONDO:0016120</a> (myotonic syndrome) [6][69.10%]</li>
<li><a href="html/MONDO_0016121.html">MONDO:0016121</a> (congenital myotonia) [1][75.00%]</li>
<li><a href="html/MONDO_0016122.html">MONDO:0016122</a> (periodic paralysis (disease)) [2][64.29%]</li>
<li><a href="html/MONDO_0016123.html">MONDO:0016123</a> (muscular tumor) [4][66.67%]</li>
<li><a href="html/MONDO_0016131.html">MONDO:0016131</a> (spinal muscular atrophy associated with central nervous system anomaly) [2][65.00%]</li>
<li><a href="html/MONDO_0016132.html">MONDO:0016132</a> (rare hereditary disease with peripheral neuropathy) [31][44.53%]</li>
<li><a href="html/MONDO_0016133.html">MONDO:0016133</a> (rare hereditary metabolic disease with peripheral neuropathy) [24][46.42%]</li>
<li><a href="html/MONDO_0016134.html">MONDO:0016134</a> (rare hereditary systemic disease with peripheral neuropathy) [1][66.67%]</li>
<li><a href="html/MONDO_0016135.html">MONDO:0016135</a> (rare hereditary neurologic disease with peripheral neuropathy) [2][75.00%]</li>
<li><a href="html/MONDO_0016136.html">MONDO:0016136</a> (cerebellar ataxia with peripheral neuropathy) [1][83.33%]</li>
<li><a href="html/MONDO_0016137.html">MONDO:0016137</a> (acute and subacute inflammatory demyelinating polyneuropathy) [6][35.61%]</li>
<li><a href="html/MONDO_0016138.html">MONDO:0016138</a> (malignant lymphoma with peripheral neuropathy) [1][83.33%]</li>
<li><a href="html/MONDO_0016139.html">MONDO:0016139</a> (qualitative or quantitative protein defects in neuromuscular diseases) [69][39.53%]</li>
<li><a href="html/MONDO_0016145.html">MONDO:0016145</a> (qualitative or quantitative defects of dysferlin) [1][66.67%]</li>
<li><a href="html/MONDO_0016146.html">MONDO:0016146</a> (qualitative or quantitative defects of caveolin-3) [1][83.33%]</li>
<li><a href="html/MONDO_0016147.html">MONDO:0016147</a> (qualitative or quantitative defects of dystrophin) [2][62.50%]</li>
<li><a href="html/MONDO_0016148.html">MONDO:0016148</a> (qualitative or quantitative defects of collagen 6) [4][75.00%]</li>
<li><a href="html/MONDO_0016154.html">MONDO:0016154</a> (qualitative or quantitative defects of myotubularin) [1][75.00%]</li>
<li><a href="html/MONDO_0016155.html">MONDO:0016155</a> (qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan) [7][62.08%]</li>
<li><a href="html/MONDO_0016156.html">MONDO:0016156</a> (qualitative or quantitative defects of FKRP) [2][71.43%]</li>
<li><a href="html/MONDO_0016157.html">MONDO:0016157</a> (qualitative or quantitative defects of fukutin) [2][71.43%]</li>
<li><a href="html/MONDO_0016158.html">MONDO:0016158</a> (narcolepsy) [1][90.82%]</li>
<li><a href="html/MONDO_0016165.html">MONDO:0016165</a> (genetic hypoparathyroidism) [13][54.33%]</li>
<li><a href="html/MONDO_0016166.html">MONDO:0016166</a> (genetic hyperparathyroidism) [4][62.50%]</li>
<li><a href="html/MONDO_0016168.html">MONDO:0016168</a> (Cryopyrin-associated periodic syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0016169.html">MONDO:0016169</a> (chronic acquired demyelinating polyneuropathy) [2][62.50%]</li>
<li><a href="html/MONDO_0016170.html">MONDO:0016170</a> (chronic polyradiculoneuropathy) [1][66.67%]</li>
<li><a href="html/MONDO_0016175.html">MONDO:0016175</a> (cutis laxa) [5][81.59%]</li>
<li><a href="html/MONDO_0016177.html">MONDO:0016177</a> (systemic inflammatory disease associated with an acquired peripheral neuropathy) [4][62.50%]</li>
<li><a href="html/MONDO_0016179.html">MONDO:0016179</a> (acquired amyloid peripheral neuropathy) [1][100.00%]</li>
<li><a href="html/MONDO_0016180.html">MONDO:0016180</a> (hematological disease associated with an acquired peripheral neuropathy) [5][66.67%]</li>
<li><a href="html/MONDO_0016182.html">MONDO:0016182</a> (qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase) [2][71.43%]</li>
<li><a href="html/MONDO_0016184.html">MONDO:0016184</a> (qualitative or quantitative defects of protein O-mannosyltransferase 1) [2][71.43%]</li>
<li><a href="html/MONDO_0016185.html">MONDO:0016185</a> (qualitative or quantitative defects of protein O-mannosyltransferase 2) [2][71.43%]</li>
<li><a href="html/MONDO_0016191.html">MONDO:0016191</a> (qualitative or quantitative defects of titin) [1][83.33%]</li>
<li><a href="html/MONDO_0016193.html">MONDO:0016193</a> (qualitative or quantitative defects of alpha-actin) [8][63.16%]</li>
<li><a href="html/MONDO_0016194.html">MONDO:0016194</a> (qualitative or quantitative defects of nebulin) [7][65.62%]</li>
<li><a href="html/MONDO_0016195.html">MONDO:0016195</a> (qualitative or quantitative defects of beta-myosin heavy chain (MYH7)) [1][66.67%]</li>
<li><a href="html/MONDO_0016196.html">MONDO:0016196</a> (qualitative or quantitative defects of emerin) [1][62.50%]</li>
<li><a href="html/MONDO_0016197.html">MONDO:0016197</a> (qualitative or quantitative defects of selenoprotein N1) [3][65.00%]</li>
<li><a href="html/MONDO_0016200.html">MONDO:0016200</a> (qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase -) [1][66.67%]</li>
<li><a href="html/MONDO_0016210.html">MONDO:0016210</a> (alternating hemiplegia) [1][83.33%]</li>
<li><a href="html/MONDO_0016218.html">MONDO:0016218</a> (Guillain-BarrC) syndrome) [5][37.99%]</li>
<li><a href="html/MONDO_0016224.html">MONDO:0016224</a> (autosomal dominant proximal spinal muscular atrophy) [1][66.67%]</li>
<li><a href="html/MONDO_0016227.html">MONDO:0016227</a> (hereditary episodic ataxia) [1][83.33%]</li>
<li><a href="html/MONDO_0016228.html">MONDO:0016228</a> (rare vascular tumor) [5][57.49%]</li>
<li><a href="html/MONDO_0016229.html">MONDO:0016229</a> (genetic vascular anomaly) [13][52.95%]</li>
<li><a href="html/MONDO_0016230.html">MONDO:0016230</a> (simple vascular malformation) [19][35.29%]</li>
<li><a href="html/MONDO_0016231.html">MONDO:0016231</a> (rare capillary malformation) [3][70.00%]</li>
<li><a href="html/MONDO_0016232.html">MONDO:0016232</a> (rare venous malformation) [1][75.00%]</li>
<li><a href="html/MONDO_0016233.html">MONDO:0016233</a> (rare lymphatic system malformation) [8][60.23%]</li>
<li><a href="html/MONDO_0016235.html">MONDO:0016235</a> (complex vascular malformation with associated anomalies) [2][70.00%]</li>
<li><a href="html/MONDO_0016239.html">MONDO:0016239</a> (cystinosis) [1][83.33%]</li>
<li><a href="html/MONDO_0016244.html">MONDO:0016244</a> (atypical hemolytic-uremic syndrome) [3][24.63%]</li>
<li><a href="html/MONDO_0016248.html">MONDO:0016248</a> (familial ovarian cancer) [1][70.00%]</li>
<li><a href="html/MONDO_0016292.html">MONDO:0016292</a> (nodular neuronal heterotopia) [1][64.29%]</li>
<li><a href="html/MONDO_0016295.html">MONDO:0016295</a> (neuronal ceroid lipofuscinosis) [4][72.22%]</li>
<li><a href="html/MONDO_0016296.html">MONDO:0016296</a> (holoprosencephaly) [5][53.32%]</li>
<li><a href="html/MONDO_0016297.html">MONDO:0016297</a> (prelingual non-syndromic genetic deafness) [4][49.05%]</li>
<li><a href="html/MONDO_0016298.html">MONDO:0016298</a> (postlingual non-syndromic genetic deafness) [4][49.05%]</li>
<li><a href="html/MONDO_0016320.html">MONDO:0016320</a> (rare hereditary thrombophilia) [2][87.31%]</li>
<li><a href="html/MONDO_0016325.html">MONDO:0016325</a> (glycogen storage disease with hypertrophic cardiomyopathy) [1][75.00%]</li>
<li><a href="html/MONDO_0016326.html">MONDO:0016326</a> (lysosomal disease with hypertrophic cardiomyopathy) [2][62.50%]</li>
<li><a href="html/MONDO_0016327.html">MONDO:0016327</a> (mitochondrial disease with hypertrophic cardiomyopathy) [3][66.67%]</li>
<li><a href="html/MONDO_0016328.html">MONDO:0016328</a> (fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy) [2][62.50%]</li>
<li><a href="html/MONDO_0016329.html">MONDO:0016329</a> (syndrome associated with hypertrophic cardiomyopathy) [7][60.29%]</li>
<li><a href="html/MONDO_0016330.html">MONDO:0016330</a> (non-familial hypertrophic cardiomyopathy) [2][75.00%]</li>
<li><a href="html/MONDO_0016333.html">MONDO:0016333</a> (familial dilated cardiomyopathy) [19][32.53%]</li>
<li><a href="html/MONDO_0016334.html">MONDO:0016334</a> (neuromuscular disease with dilated cardiomyopathy) [7][65.62%]</li>
<li><a href="html/MONDO_0016335.html">MONDO:0016335</a> (mitochondrial disease with dilated cardiomyopathy) [3][66.67%]</li>
<li><a href="html/MONDO_0016337.html">MONDO:0016337</a> (syndrome associated with dilated cardiomyopathy) [1][100.00%]</li>
<li><a href="html/MONDO_0016340.html">MONDO:0016340</a> (familial restrictive cardiomyopathy) [5][44.24%]</li>
<li><a href="html/MONDO_0016341.html">MONDO:0016341</a> (lysosomal disease with restrictive cardiomyopathy) [1][75.00%]</li>
<li><a href="html/MONDO_0016342.html">MONDO:0016342</a> (familial isolated arrhythmogenic right ventricular dysplasia) [3][60.82%]</li>
<li><a href="html/MONDO_0016343.html">MONDO:0016343</a> (unclassified cardiomyopathy) [1][83.50%]</li>
<li><a href="html/MONDO_0016345.html">MONDO:0016345</a> (non-familial restrictive cardiomyopathy) [6][63.64%]</li>
<li><a href="html/MONDO_0016347.html">MONDO:0016347</a> (rare cardiac rhythm disease) [14][62.50%]</li>
<li><a href="html/MONDO_0016361.html">MONDO:0016361</a> (isolated hereditary giant platelet disorder) [5][63.64%]</li>
<li><a href="html/MONDO_0016362.html">MONDO:0016362</a> (attenuated familial adenomatous polyposis) [2][65.00%]</li>
<li><a href="html/MONDO_0016363.html">MONDO:0016363</a> (rare hereditary hemochromatosis) [1][66.67%]</li>
<li><a href="html/MONDO_0016365.html">MONDO:0016365</a> (familial primary hyperparathyroidism) [3][64.85%]</li>
<li><a href="html/MONDO_0016375.html">MONDO:0016375</a> (acquired peripheral movement disorder) [2][75.00%]</li>
<li><a href="html/MONDO_0016382.html">MONDO:0016382</a> (hereditary poikiloderma) [4][73.14%]</li>
<li><a href="html/MONDO_0016387.html">MONDO:0016387</a> (mitochondrial oxidative phosphorylation disorder) [43][45.40%]</li>
<li><a href="html/MONDO_0016388.html">MONDO:0016388</a> (bone sarcoma) [4][44.58%]</li>
<li><a href="html/MONDO_0016390.html">MONDO:0016390</a> (familial isolated hypoparathyroidism) [3][62.50%]</li>
<li><a href="html/MONDO_0016391.html">MONDO:0016391</a> (neonatal diabetes mellitus) [3][78.57%]</li>
<li><a href="html/MONDO_0016397.html">MONDO:0016397</a> (lysosomal disease with epilepsy) [21][54.76%]</li>
<li><a href="html/MONDO_0016398.html">MONDO:0016398</a> (peroxisomal disease with epilepsy) [6][63.15%]</li>
<li><a href="html/MONDO_0016399.html">MONDO:0016399</a> (amino acid or protein metabolism disease with epilepsy) [8][63.64%]</li>
<li><a href="html/MONDO_0016401.html">MONDO:0016401</a> (energy metabolism disorder with epilepsy) [7][58.80%]</li>
<li><a href="html/MONDO_0016402.html">MONDO:0016402</a> (mitochondrial disease with epilepsy) [4][64.29%]</li>
<li><a href="html/MONDO_0016403.html">MONDO:0016403</a> (mitochondrial disease with peripheral neuropathy) [7][62.50%]</li>
<li><a href="html/MONDO_0016404.html">MONDO:0016404</a> (metabolic neurotransmission anomaly with epilepsy) [3][68.75%]</li>
<li><a href="html/MONDO_0016408.html">MONDO:0016408</a> (permanent congenital hypothyroidism) [11][68.39%]</li>
<li><a href="html/MONDO_0016409.html">MONDO:0016409</a> (primary congenital hypothyroidism) [6][62.68%]</li>
<li><a href="html/MONDO_0016412.html">MONDO:0016412</a> (peripheral hypothyroidism) [1][66.67%]</li>
<li><a href="html/MONDO_0016419.html">MONDO:0016419</a> (hereditary breast cancer) [1][70.00%]</li>
<li><a href="html/MONDO_0016420.html">MONDO:0016420</a> (familial flecked retinopathy) [3][53.73%]</li>
<li><a href="html/MONDO_0016432.html">MONDO:0016432</a> (heart-hand syndrome) [1][100.00%]</li>
<li><a href="html/MONDO_0016462.html">MONDO:0016462</a> (isolated agammaglobulinemia) [2][92.31%]</li>
<li><a href="html/MONDO_0016468.html">MONDO:0016468</a> (toxin-mediated infectious botulism) [1][100.00%]</li>
<li><a href="html/MONDO_0016517.html">MONDO:0016517</a> (rare genetic vascular disease) [32][45.28%]</li>
<li><a href="html/MONDO_0016518.html">MONDO:0016518</a> (isolated punctate palmoplantar keratoderma) [2][62.50%]</li>
<li><a href="html/MONDO_0016524.html">MONDO:0016524</a> (congenital vascular bone syndrome) [2][70.00%]</li>
<li><a href="html/MONDO_0016535.html">MONDO:0016535</a> (hypohidrotic ectodermal dysplasia) [3][70.00%]</li>
<li><a href="html/MONDO_0016537.html">MONDO:0016537</a> (lymphoproliferative syndrome) [3][65.00%]</li>
<li><a href="html/MONDO_0016538.html">MONDO:0016538</a> (hypotonia-cystinuria syndrome type 1) [1][87.50%]</li>
<li><a href="html/MONDO_0016540.html">MONDO:0016540</a> (congenital secondary polycythemia) [1][83.33%]</li>
<li><a href="html/MONDO_0016565.html">MONDO:0016565</a> (syndromic obesity) [10][56.55%]</li>
<li><a href="html/MONDO_0016578.html">MONDO:0016578</a> (mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies) [29][49.91%]</li>
<li><a href="html/MONDO_0016581.html">MONDO:0016581</a> (conotruncal heart malformations) [4][55.11%]</li>
<li><a href="html/MONDO_0016582.html">MONDO:0016582</a> (congenital mitral malformation) [3][66.67%]</li>
<li><a href="html/MONDO_0016586.html">MONDO:0016586</a> (systemic mastocytosis) [3][83.33%]</li>
<li><a href="html/MONDO_0016587.html">MONDO:0016587</a> (arrhythmogenic right ventricular cardiomyopathy) [4][75.00%]</li>
<li><a href="html/MONDO_0016602.html">MONDO:0016602</a> (citrin deficiency) [1][75.00%]</li>
<li><a href="html/MONDO_0016620.html">MONDO:0016620</a> (primary hypertrophic osteoarthropathy) [1][73.84%]</li>
<li><a href="html/MONDO_0016623.html">MONDO:0016623</a> (rare deficiency anemia) [12][60.72%]</li>
<li><a href="html/MONDO_0016624.html">MONDO:0016624</a> (constitutional deficiency anemia) [10][63.04%]</li>
<li><a href="html/MONDO_0016627.html">MONDO:0016627</a> (rare hemorrhagic disorder) [41][57.92%]</li>
<li><a href="html/MONDO_0016628.html">MONDO:0016628</a> (rare hemorrhagic disorder due to a coagulation factors defect) [14][63.64%]</li>
<li><a href="html/MONDO_0016629.html">MONDO:0016629</a> (rare hemorrhagic disorder due to a platelet anomaly) [25][58.43%]</li>
<li><a href="html/MONDO_0016632.html">MONDO:0016632</a> (rare thrombotic disorder due to a coagulation factors defect) [5][73.42%]</li>
<li><a href="html/MONDO_0016633.html">MONDO:0016633</a> (rare thrombotic disorder due to a constitutional coagulation factors defect) [3][81.36%]</li>
<li><a href="html/MONDO_0016635.html">MONDO:0016635</a> (rare thrombotic disorder due to a platelet anomaly) [8][65.00%]</li>
<li><a href="html/MONDO_0016636.html">MONDO:0016636</a> (rare thrombotic disorder due to a constitutional platelet anomaly) [1][83.71%]</li>
<li><a href="html/MONDO_0016637.html">MONDO:0016637</a> (rare thrombotic disorder due to an acquired platelet anomaly) [5][75.38%]</li>
<li><a href="html/MONDO_0016645.html">MONDO:0016645</a> (rare neoplastic disease) [395][54.38%]</li>
<li><a href="html/MONDO_0016648.html">MONDO:0016648</a> (multiple epiphyseal dysplasia (disease)) [1][62.50%]</li>
<li><a href="html/MONDO_0016677.html">MONDO:0016677</a> (toxic or drug-related embryofetopathy) [2][75.00%]</li>
<li><a href="html/MONDO_0016678.html">MONDO:0016678</a> (maternal disease-related embryofetopathy) [1][75.00%]</li>
<li><a href="html/MONDO_0016679.html">MONDO:0016679</a> (rare tumor of neuroepithelial tissue) [32][22.35%]</li>
<li><a href="html/MONDO_0016680.html">MONDO:0016680</a> (high-grade astrocytoma) [1][83.33%]</li>
<li><a href="html/MONDO_0016697.html">MONDO:0016697</a> (low grade ependymoma) [3][16.77%]</li>
<li><a href="html/MONDO_0016708.html">MONDO:0016708</a> (embryonal tumor of neuroepithelial tissue) [6][46.87%]</li>
<li><a href="html/MONDO_0016713.html">MONDO:0016713</a> (central nervous system primitive neuroectodermal tumor) [3][41.02%]</li>
<li><a href="html/MONDO_0016717.html">MONDO:0016717</a> (choroid plexus tumor) [1][83.33%]</li>
<li><a href="html/MONDO_0016721.html">MONDO:0016721</a> (pineal tumor of neuroepithelial tissue) [1][100.00%]</li>
<li><a href="html/MONDO_0016743.html">MONDO:0016743</a> (tumor of meninges) [3][55.36%]</li>
<li><a href="html/MONDO_0016749.html">MONDO:0016749</a> (tumor of cranial and spinal nerves) [6][66.67%]</li>
<li><a href="html/MONDO_0016752.html">MONDO:0016752</a> (benign peripheral nerve sheath tumor) [2][75.00%]</li>
<li><a href="html/MONDO_0016756.html">MONDO:0016756</a> (inherited nervous system cancer-predisposing syndrome) [9][60.47%]</li>
<li><a href="html/MONDO_0016761.html">MONDO:0016761</a> (spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia) [10][63.46%]</li>
<li><a href="html/MONDO_0016764.html">MONDO:0016764</a> (isolated anophthalmia-microphthalmia syndrome) [8][55.24%]</li>
<li><a href="html/MONDO_0016784.html">MONDO:0016784</a> (gestational trophoblastic disease) [4][66.67%]</li>
<li><a href="html/MONDO_0016789.html">MONDO:0016789</a> (pyruvate metabolism disorder) [1][78.57%]</li>
<li><a href="html/MONDO_0016791.html">MONDO:0016791</a> (mitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies) [8][25.52%]</li>
<li><a href="html/MONDO_0016792.html">MONDO:0016792</a> (mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mitochondrial DNA) [1][75.00%]</li>
<li><a href="html/MONDO_0016793.html">MONDO:0016793</a> (mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA) [4][65.00%]</li>
<li><a href="html/MONDO_0016796.html">MONDO:0016796</a> (mitochondrial DNA depletion syndrome, encephalomyopathic form) [1][62.50%]</li>
<li><a href="html/MONDO_0016797.html">MONDO:0016797</a> (multiple mitochondrial DNA deletion syndrome) [5][70.67%]</li>
<li><a href="html/MONDO_0016798.html">MONDO:0016798</a> (ataxia neuropathy spectrum) [1][66.67%]</li>
<li><a href="html/MONDO_0016799.html">MONDO:0016799</a> (mitochondrial oxidative phosphorylation disorder with no known mechanism) [1][62.50%]</li>
<li><a href="html/MONDO_0016800.html">MONDO:0016800</a> (mitochondrial membrane transport disorder) [4][59.97%]</li>
<li><a href="html/MONDO_0016801.html">MONDO:0016801</a> (mitochondrial substrate carrier disorder) [2][64.29%]</li>
<li><a href="html/MONDO_0016805.html">MONDO:0016805</a> (isolated oxidative phosphorylation complex disorder) [3][53.32%]</li>
<li><a href="html/MONDO_0016808.html">MONDO:0016808</a> (mitochondrial DNA depletion syndrome, hepatocerebral form) [1][75.00%]</li>
<li><a href="html/MONDO_0016812.html">MONDO:0016812</a> (Dopa-responsive dystonia) [1][75.00%]</li>
<li><a href="html/MONDO_0016826.html">MONDO:0016826</a> (methylmalonic acidemia with homocystinuria) [1][71.43%]</li>
<li><a href="html/MONDO_0016828.html">MONDO:0016828</a> (autosomal recessive sideroblastic anemia) [1][66.67%]</li>
<li><a href="html/MONDO_0016830.html">MONDO:0016830</a> (Emery-Dreifuss muscular dystrophy) [4][62.50%]</li>
<li><a href="html/MONDO_0016867.html">MONDO:0016867</a> (partial deletion of chromosome 2) [5][68.75%]</li>
<li><a href="html/MONDO_0016870.html">MONDO:0016870</a> (partial deletion of chromosome 5) [3][66.67%]</li>
<li><a href="html/MONDO_0016876.html">MONDO:0016876</a> (partial deletion of chromosome 11) [4][20.17%]</li>
<li><a href="html/MONDO_0016879.html">MONDO:0016879</a> (partial deletion of chromosome 17) [3][57.49%]</li>
<li><a href="html/MONDO_0016884.html">MONDO:0016884</a> (partial deletion of the short arm of chromosome 2) [3][75.00%]</li>
<li><a href="html/MONDO_0016893.html">MONDO:0016893</a> (partial deletion of the short arm of chromosome 11) [1][66.67%]</li>
<li><a href="html/MONDO_0016899.html">MONDO:0016899</a> (Duchenne and Becker muscular dystrophy) [1][66.67%]</li>
<li><a href="html/MONDO_0016904.html">MONDO:0016904</a> (partial deletion of the long arm of chromosome 5) [1][75.00%]</li>
<li><a href="html/MONDO_0016910.html">MONDO:0016910</a> (partial deletion of the long arm of chromosome 11) [1][66.67%]</li>
<li><a href="html/MONDO_0016915.html">MONDO:0016915</a> (partial deletion of the long arm of chromosome 17) [1][62.50%]</li>
<li><a href="html/MONDO_0016920.html">MONDO:0016920</a> (partial deletion of the long arm of chromosome 22) [3][62.50%]</li>
<li><a href="html/MONDO_0016965.html">MONDO:0016965</a> (partial duplication of the long arm of chromosome 15) [1][75.00%]</li>
<li><a href="html/MONDO_0016987.html">MONDO:0016987</a> (neuroacanthocytosis) [1][100.00%]</li>
<li><a href="html/MONDO_0016997.html">MONDO:0016997</a> (hereditary epidermolysis bullosa associated with ocular features) [1][100.00%]</li>
<li><a href="html/MONDO_0016999.html">MONDO:0016999</a> (X chromosome number anomaly) [4][62.50%]</li>
<li><a href="html/MONDO_0017000.html">MONDO:0017000</a> (X chromosome number anomaly with female phenotype) [2][75.00%]</li>
<li><a href="html/MONDO_0017003.html">MONDO:0017003</a> (partial deletion of chromosome X) [4][62.50%]</li>
<li><a href="html/MONDO_0017007.html">MONDO:0017007</a> (partial deletion of the long arm of chromosome X) [2][66.67%]</li>
<li><a href="html/MONDO_0017008.html">MONDO:0017008</a> (partial duplication of chromosome X) [3][66.67%]</li>
<li><a href="html/MONDO_0017010.html">MONDO:0017010</a> (partial duplication of the long arm of chromosome X) [1][62.50%]</li>
<li><a href="html/MONDO_0017014.html">MONDO:0017014</a> (interstitial lung disease specific to childhood) [25][34.40%]</li>
<li><a href="html/MONDO_0017015.html">MONDO:0017015</a> (primary interstitial lung disease specific to childhood) [6][66.67%]</li>
<li><a href="html/MONDO_0017016.html">MONDO:0017016</a> (primary interstitial lung disease specific to childhood due to alveolar structure disorder) [3][72.22%]</li>
<li><a href="html/MONDO_0017020.html">MONDO:0017020</a> (secondary interstitial lung disease specific to childhood associated with a systemic disease) [17][39.81%]</li>
<li><a href="html/MONDO_0017021.html">MONDO:0017021</a> (secondary interstitial lung disease specific to childhood associated with a connective tissue disease) [8][63.33%]</li>
<li><a href="html/MONDO_0017023.html">MONDO:0017023</a> (secondary interstitial lung disease specific to childhood associated with a granulomatous disease) [1][81.25%]</li>
<li><a href="html/MONDO_0017024.html">MONDO:0017024</a> (secondary interstitial lung disease specific to childhood associated with a metabolic disease) [3][65.00%]</li>
<li><a href="html/MONDO_0017026.html">MONDO:0017026</a> (interstitial lung disease specific to adulthood) [14][27.86%]</li>
<li><a href="html/MONDO_0017027.html">MONDO:0017027</a> (primary interstitial lung disease specific to adulthood) [11][31.43%]</li>
<li><a href="html/MONDO_0017030.html">MONDO:0017030</a> (interstitial lung disease in childhood and adulthood) [19][18.35%]</li>
<li><a href="html/MONDO_0017031.html">MONDO:0017031</a> (primary interstitial lung disease in childhood and adulthood) [4][21.50%]</li>
<li><a href="html/MONDO_0017034.html">MONDO:0017034</a> (secondary interstitial lung disease in childhood and adulthood) [13][19.67%]</li>
<li><a href="html/MONDO_0017035.html">MONDO:0017035</a> (secondary interstitial lung disease in childhood and adulthood associated with a systemic disease) [7][65.00%]</li>
<li><a href="html/MONDO_0017037.html">MONDO:0017037</a> (secondary interstitial lung disease in childhood and adulthood associated with a metabolic disease) [1][83.33%]</li>
<li><a href="html/MONDO_0017038.html">MONDO:0017038</a> (secondary interstitial lung disease in childhood and adulthood associated with a systemic vasculitis) [2][83.33%]</li>
<li><a href="html/MONDO_0017040.html">MONDO:0017040</a> (exposure-related interstitial lung disease) [3][62.50%]</li>
<li><a href="html/MONDO_0017042.html">MONDO:0017042</a> (thanatophoric dysplasia) [1][75.00%]</li>
<li><a href="html/MONDO_0017057.html">MONDO:0017057</a> (hereditary thrombocytopenia with normal platelets) [1][62.50%]</li>
<li><a href="html/MONDO_0017059.html">MONDO:0017059</a> (neural tube closure defect) [9][62.50%]</li>
<li><a href="html/MONDO_0017090.html">MONDO:0017090</a> (midline cerebral malformation) [7][68.42%]</li>
<li><a href="html/MONDO_0017091.html">MONDO:0017091</a> (bilateral polymicrogyria) [2][66.67%]</li>
<li><a href="html/MONDO_0017103.html">MONDO:0017103</a> (Encephaloclastic disorder) [3][68.69%]</li>
<li><a href="html/MONDO_0017104.html">MONDO:0017104</a> (central nervous system cystic malformation) [3][66.67%]</li>
<li><a href="html/MONDO_0017114.html">MONDO:0017114</a> (global cerebellar malformation) [1][66.67%]</li>
<li><a href="html/MONDO_0017118.html">MONDO:0017118</a> (syndrome with a cerebellar malformation as major feature) [7][64.77%]</li>
<li><a href="html/MONDO_0017119.html">MONDO:0017119</a> (syndrome with microcephaly as major feature) [7][58.51%]</li>
<li><a href="html/MONDO_0017120.html">MONDO:0017120</a> (other syndrome with a central nervous system malformation as major feature) [6][62.50%]</li>
<li><a href="html/MONDO_0017121.html">MONDO:0017121</a> (syndrome with a Dandy-Walker malformation as major feature) [2][66.67%]</li>
<li><a href="html/MONDO_0017122.html">MONDO:0017122</a> (genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature) [3][75.00%]</li>
<li><a href="html/MONDO_0017127.html">MONDO:0017127</a> (genetic soft tissue tumor) [2][34.97%]</li>
<li><a href="html/MONDO_0017128.html">MONDO:0017128</a> (genetic digestive tract tumor) [8][50.95%]</li>
<li><a href="html/MONDO_0017129.html">MONDO:0017129</a> (genetic cardiac tumor) [1][62.50%]</li>
<li><a href="html/MONDO_0017131.html">MONDO:0017131</a> (genetic cardiac anomaly) [9][41.30%]</li>
<li><a href="html/MONDO_0017132.html">MONDO:0017132</a> (hereditary ATTR amyloidosis) [1][66.67%]</li>
<li><a href="html/MONDO_0017133.html">MONDO:0017133</a> (rare genetic systemic or rheumatologic disease) [39][43.39%]</li>
<li><a href="html/MONDO_0017140.html">MONDO:0017140</a> (L1 syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0017141.html">MONDO:0017141</a> (rare hemorrhagic disorder due to a constitutional thrombocytopenia) [19][60.55%]</li>
<li><a href="html/MONDO_0017142.html">MONDO:0017142</a> (rare hemorrhagic disorder due to a qualitative platelet defect) [1][66.67%]</li>
<li><a href="html/MONDO_0017143.html">MONDO:0017143</a> (genetic infertility) [66][53.01%]</li>
<li><a href="html/MONDO_0017144.html">MONDO:0017144</a> (alpha-thalassemia and related diseases) [2][66.67%]</li>
<li><a href="html/MONDO_0017145.html">MONDO:0017145</a> (beta-thalassemia and related diseases) [4][70.23%]</li>
<li><a href="html/MONDO_0017160.html">MONDO:0017160</a> (behavioral variant of frontotemporal dementia) [1][66.67%]</li>
<li><a href="html/MONDO_0017166.html">MONDO:0017166</a> (rare tumor of salivary glands) [1][75.00%]</li>
<li><a href="html/MONDO_0017169.html">MONDO:0017169</a> (multiple endocrine neoplasia) [1][100.00%]</li>
<li><a href="html/MONDO_0017182.html">MONDO:0017182</a> (familial hyperinsulinism) [7][47.86%]</li>
<li><a href="html/MONDO_0017198.html">MONDO:0017198</a> (osteopetrosis (disease)) [4][77.37%]</li>
<li><a href="html/MONDO_0017214.html">MONDO:0017214</a> (vitamin B12-responsive methylmalonic acidemia) [1][71.43%]</li>
<li><a href="html/MONDO_0017234.html">MONDO:0017234</a> (inherited prion disease) [1][83.33%]</li>
<li><a href="html/MONDO_0017253.html">MONDO:0017253</a> (anterior uveitis) [6][65.62%]</li>
<li><a href="html/MONDO_0017254.html">MONDO:0017254</a> (posterior uveitis (disease)) [4][67.86%]</li>
<li><a href="html/MONDO_0017255.html">MONDO:0017255</a> (panuveitis (disease)) [3][69.23%]</li>
<li><a href="html/MONDO_0017259.html">MONDO:0017259</a> (systemic diseases with anterior uveitis) [4][67.86%]</li>
<li><a href="html/MONDO_0017260.html">MONDO:0017260</a> (systemic diseases with posterior uveitis) [2][70.83%]</li>
<li><a href="html/MONDO_0017261.html">MONDO:0017261</a> (systemic diseases with panuveitis) [2][70.83%]</li>
<li><a href="html/MONDO_0017262.html">MONDO:0017262</a> (inherited non-syndromic ichthyosis) [13][61.29%]</li>
<li><a href="html/MONDO_0017263.html">MONDO:0017263</a> (inherited ichthyosis syndromic form) [16][60.39%]</li>
<li><a href="html/MONDO_0017265.html">MONDO:0017265</a> (autosomal recessive congenital ichthyosis) [5][69.36%]</li>
<li><a href="html/MONDO_0017266.html">MONDO:0017266</a> (Keratinopathic ichthyosis) [1][93.30%]</li>
<li><a href="html/MONDO_0017269.html">MONDO:0017269</a> (X-linked ichthyosis syndrome) [3][70.00%]</li>
<li><a href="html/MONDO_0017270.html">MONDO:0017270</a> (autosomal ichthyosis syndrome) [11][56.54%]</li>
<li><a href="html/MONDO_0017271.html">MONDO:0017271</a> (autosomal ichthyosis syndrome with prominent hair abnormalities) [2][64.29%]</li>
<li><a href="html/MONDO_0017272.html">MONDO:0017272</a> (autosomal ichthyosis syndrome with prominent neurologics signs) [3][62.50%]</li>
<li><a href="html/MONDO_0017273.html">MONDO:0017273</a> (autosomal ichthyosis syndrome with fatal disease course) [1][83.33%]</li>
<li><a href="html/MONDO_0017274.html">MONDO:0017274</a> (autosomal ichthyosis syndrome with other associated signs) [1][62.50%]</li>
<li><a href="html/MONDO_0017276.html">MONDO:0017276</a> (frontotemporal dementia) [5][62.50%]</li>
<li><a href="html/MONDO_0017279.html">MONDO:0017279</a> (young-onset Parkinson disease) [1][62.50%]</li>
<li><a href="html/MONDO_0017287.html">MONDO:0017287</a> (IgG4-related disease) [2][66.67%]</li>
<li><a href="html/MONDO_0017290.html">MONDO:0017290</a> (familial intrahepatic cholestasis) [6][71.43%]</li>
<li><a href="html/MONDO_0017303.html">MONDO:0017303</a> (qualitative or quantitative defects of tropomyosin) [7][64.71%]</li>
<li><a href="html/MONDO_0017305.html">MONDO:0017305</a> (syndromic oculocutaneous albinism) [4][68.42%]</li>
<li><a href="html/MONDO_0017306.html">MONDO:0017306</a> (disorder of phenylalanine metabolism) [2][81.25%]</li>
<li><a href="html/MONDO_0017307.html">MONDO:0017307</a> (disorder of tyrosine metabolism) [1][75.00%]</li>
<li><a href="html/MONDO_0017310.html">MONDO:0017310</a> (Marfan and Marfan-related disorder) [6][64.58%]</li>
<li><a href="html/MONDO_0017311.html">MONDO:0017311</a> (rare disease with thoracic aortic aneurysm and aortic dissection) [7][66.31%]</li>
<li><a href="html/MONDO_0017322.html">MONDO:0017322</a> (disorders of vitamin d metabolism) [6][64.29%]</li>
<li><a href="html/MONDO_0017323.html">MONDO:0017323</a> (Hypocalcemic rickets) [2][66.67%]</li>
<li><a href="html/MONDO_0017333.html">MONDO:0017333</a> (hypomyelinating leukodystrophy with or without oligondontia and/or hypogonadism) [1][66.67%]</li>
<li><a href="html/MONDO_0017341.html">MONDO:0017341</a> (rare virus associated tumor) [14][30.80%]</li>
<li><a href="html/MONDO_0017342.html">MONDO:0017342</a> (Epstein-Barr virus-related tumor) [9][33.27%]</li>
<li><a href="html/MONDO_0017343.html">MONDO:0017343</a> (Epstein-Barr virus-associated malignant lymphoproliferative disorder) [3][64.29%]</li>
<li><a href="html/MONDO_0017344.html">MONDO:0017344</a> (Epstein-Barr virus-associated carcinoma) [1][62.50%]</li>
<li><a href="html/MONDO_0017345.html">MONDO:0017345</a> (Epstein-Barr virus-associated mesenchymal tumor) [2][62.50%]</li>
<li><a href="html/MONDO_0017351.html">MONDO:0017351</a> (disorder of lysine and hydroxylysine metabolism) [1][83.33%]</li>
<li><a href="html/MONDO_0017355.html">MONDO:0017355</a> (disorder of proline metabolism) [3][64.29%]</li>
<li><a href="html/MONDO_0017368.html">MONDO:0017368</a> (systemic disease with skin involvement) [13][37.40%]</li>
<li><a href="html/MONDO_0017369.html">MONDO:0017369</a> (autoinflammatory syndrome with immune deficiency) [4][65.00%]</li>
<li><a href="html/MONDO_0017370.html">MONDO:0017370</a> (autoinflammatory syndrome with skin involvement) [4][65.00%]</li>
<li><a href="html/MONDO_0017371.html">MONDO:0017371</a> (rare head and neck tumor) [6][24.56%]</li>
<li><a href="html/MONDO_0017385.html">MONDO:0017385</a> (malignant migrating partial seizures of infancy) [1][66.67%]</li>
<li><a href="html/MONDO_0017390.html">MONDO:0017390</a> (methylmalonic acidemia without homocystinuria) [3][60.11%]</li>
<li><a href="html/MONDO_0017397.html">MONDO:0017397</a> (constitutional dyserythropoietic anemia) [2][71.43%]</li>
<li><a href="html/MONDO_0017410.html">MONDO:0017410</a> (porencephaly) [1][66.67%]</li>
<li><a href="html/MONDO_0017414.html">MONDO:0017414</a> (rare nevus) [5][62.50%]</li>
<li><a href="html/MONDO_0017415.html">MONDO:0017415</a> (multiple pterygium syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0017421.html">MONDO:0017421</a> (non-syndromic terminal limb defects) [18][23.56%]</li>
<li><a href="html/MONDO_0017422.html">MONDO:0017422</a> (Adactyly of hand) [2][66.67%]</li>
<li><a href="html/MONDO_0017423.html">MONDO:0017423</a> (split hand or/and split foot malformation) [3][56.65%]</li>
<li><a href="html/MONDO_0017424.html">MONDO:0017424</a> (non-syndromic brachydactyly) [3][66.67%]</li>
<li><a href="html/MONDO_0017425.html">MONDO:0017425</a> (preaxial polydactyly of fingers) [4][66.67%]</li>
<li><a href="html/MONDO_0017426.html">MONDO:0017426</a> (postaxial polydactyly of fingers) [3][62.50%]</li>
<li><a href="html/MONDO_0017427.html">MONDO:0017427</a> (congenital deformities of limbs) [3][57.49%]</li>
<li><a href="html/MONDO_0017429.html">MONDO:0017429</a> (joint formation defects) [5][62.50%]</li>
<li><a href="html/MONDO_0017430.html">MONDO:0017430</a> (congenital joint dislocations) [3][66.67%]</li>
<li><a href="html/MONDO_0017432.html">MONDO:0017432</a> (syndrome with limb reduction defects) [8][57.22%]</li>
<li><a href="html/MONDO_0017433.html">MONDO:0017433</a> (dysostosis with combined reduction defects of upper and lower limbs) [1][62.50%]</li>
<li><a href="html/MONDO_0017434.html">MONDO:0017434</a> (syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy) [5][59.33%]</li>
<li><a href="html/MONDO_0017576.html">MONDO:0017576</a> (46,XX disorder of sex development) [10][48.72%]</li>
<li><a href="html/MONDO_0017578.html">MONDO:0017578</a> (disorder of thiamine metabolism and transport) [1][66.67%]</li>
<li><a href="html/MONDO_0017594.html">MONDO:0017594</a> (indolent b-cell non-Hodgkin lymphoma) [5][39.29%]</li>
<li><a href="html/MONDO_0017595.html">MONDO:0017595</a> (aggressive b-cell non-Hodgkin lymphoma) [4][22.87%]</li>
<li><a href="html/MONDO_0017605.html">MONDO:0017605</a> (ependymal tumor) [4][15.41%]</li>
<li><a href="html/MONDO_0017608.html">MONDO:0017608</a> (dystrophic epidermolysis bullosa) [1][100.00%]</li>
<li><a href="html/MONDO_0017611.html">MONDO:0017611</a> (pituitary tumor) [9][62.50%]</li>
<li><a href="html/MONDO_0017612.html">MONDO:0017612</a> (junctional epidermolysis bullosa) [1][80.00%]</li>
<li><a href="html/MONDO_0017615.html">MONDO:0017615</a> (benign familial infantile epilepsy) [1][52.02%]</li>
<li><a href="html/MONDO_0017623.html">MONDO:0017623</a> (PTEN hamartoma tumor syndrome) [2][70.00%]</li>
<li><a href="html/MONDO_0017626.html">MONDO:0017626</a> (familial primary hypomagnesemia with normocalcuria) [1][75.00%]</li>
<li><a href="html/MONDO_0017631.html">MONDO:0017631</a> (rare tumor of gallbladder and extrahepatic biliary tract) [2][88.73%]</li>
<li><a href="html/MONDO_0017632.html">MONDO:0017632</a> (rare tumor of liver and intrahepatic biliary tract) [6][44.05%]</li>
<li><a href="html/MONDO_0017635.html">MONDO:0017635</a> (rare parkinsonian syndrome due to neurodegenerative disease) [6][63.19%]</li>
<li><a href="html/MONDO_0017641.html">MONDO:0017641</a> (miscellaneous movement disorder due to neurodegenerative disease) [21][52.47%]</li>
<li><a href="html/MONDO_0017643.html">MONDO:0017643</a> (frontotemporal neurodegeneration with movement disorder) [7][63.64%]</li>
<li><a href="html/MONDO_0017645.html">MONDO:0017645</a> (rare choreic movement disorder) [5][41.32%]</li>
<li><a href="html/MONDO_0017646.html">MONDO:0017646</a> (neurodegenerative disease with chorea) [2][52.02%]</li>
<li><a href="html/MONDO_0017650.html">MONDO:0017650</a> (rare myoclonus) [14][54.71%]</li>
<li><a href="html/MONDO_0017651.html">MONDO:0017651</a> (primary myoclonus) [3][72.22%]</li>
<li><a href="html/MONDO_0017652.html">MONDO:0017652</a> (rare disease with myoclonus as a major feature) [9][60.77%]</li>
<li><a href="html/MONDO_0017653.html">MONDO:0017653</a> (epilepsy and/or ataxia with myoclonus as major feature) [8][61.35%]</li>
<li><a href="html/MONDO_0017654.html">MONDO:0017654</a> (non progressive epilepsy and/or ataxia with myoclonus as a major feature) [5][66.22%]</li>
<li><a href="html/MONDO_0017655.html">MONDO:0017655</a> (progressive epilepsy and/or ataxia with myoclonus as a major feature) [1][62.50%]</li>
<li><a href="html/MONDO_0017656.html">MONDO:0017656</a> (motor stereotypies) [3][64.29%]</li>
<li><a href="html/MONDO_0017657.html">MONDO:0017657</a> (rare paroxysmal movement disorder) [4][68.75%]</li>
<li><a href="html/MONDO_0017658.html">MONDO:0017658</a> (hyperekplexia) [1][87.50%]</li>
<li><a href="html/MONDO_0017660.html">MONDO:0017660</a> (rare genetic parkinsonian disorder) [7][62.46%]</li>
<li><a href="html/MONDO_0017661.html">MONDO:0017661</a> (rare parkinsonian syndrome due to genetic neurodegenerative disease) [6][63.19%]</li>
<li><a href="html/MONDO_0017662.html">MONDO:0017662</a> (miscellaneous movement disorder due to genetic neurodegenerative disease) [18][53.90%]</li>
<li><a href="html/MONDO_0017664.html">MONDO:0017664</a> (rare genetic myoclonus) [14][54.71%]</li>
<li><a href="html/MONDO_0017665.html">MONDO:0017665</a> (rare genetic disease with myoclonus as a major feature) [9][60.77%]</li>
<li><a href="html/MONDO_0017666.html">MONDO:0017666</a> (diffuse palmoplantar keratoderma) [11][53.50%]</li>
<li><a href="html/MONDO_0017667.html">MONDO:0017667</a> (isolated diffuse palmoplantar keratoderma) [3][64.29%]</li>
<li><a href="html/MONDO_0017669.html">MONDO:0017669</a> (disease with diffuse palmoplantar keratoderma as a major feature) [6][64.29%]</li>
<li><a href="html/MONDO_0017670.html">MONDO:0017670</a> (autosomal dominant diffuse mutilating palmoplantar keratoderma) [1][83.33%]</li>
<li><a href="html/MONDO_0017672.html">MONDO:0017672</a> (focal palmoplantar keratoderma) [7][54.49%]</li>
<li><a href="html/MONDO_0017673.html">MONDO:0017673</a> (isolated focal palmoplantar keratoderma) [1][62.50%]</li>
<li><a href="html/MONDO_0017674.html">MONDO:0017674</a> (disease with focal palmoplantar keratoderma as a major feature) [4][63.64%]</li>
<li><a href="html/MONDO_0017675.html">MONDO:0017675</a> (punctate palmoplantar keratoderma) [6][62.50%]</li>
<li><a href="html/MONDO_0017681.html">MONDO:0017681</a> (Erythrokeratoderma variabilis progressiva) [1][75.00%]</li>
<li><a href="html/MONDO_0017686.html">MONDO:0017686</a> (aminoacylase deficiency) [1][75.00%]</li>
<li><a href="html/MONDO_0017690.html">MONDO:0017690</a> (disorder of galactose metabolism) [2][84.72%]</li>
<li><a href="html/MONDO_0017703.html">MONDO:0017703</a> (disorder of glyoxylate metabolism) [1][75.00%]</li>
<li><a href="html/MONDO_0017704.html">MONDO:0017704</a> (familial partial epilepsy) [12][54.87%]</li>
<li><a href="html/MONDO_0017706.html">MONDO:0017706</a> (disorder of carbohydrate absorption and transport) [2][66.67%]</li>
<li><a href="html/MONDO_0017707.html">MONDO:0017707</a> (disorder of lipid metabolism) [46][45.66%]</li>
<li><a href="html/MONDO_0017709.html">MONDO:0017709</a> (disorder of lipid absorption and transport) [1][62.50%]</li>
<li><a href="html/MONDO_0017713.html">MONDO:0017713</a> (disorder of fatty acid oxidation and ketogenesis) [6][63.64%]</li>
<li><a href="html/MONDO_0017714.html">MONDO:0017714</a> (acyl-CoA dehydrogenase deficiency) [2][75.00%]</li>
<li><a href="html/MONDO_0017715.html">MONDO:0017715</a> (3-hydroxyacyl-CoA dehydrogenase deficiency) [2][70.00%]</li>
<li><a href="html/MONDO_0017716.html">MONDO:0017716</a> (disorder of carnitine cycle and carnitine transport) [1][75.00%]</li>
<li><a href="html/MONDO_0017718.html">MONDO:0017718</a> (mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes) [3][62.50%]</li>
<li><a href="html/MONDO_0017719.html">MONDO:0017719</a> (gangliosidosis) [5][71.29%]</li>
<li><a href="html/MONDO_0017720.html">MONDO:0017720</a> (GM2 gangliosidosis) [2][78.57%]</li>
<li><a href="html/MONDO_0017727.html">MONDO:0017727</a> (fixed subaortic stenosis) [1][60.36%]</li>
<li><a href="html/MONDO_0017731.html">MONDO:0017731</a> (glycoproteinosis) [9][62.96%]</li>
<li><a href="html/MONDO_0017734.html">MONDO:0017734</a> (sialidosis) [1][75.00%]</li>
<li><a href="html/MONDO_0017736.html">MONDO:0017736</a> (disorder of sialic acid metabolism) [1][83.33%]</li>
<li><a href="html/MONDO_0017738.html">MONDO:0017738</a> (lysosomal glycogen storage disease) [1][75.00%]</li>
<li><a href="html/MONDO_0017739.html">MONDO:0017739</a> (disorder of lysosomal-related organelles) [3][73.33%]</li>
<li><a href="html/MONDO_0017740.html">MONDO:0017740</a> (disorder of protein N-glycosylation) [2][62.50%]</li>
<li><a href="html/MONDO_0017741.html">MONDO:0017741</a> (disorder of protein O-glycosylation) [16][62.84%]</li>
<li><a href="html/MONDO_0017742.html">MONDO:0017742</a> (disorder of O-xylosylglycan synthesis) [5][64.29%]</li>
<li><a href="html/MONDO_0017745.html">MONDO:0017745</a> (disorder of O-mannosylglycan synthesis) [4][73.41%]</li>
<li><a href="html/MONDO_0017747.html">MONDO:0017747</a> (disorder of fucoglycosan synthesis) [2][56.94%]</li>
<li><a href="html/MONDO_0017748.html">MONDO:0017748</a> (disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation) [4][65.38%]</li>
<li><a href="html/MONDO_0017749.html">MONDO:0017749</a> (disorder of multiple glycosylation) [4][62.50%]</li>
<li><a href="html/MONDO_0017752.html">MONDO:0017752</a> (defect in v-ATPase) [1][66.67%]</li>
<li><a href="html/MONDO_0017753.html">MONDO:0017753</a> (disorder of peroxisomal alpha-, beta- and omega-oxidation) [6][62.50%]</li>
<li><a href="html/MONDO_0017754.html">MONDO:0017754</a> (disorder of porphyrin and haem metabolism) [14][51.13%]</li>
<li><a href="html/MONDO_0017755.html">MONDO:0017755</a> (disorder of bilirubin metabolism and excretion) [5][67.86%]</li>
<li><a href="html/MONDO_0017756.html">MONDO:0017756</a> (disorder of pterin metabolism) [2][78.57%]</li>
<li><a href="html/MONDO_0017757.html">MONDO:0017757</a> (disorder of metabolite absorption and transport) [28][32.29%]</li>
<li><a href="html/MONDO_0017758.html">MONDO:0017758</a> (disorder of vitamin and non-protein cofactor absorption and transportB) [13][61.07%]</li>
<li><a href="html/MONDO_0017760.html">MONDO:0017760</a> (disorder of other vitamins and cofactors metabolism and transport) [3][66.67%]</li>
<li><a href="html/MONDO_0017761.html">MONDO:0017761</a> (disorder of mineral absorption and transport) [13][29.45%]</li>
<li><a href="html/MONDO_0017763.html">MONDO:0017763</a> (disorder of iron metabolism and transport) [3][66.67%]</li>
<li><a href="html/MONDO_0017765.html">MONDO:0017765</a> (disorder of magnesium transport) [5][62.50%]</li>
<li><a href="html/MONDO_0017768.html">MONDO:0017768</a> (reflex epilepsy) [2][26.41%]</li>
<li><a href="html/MONDO_0017773.html">MONDO:0017773</a> (hypoalphalipoproteinemia) [1][83.33%]</li>
<li><a href="html/MONDO_0017779.html">MONDO:0017779</a> (alpha-N-acetylgalactosaminidase deficiency) [1][62.50%]</li>
<li><a href="html/MONDO_0017820.html">MONDO:0017820</a> (disease with Cushing syndrome as a major feature) [2][62.50%]</li>
<li><a href="html/MONDO_0017821.html">MONDO:0017821</a> (functioning pituitary adenoma) [5][68.75%]</li>
<li><a href="html/MONDO_0017828.html">MONDO:0017828</a> (primary renal tubular acidosis) [4][66.67%]</li>
<li><a href="html/MONDO_0017841.html">MONDO:0017841</a> (autoimmune disease with skin involvement) [7][56.94%]</li>
<li><a href="html/MONDO_0017853.html">MONDO:0017853</a> (hypersensitivity pneumonitis) [2][66.67%]</li>
<li><a href="html/MONDO_0017854.html">MONDO:0017854</a> (T-b+ severe combined immunodeficiency) [1][70.00%]</li>
<li><a href="html/MONDO_0017855.html">MONDO:0017855</a> (T-b- severe combined immunodeficiency) [1][75.00%]</li>
<li><a href="html/MONDO_0017891.html">MONDO:0017891</a> (inherited renal cancer-predisposing syndrome) [3][62.50%]</li>
<li><a href="html/MONDO_0017896.html">MONDO:0017896</a> (familial nonmedullary thyroid carcinoma) [1][62.50%]</li>
<li><a href="html/MONDO_0017950.html">MONDO:0017950</a> (microcephalic primordial dwarfism) [4][64.00%]</li>
<li><a href="html/MONDO_0017951.html">MONDO:0017951</a> (trichorhinophalangeal syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0017953.html">MONDO:0017953</a> (hereditary periodic fever syndrome) [4][68.75%]</li>
<li><a href="html/MONDO_0017955.html">MONDO:0017955</a> (granulomatous autoinflammatory syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0017961.html">MONDO:0017961</a> (46,XX disorder of gonadal development) [2][65.00%]</li>
<li><a href="html/MONDO_0017965.html">MONDO:0017965</a> (syndrome with 46,XX disorder of sex development) [1][66.67%]</li>
<li><a href="html/MONDO_0017966.html">MONDO:0017966</a> (46,XY disorder of gonadal development) [2][66.67%]</li>
<li><a href="html/MONDO_0017969.html">MONDO:0017969</a> (46,XY disorder of sex development of endocrine origin) [13][63.16%]</li>
<li><a href="html/MONDO_0017970.html">MONDO:0017970</a> (46,XY disorder of sex development due to impaired androgen production) [11][62.50%]</li>
<li><a href="html/MONDO_0017975.html">MONDO:0017975</a> (sex chromosome disorder of sex development) [1][100.00%]</li>
<li><a href="html/MONDO_0017976.html">MONDO:0017976</a> (disorder of sex development of gynecological interest) [23][52.53%]</li>
<li><a href="html/MONDO_0017977.html">MONDO:0017977</a> (46,XY disorder of sex development of gynecological interest) [7][56.94%]</li>
<li><a href="html/MONDO_0017978.html">MONDO:0017978</a> (syndrome with disorder of sex development of gynecological interest) [4][45.70%]</li>
<li><a href="html/MONDO_0017986.html">MONDO:0017986</a> (disorder of plasmalogens biosynthesis) [1][70.00%]</li>
<li><a href="html/MONDO_0017998.html">MONDO:0017998</a> (PLA2G6-associated neurodegeneration) [1][66.67%]</li>
<li><a href="html/MONDO_0018010.html">MONDO:0018010</a> (juvenile idiopathic inflammatory myopathy) [4][72.22%]</li>
<li><a href="html/MONDO_0018013.html">MONDO:0018013</a> (non-immunoglobulin-mediated membranoproliferative glomerulonephritis) [1][64.29%]</li>
<li><a href="html/MONDO_0018033.html">MONDO:0018033</a> (other immunodeficiency syndromes due to defects in innate immunity) [1][93.30%]</li>
<li><a href="html/MONDO_0018035.html">MONDO:0018035</a> (syndrome with combined immunodeficiency) [18][45.16%]</li>
<li><a href="html/MONDO_0018036.html">MONDO:0018036</a> (immunodeficiency due to absence of thymus) [3][62.50%]</li>
<li><a href="html/MONDO_0018037.html">MONDO:0018037</a> (hyper-IgE syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0018040.html">MONDO:0018040</a> (immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of b-cells) [1][87.50%]</li>
<li><a href="html/MONDO_0018053.html">MONDO:0018053</a> (trichothiodystrophy) [1][100.00%]</li>
<li><a href="html/MONDO_0018060.html">MONDO:0018060</a> (congenital fibrinogen deficiency) [2][64.29%]</li>
<li><a href="html/MONDO_0018075.html">MONDO:0018075</a> (neural tube defect) [13][42.76%]</li>
<li><a href="html/MONDO_0018078.html">MONDO:0018078</a> (soft tissue sarcoma) [16][41.58%]</li>
<li><a href="html/MONDO_0018079.html">MONDO:0018079</a> (thymic epithelial neoplasm) [3][75.00%]</li>
<li><a href="html/MONDO_0018093.html">MONDO:0018093</a> (arbovirus fever) [1][75.00%]</li>
<li><a href="html/MONDO_0018094.html">MONDO:0018094</a> (Waardenburg's syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0018097.html">MONDO:0018097</a> (West syndrome) [1][62.50%]</li>
<li><a href="html/MONDO_0018100.html">MONDO:0018100</a> (primary hypomagnesemia) [4][64.29%]</li>
<li><a href="html/MONDO_0018102.html">MONDO:0018102</a> (corneal dystrophy (disease)) [11][57.36%]</li>
<li><a href="html/MONDO_0018116.html">MONDO:0018116</a> (galactosemia) [1][83.33%]</li>
<li><a href="html/MONDO_0018117.html">MONDO:0018117</a> (disorder of phospholipids, sphingolipids and fatty acids biosynthesis) [12][34.59%]</li>
<li><a href="html/MONDO_0018118.html">MONDO:0018118</a> (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement) [5][55.40%]</li>
<li><a href="html/MONDO_0018119.html">MONDO:0018119</a> (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement) [1][80.00%]</li>
<li><a href="html/MONDO_0018120.html">MONDO:0018120</a> (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement) [3][64.29%]</li>
<li><a href="html/MONDO_0018121.html">MONDO:0018121</a> (mitochondrial DNA maintenance syndrome) [13][67.24%]</li>
<li><a href="html/MONDO_0018132.html">MONDO:0018132</a> (congenital muscular alpha-dystroglycanopathy with brain and eye anomalies) [2][71.43%]</li>
<li><a href="html/MONDO_0018134.html">MONDO:0018134</a> (disorder of melanin metabolism) [4][75.00%]</li>
<li><a href="html/MONDO_0018135.html">MONDO:0018135</a> (oculocutaneous albinism type 1) [1][75.00%]</li>
<li><a href="html/MONDO_0018151.html">MONDO:0018151</a> (coenzyme Q10 deficiency) [1][66.67%]</li>
<li><a href="html/MONDO_0018157.html">MONDO:0018157</a> (mitochondrial disorder due to a defect in mitochondrial protein synthesis) [2][65.00%]</li>
<li><a href="html/MONDO_0018158.html">MONDO:0018158</a> (mitochondrial DNA depletion syndrome) [6][65.00%]</li>
<li><a href="html/MONDO_0018162.html">MONDO:0018162</a> (neurometabolic disorder due to serine deficiency) [2][75.00%]</li>
<li><a href="html/MONDO_0018170.html">MONDO:0018170</a> (idiopathic nephrotic syndrome) [4][35.51%]</li>
<li><a href="html/MONDO_0018174.html">MONDO:0018174</a> (hereditary glaucoma) [22][44.76%]</li>
<li><a href="html/MONDO_0018187.html">MONDO:0018187</a> (genetic syndromic Pierre robin syndrome) [13][55.14%]</li>
<li><a href="html/MONDO_0018188.html">MONDO:0018188</a> (genetic intestinal polyposis) [7][53.87%]</li>
<li><a href="html/MONDO_0018230.html">MONDO:0018230</a> (primary bone dysplasia) [128][58.63%]</li>
<li><a href="html/MONDO_0018232.html">MONDO:0018232</a> (primary bone dysplasia with micromelia) [3][58.30%]</li>
<li><a href="html/MONDO_0018233.html">MONDO:0018233</a> (Otopalatodigital syndrome spectrum disorder) [2][75.00%]</li>
<li><a href="html/MONDO_0018234.html">MONDO:0018234</a> (dysostosis) [130][52.54%]</li>
<li><a href="html/MONDO_0018235.html">MONDO:0018235</a> (dysostosis with limb anomaly as a major feature) [103][50.96%]</li>
<li><a href="html/MONDO_0018236.html">MONDO:0018236</a> (dysostosis with limb and face anomalies as a major feature) [4][62.50%]</li>
<li><a href="html/MONDO_0018237.html">MONDO:0018237</a> (acrofacial dysostosis) [2][66.67%]</li>
<li><a href="html/MONDO_0018238.html">MONDO:0018238</a> (rare bone disease related to a common gene or pathway defect) [26][44.65%]</li>
<li><a href="html/MONDO_0018241.html">MONDO:0018241</a> (primary short bowel syndrome) [1][83.33%]</li>
<li><a href="html/MONDO_0018246.html">MONDO:0018246</a> (homozygous 2p21 microdeletion syndrome) [2][80.00%]</li>
<li><a href="html/MONDO_0018251.html">MONDO:0018251</a> (glycogen storage disease due to phosphorylase kinase deficiency) [1][66.67%]</li>
<li><a href="html/MONDO_0018262.html">MONDO:0018262</a> (fetal anticonvulsant syndrome) [1][100.00%]</li>
<li><a href="html/MONDO_0018265.html">MONDO:0018265</a> (rare disorder with dystonia and other neurologic or systemic manifestation) [1][66.67%]</li>
<li><a href="html/MONDO_0018266.html">MONDO:0018266</a> (ataxia-telangiectasia variant) [1][66.67%]</li>
<li><a href="html/MONDO_0018274.html">MONDO:0018274</a> (GM3 synthase deficiency) [1][75.00%]</li>
<li><a href="html/MONDO_0018276.html">MONDO:0018276</a> (muscular dystrophy-dystroglycanopathy) [12][67.98%]</li>
<li><a href="html/MONDO_0018282.html">MONDO:0018282</a> (qualitative or quantitative defects of alpha-dystroglycan) [9][60.58%]</li>
<li><a href="html/MONDO_0018284.html">MONDO:0018284</a> (congenital disorder of glycosylation with neurological involvement) [13][65.46%]</li>
<li><a href="html/MONDO_0018286.html">MONDO:0018286</a> (non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature) [6][78.79%]</li>
<li><a href="html/MONDO_0018287.html">MONDO:0018287</a> (congenital disorder of glycosylation with epilepsy as a major feature) [6][59.33%]</li>
<li><a href="html/MONDO_0018288.html">MONDO:0018288</a> (congenital disorder of glycosylation with hepatic involvement) [1][66.67%]</li>
<li><a href="html/MONDO_0018290.html">MONDO:0018290</a> (congenital disorder of glycosylation with cardiac malformation as a major feature) [1][66.67%]</li>
<li><a href="html/MONDO_0018292.html">MONDO:0018292</a> (congenital disorder of glycosylation-related bone disorder) [7][50.52%]</li>
<li><a href="html/MONDO_0018293.html">MONDO:0018293</a> (congenital disorder of glycosylation with skin involvement) [7][63.16%]</li>
<li><a href="html/MONDO_0018294.html">MONDO:0018294</a> (congenital disorder of glycosylation with nephropathy as a major feature) [1][66.67%]</li>
<li><a href="html/MONDO_0018296.html">MONDO:0018296</a> (congenital disorder of glycosylation with developmental anomaly) [13][60.80%]</li>
<li><a href="html/MONDO_0018297.html">MONDO:0018297</a> (hypotonia-speech impairment-severe cognitive delay syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0018298.html">MONDO:0018298</a> (multicentric osteolysis-nodulosis-arthropathy spectrum) [2][62.50%]</li>
<li><a href="html/MONDO_0018299.html">MONDO:0018299</a> (sphingolipidosis with epilepsy) [10][52.19%]</li>
<li><a href="html/MONDO_0018303.html">MONDO:0018303</a> (generalized isolated dystonia) [1][66.67%]</li>
<li><a href="html/MONDO_0018307.html">MONDO:0018307</a> (neurodegeneration with brain iron accumulation) [4][55.40%]</li>
<li><a href="html/MONDO_0018310.html">MONDO:0018310</a> (Langerhans cell histiocytosis) [1][66.67%]</li>
<li><a href="html/MONDO_0018320.html">MONDO:0018320</a> (primary microcephaly-mild intellectual disability-young-onset diabetes syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0018321.html">MONDO:0018321</a> (atypical juvenile parkinsonism) [3][57.22%]</li>
<li><a href="html/MONDO_0018329.html">MONDO:0018329</a> (persistent combined dystonia) [6][65.00%]</li>
<li><a href="html/MONDO_0018331.html">MONDO:0018331</a> (rare genetic dystonia) [18][42.66%]</li>
<li><a href="html/MONDO_0018363.html">MONDO:0018363</a> (focal facial dermal dysplasia) [1][68.69%]</li>
<li><a href="html/MONDO_0018365.html">MONDO:0018365</a> (malignant non-epithelial tumor of ovary) [5][49.40%]</li>
<li><a href="html/MONDO_0018373.html">MONDO:0018373</a> (avascular necrosis) [6][70.64%]</li>
<li><a href="html/MONDO_0018374.html">MONDO:0018374</a> (secondary avascular necrosis) [4][76.89%]</li>
<li><a href="html/MONDO_0018377.html">MONDO:0018377</a> (rare hereditary disease with avascular necrosis) [3][81.36%]</li>
<li><a href="html/MONDO_0018383.html">MONDO:0018383</a> (osteonecrosis of genetic origin) [6][70.64%]</li>
<li><a href="html/MONDO_0018384.html">MONDO:0018384</a> (avascular necrosis of genetic origin) [4][76.89%]</li>
<li><a href="html/MONDO_0018386.html">MONDO:0018386</a> (rare male infertility due to hypothalamic-pituitary-gonadal axis disorder) [29][44.44%]</li>
<li><a href="html/MONDO_0018387.html">MONDO:0018387</a> (rare male infertility due to adrenal disorder) [9][65.00%]</li>
<li><a href="html/MONDO_0018388.html">MONDO:0018388</a> (rare male infertility due to testicular endocrine disorder) [7][49.97%]</li>
<li><a href="html/MONDO_0018389.html">MONDO:0018389</a> (male infertility due to gonadal dysgenesis or sperm disorder) [17][53.09%]</li>
<li><a href="html/MONDO_0018390.html">MONDO:0018390</a> (male infertility due to sperm disorder) [13][55.93%]</li>
<li><a href="html/MONDO_0018391.html">MONDO:0018391</a> (male infertility with spermatogenesis disorder) [6][67.65%]</li>
<li><a href="html/MONDO_0018392.html">MONDO:0018392</a> (male infertility with spermatogenesis disorder due to single gene mutation) [4][62.50%]</li>
<li><a href="html/MONDO_0018393.html">MONDO:0018393</a> (male infertility with azoospermia or oligozoospermia due to single gene mutation) [1][75.00%]</li>
<li><a href="html/MONDO_0018394.html">MONDO:0018394</a> (male infertility with teratozoospermia due to single gene mutation) [1][83.33%]</li>
<li><a href="html/MONDO_0018395.html">MONDO:0018395</a> (male infertility due to sperm motility disorder) [3][32.91%]</li>
<li><a href="html/MONDO_0018396.html">MONDO:0018396</a> (rare disorder with obstructive azoospermia) [3][20.11%]</li>
<li><a href="html/MONDO_0018397.html">MONDO:0018397</a> (rare female infertility due to hypothalamic-pituitary-gonadal axis disorder) [23][50.38%]</li>
<li><a href="html/MONDO_0018398.html">MONDO:0018398</a> (rare female infertility due to a congenital hypogonadotropic hypogonadism) [9][59.53%]</li>
<li><a href="html/MONDO_0018399.html">MONDO:0018399</a> (rare disorder with female infertility due to a congenital hypogonadotropic hypogonadism) [4][66.67%]</li>
<li><a href="html/MONDO_0018400.html">MONDO:0018400</a> (rare female infertility due to an adrenal disorder) [9][63.16%]</li>
<li><a href="html/MONDO_0018401.html">MONDO:0018401</a> (rare female infertility due to an anomaly of ovarian function) [1][75.00%]</li>
<li><a href="html/MONDO_0018402.html">MONDO:0018402</a> (female infertility due to gonadal dysgenesis) [5][63.85%]</li>
<li><a href="html/MONDO_0018403.html">MONDO:0018403</a> (female infertility due to an implantation defect) [2][62.50%]</li>
<li><a href="html/MONDO_0018404.html">MONDO:0018404</a> (rare genetic male infertility) [49][53.72%]</li>
<li><a href="html/MONDO_0018405.html">MONDO:0018405</a> (rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin) [24][41.37%]</li>
<li><a href="html/MONDO_0018406.html">MONDO:0018406</a> (rare male infertility due to adrenal disorder of genetic origin) [4][70.00%]</li>
<li><a href="html/MONDO_0018407.html">MONDO:0018407</a> (male infertility due to obstructive azoospermia of genetic origin) [3][66.67%]</li>
<li><a href="html/MONDO_0018409.html">MONDO:0018409</a> (rare genetic disorder with obstructive azoospermia) [1][75.00%]</li>
<li><a href="html/MONDO_0018410.html">MONDO:0018410</a> (rare genetic female infertility) [27][45.73%]</li>
<li><a href="html/MONDO_0018411.html">MONDO:0018411</a> (rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin) [17][55.14%]</li>
<li><a href="html/MONDO_0018412.html">MONDO:0018412</a> (rare female infertility due to adrenal disorder of genetic origin) [4][72.22%]</li>
<li><a href="html/MONDO_0018413.html">MONDO:0018413</a> (rare female infertility due to an anomaly of ovarian function of genetic origin) [1][75.00%]</li>
<li><a href="html/MONDO_0018414.html">MONDO:0018414</a> (female infertility due to an implantation defect of genetic origin) [1][66.67%]</li>
<li><a href="html/MONDO_0018431.html">MONDO:0018431</a> (cold-induced sweating syndrome-hyperthermia spectrum) [1][75.00%]</li>
<li><a href="html/MONDO_0018438.html">MONDO:0018438</a> (primary eosinophilic gastrointestinal disease) [1][83.33%]</li>
<li><a href="html/MONDO_0018453.html">MONDO:0018453</a> (familial atypical multiple mole melanoma syndrome) [2][56.94%]</li>
<li><a href="html/MONDO_0018454.html">MONDO:0018454</a> (dysostosis of genetic origin) [126][52.68%]</li>
<li><a href="html/MONDO_0018455.html">MONDO:0018455</a> (dysostosis of genetic origin with limb anomaly as a major feature) [102][51.09%]</li>
<li><a href="html/MONDO_0018456.html">MONDO:0018456</a> (polyarticular juvenile idiopathic arthritis) [1][100.00%]</li>
<li><a href="html/MONDO_0018457.html">MONDO:0018457</a> (rare genetic bone development disorder) [252][63.13%]</li>
<li><a href="html/MONDO_0018479.html">MONDO:0018479</a> (congenital adrenal hyperplasia) [4][72.22%]</li>
<li><a href="html/MONDO_0018488.html">MONDO:0018488</a> (rare genetic odontal or periodontal disorder) [11][59.33%]</li>
<li><a href="html/MONDO_0018491.html">MONDO:0018491</a> (3-phosphoglycerate dehydrogenase deficiency) [1][100.00%]</li>
<li><a href="html/MONDO_0018493.html">MONDO:0018493</a> (malignant hyperthermia (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0018497.html">MONDO:0018497</a> (rare autonomic nervous system disorder) [3][66.67%]</li>
<li><a href="html/MONDO_0018501.html">MONDO:0018501</a> (rare carcinoma of stomach) [2][66.67%]</li>
<li><a href="html/MONDO_0018510.html">MONDO:0018510</a> (neuroendocrine tumor of the small intestine) [1][100.00%]</li>
<li><a href="html/MONDO_0018516.html">MONDO:0018516</a> (epithelial tumor of anal canal) [2][66.67%]</li>
<li><a href="html/MONDO_0018530.html">MONDO:0018530</a> (rare epithelial tumor of liver and intrahepatic biliary tract) [4][66.67%]</li>
<li><a href="html/MONDO_0018531.html">MONDO:0018531</a> (carcinoma of liver and intrahepatic biliary tract) [3][70.00%]</li>
<li><a href="html/MONDO_0018538.html">MONDO:0018538</a> (inherited digestive cancer-predisposing syndrome) [13][63.20%]</li>
<li><a href="html/MONDO_0018539.html">MONDO:0018539</a> (rare epithelial tumor of small intestine) [3][66.67%]</li>
<li><a href="html/MONDO_0018541.html">MONDO:0018541</a> (familial hypoaldosteronism) [1][83.33%]</li>
<li><a href="html/MONDO_0018542.html">MONDO:0018542</a> (severe congenital neutropenia) [1][75.00%]</li>
<li><a href="html/MONDO_0018543.html">MONDO:0018543</a> (autosomal dominant hypocalcemia) [1][70.00%]</li>
<li><a href="html/MONDO_0018544.html">MONDO:0018544</a> (X-linked adrenoleukodystrophy) [1][75.00%]</li>
<li><a href="html/MONDO_0018545.html">MONDO:0018545</a> (primary immunodeficiency with predisposition to severe viral infection) [1][52.02%]</li>
<li><a href="html/MONDO_0018555.html">MONDO:0018555</a> (hypogonadotropic hypogonadism) [1][62.08%]</li>
<li><a href="html/MONDO_0018557.html">MONDO:0018557</a> (rare genetic autonomic nervous system disorder) [1][83.33%]</li>
<li><a href="html/MONDO_0018558.html">MONDO:0018558</a> (syndrome with woolly hair) [1][100.00%]</li>
<li><a href="html/MONDO_0018561.html">MONDO:0018561</a> (precocious puberty in female) [1][83.33%]</li>
<li><a href="html/MONDO_0018562.html">MONDO:0018562</a> (genetic otorhinolaryngological malformation) [6][38.54%]</li>
<li><a href="html/MONDO_0018570.html">MONDO:0018570</a> (hypophosphatasia) [2][64.29%]</li>
<li><a href="html/MONDO_0018609.html">MONDO:0018609</a> (syndromic hereditary optic neuropathy) [6][46.31%]</li>
<li><a href="html/MONDO_0018612.html">MONDO:0018612</a> (congenital hypothyroidism) [16][61.51%]</li>
<li><a href="html/MONDO_0018619.html">MONDO:0018619</a> (hyperinsulinemic hypoglycaemia) [8][53.18%]</li>
<li><a href="html/MONDO_0018627.html">MONDO:0018627</a> (ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor) [1][75.00%]</li>
<li><a href="html/MONDO_0018630.html">MONDO:0018630</a> (hereditary nonpolyposis colon cancer) [1][81.25%]</li>
<li><a href="html/MONDO_0018634.html">MONDO:0018634</a> (hereditary amyloidosis) [6][66.67%]</li>
<li><a href="html/MONDO_0018638.html">MONDO:0018638</a> (pseudohypoaldosteronism) [2][88.89%]</li>
<li><a href="html/MONDO_0018639.html">MONDO:0018639</a> (caudal regression-sirenomelia spectrum) [1][62.50%]</li>
<li><a href="html/MONDO_0018646.html">MONDO:0018646</a> (sclerosing cholangitis (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0018660.html">MONDO:0018660</a> (hemophilia) [2][87.50%]</li>
<li><a href="html/MONDO_0018701.html">MONDO:0018701</a> (congenital nemaline myopathy) [6][64.29%]</li>
<li><a href="html/MONDO_0018722.html">MONDO:0018722</a> (primary lymphedema with associated anomalies) [3][63.33%]</li>
<li><a href="html/MONDO_0018723.html">MONDO:0018723</a> (rare vascular malformation of major vessels) [25][40.87%]</li>
<li><a href="html/MONDO_0018726.html">MONDO:0018726</a> (immunodeficiency due to a complement cascade component deficiency) [2][85.71%]</li>
<li><a href="html/MONDO_0018728.html">MONDO:0018728</a> (rare genetic capillary malformation) [2][78.57%]</li>
<li><a href="html/MONDO_0018730.html">MONDO:0018730</a> (rare genetic venous malformation) [1][75.00%]</li>
<li><a href="html/MONDO_0018731.html">MONDO:0018731</a> (lethal multiple congenital anomalies/dysmorphic syndrome) [2][66.67%]</li>
<li><a href="html/MONDO_0018743.html">MONDO:0018743</a> (immune-mediated acquired neuromuscular junction disease) [1][75.00%]</li>
<li><a href="html/MONDO_0018744.html">MONDO:0018744</a> (oligodendroglial tumor) [1][66.67%]</li>
<li><a href="html/MONDO_0018751.html">MONDO:0018751</a> (genetic otorhinolaryngologic disease) [63][54.92%]</li>
<li><a href="html/MONDO_0018753.html">MONDO:0018753</a> (rare disease with malignant hyperthermia) [4][63.33%]</li>
<li><a href="html/MONDO_0018758.html">MONDO:0018758</a> (familial patent arterial duct) [1][37.50%]</li>
<li><a href="html/MONDO_0018760.html">MONDO:0018760</a> (WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0018762.html">MONDO:0018762</a> (non-acquired combined pituitary hormone deficiency) [14][57.68%]</li>
<li><a href="html/MONDO_0018770.html">MONDO:0018770</a> (asphyxiating thoracic dystrophy) [2][62.50%]</li>
<li><a href="html/MONDO_0018772.html">MONDO:0018772</a> (Joubert syndrome) [1][75.00%]</li>
<li><a href="html/MONDO_0018775.html">MONDO:0018775</a> (axonal hereditary motor and sensory neuropathy) [7][43.62%]</li>
<li><a href="html/MONDO_0018782.html">MONDO:0018782</a> (type 1 interferonopathy) [8][36.09%]</li>
<li><a href="html/MONDO_0018787.html">MONDO:0018787</a> (genetic cerebral small vessel disease) [9][63.04%]</li>
<li><a href="html/MONDO_0018788.html">MONDO:0018788</a> (COL4A1 or COL4A2-related cerebral small vessel disease) [3][70.00%]</li>
<li><a href="html/MONDO_0018790.html">MONDO:0018790</a> (COL4A1 or COL4A2-related cerebral small vessel disease with hemorrhagic tendancy) [1][66.67%]</li>
<li><a href="html/MONDO_0018791.html">MONDO:0018791</a> (Moyomoya angiopathy) [9][44.95%]</li>
<li><a href="html/MONDO_0018792.html">MONDO:0018792</a> (Moyamoya syndrome) [7][47.37%]</li>
<li><a href="html/MONDO_0018795.html">MONDO:0018795</a> (syndromic constitutional thrombocytopenia) [9][51.52%]</li>
<li><a href="html/MONDO_0018796.html">MONDO:0018796</a> (isolated constitutional thrombocytopenia) [9][60.76%]</li>
<li><a href="html/MONDO_0018797.html">MONDO:0018797</a> (genetic cardiac malformation) [1][83.50%]</li>
<li><a href="html/MONDO_0018798.html">MONDO:0018798</a> (other genetic dermis disorder) [3][66.94%]</li>
<li><a href="html/MONDO_0018799.html">MONDO:0018799</a> (rare hypercholesterolemia) [1][75.00%]</li>
<li><a href="html/MONDO_0018814.html">MONDO:0018814</a> (non-severe combined immunodeficiency) [3][66.67%]</li>
<li><a href="html/MONDO_0018838.html">MONDO:0018838</a> (lissencephaly (disease)) [15][64.79%]</li>
<li><a href="html/MONDO_0018841.html">MONDO:0018841</a> (congenital bile acid synthesis defect) [1][66.67%]</li>
<li><a href="html/MONDO_0018849.html">MONDO:0018849</a> (dentinogenesis imperfecta (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0018855.html">MONDO:0018855</a> (keratosis pilaris atrophicans) [1][75.00%]</li>
<li><a href="html/MONDO_0018859.html">MONDO:0018859</a> (Leigh disease) [3][62.50%]</li>
<li><a href="html/MONDO_0018868.html">MONDO:0018868</a> (metachromatic leukodystrophy) [1][62.50%]</li>
<li><a href="html/MONDO_0018869.html">MONDO:0018869</a> (cobblestone lissencephaly) [3][68.33%]</li>
<li><a href="html/MONDO_0018874.html">MONDO:0018874</a> (acute myeloid leukemia) [8][33.50%]</li>
<li><a href="html/MONDO_0018880.html">MONDO:0018880</a> (rare teratologic disease) [6][64.29%]</li>
<li><a href="html/MONDO_0018881.html">MONDO:0018881</a> (myelodysplastic syndrome) [3][62.50%]</li>
<li><a href="html/MONDO_0018882.html">MONDO:0018882</a> (vasculitis) [11][22.32%]</li>
<li><a href="html/MONDO_0018887.html">MONDO:0018887</a> (rare cutaneous lupus erythematosus) [2][62.50%]</li>
<li><a href="html/MONDO_0018894.html">MONDO:0018894</a> (distal hereditary motor neuropathy) [7][62.50%]</li>
<li><a href="html/MONDO_0018902.html">MONDO:0018902</a> (hepatocellular adenoma) [2][66.67%]</li>
<li><a href="html/MONDO_0018904.html">MONDO:0018904</a> (primary membranoproliferative glomerulonephritis) [3][33.50%]</li>
<li><a href="html/MONDO_0018908.html">MONDO:0018908</a> (non-Hodgkin lymphoma) [21][38.98%]</li>
<li><a href="html/MONDO_0018910.html">MONDO:0018910</a> (oculocutaneous albinism) [2][70.00%]</li>
<li><a href="html/MONDO_0018911.html">MONDO:0018911</a> (maturity-onset diabetes of the young (disease)) [1][66.67%]</li>
<li><a href="html/MONDO_0018912.html">MONDO:0018912</a> (Cushing syndrome) [9][59.93%]</li>
<li><a href="html/MONDO_0018918.html">MONDO:0018918</a> (carcinoma of gallbladder and extrahepatic biliary tract) [1][81.62%]</li>
<li><a href="html/MONDO_0018923.html">MONDO:0018923</a> (22q11.2 deletion syndrome) [2][60.82%]</li>
<li><a href="html/MONDO_0018926.html">MONDO:0018926</a> (human prion disease) [3][66.67%]</li>
<li><a href="html/MONDO_0018928.html">MONDO:0018928</a> (rare hepatic disease) [50][48.04%]</li>
<li><a href="html/MONDO_0018931.html">MONDO:0018931</a> (mucolipidosis type III) [1][62.50%]</li>
<li><a href="html/MONDO_0018940.html">MONDO:0018940</a> (congenital myasthenic syndrome) [4][70.89%]</li>
<li><a href="html/MONDO_0018947.html">MONDO:0018947</a> (centronuclear myopathy) [3][62.50%]</li>
<li><a href="html/MONDO_0018948.html">MONDO:0018948</a> (multiminicore myopathy) [1][70.00%]</li>
<li><a href="html/MONDO_0018949.html">MONDO:0018949</a> (distal myopathy) [5][64.72%]</li>
<li><a href="html/MONDO_0018954.html">MONDO:0018954</a> (Loeys-Dietz syndrome) [3][64.77%]</li>
<li><a href="html/MONDO_0018958.html">MONDO:0018958</a> (nemaline myopathy) [7][65.62%]</li>
<li><a href="html/MONDO_0018959.html">MONDO:0018959</a> (potassium-aggravated myotonia) [2][75.00%]</li>
<li><a href="html/MONDO_0018964.html">MONDO:0018964</a> (homocystinuria without methylmalonic aciduria) [1][71.43%]</li>
<li><a href="html/MONDO_0018972.html">MONDO:0018972</a> (rare epithelial tumor of stomach) [3][62.50%]</li>
<li><a href="html/MONDO_0018973.html">MONDO:0018973</a> (patterned dystrophy of the retinal pigment epithelium) [2][53.32%]</li>
<li><a href="html/MONDO_0018975.html">MONDO:0018975</a> (neurofibromatosis) [3][65.00%]</li>
<li><a href="html/MONDO_0018993.html">MONDO:0018993</a> (Charcot-Marie-tooth disease type 2) [2][66.67%]</li>
<li><a href="html/MONDO_0018994.html">MONDO:0018994</a> (Charcot-Marie-tooth disease type X) [1][75.00%]</li>
<li><a href="html/MONDO_0019004.html">MONDO:0019004</a> (nephroblastoma) [1][75.00%]</li>
<li><a href="html/MONDO_0019005.html">MONDO:0019005</a> (nephronophthisis (disease)) [1][62.50%]</li>
<li><a href="html/MONDO_0019006.html">MONDO:0019006</a> (familial idiopathic steroid-resistant nephrotic syndrome) [2][66.67%]</li>
<li><a href="html/MONDO_0019008.html">MONDO:0019008</a> (benign recurrent intrahepatic cholestasis) [1][66.67%]</li>
<li><a href="html/MONDO_0019010.html">MONDO:0019010</a> (congenital isolated hyperinsulinism) [6][56.94%]</li>
<li><a href="html/MONDO_0019011.html">MONDO:0019011</a> (Charcot-Marie-tooth disease type 1) [1][75.00%]</li>
<li><a href="html/MONDO_0019013.html">MONDO:0019013</a> (non-histaminic angioedema) [1][100.00%]</li>
<li><a href="html/MONDO_0019019.html">MONDO:0019019</a> (osteogenesis imperfecta) [2][66.67%]</li>
<li><a href="html/MONDO_0019023.html">MONDO:0019023</a> (cutaneous mastocytosis) [2][93.30%]</li>
<li><a href="html/MONDO_0019037.html">MONDO:0019037</a> (progressive supranuclear palsy) [2][64.29%]</li>
<li><a href="html/MONDO_0019038.html">MONDO:0019038</a> (rare maxillo-facial surgical disease) [62][46.88%]</li>
<li><a href="html/MONDO_0019039.html">MONDO:0019039</a> (rare hemorrhagic disorder due to a constitutional coagulation factors defect) [12][64.52%]</li>
<li><a href="html/MONDO_0019041.html">MONDO:0019041</a> (rare genetic tumor) [45][48.19%]</li>
<li><a href="html/MONDO_0019042.html">MONDO:0019042</a> (multiple congenital anomalies/dysmorphic syndrome) [110][57.89%]</li>
<li><a href="html/MONDO_0019043.html">MONDO:0019043</a> (rare genetic skin disease) [315][62.37%]</li>
<li><a href="html/MONDO_0019044.html">MONDO:0019044</a> (tumor of hematopoietic and lymphoid tissues) [83][53.31%]</li>
<li><a href="html/MONDO_0019045.html">MONDO:0019045</a> (rare sleep disorder) [4][65.38%]</li>
<li><a href="html/MONDO_0019046.html">MONDO:0019046</a> (leukodystrophy) [23][48.70%]</li>
<li><a href="html/MONDO_0019047.html">MONDO:0019047</a> (rare deafness) [56][56.21%]</li>
<li><a href="html/MONDO_0019048.html">MONDO:0019048</a> (rare vascular disease) [50][42.09%]</li>
<li><a href="html/MONDO_0019049.html">MONDO:0019049</a> (rare dystonia) [19][42.12%]</li>
<li><a href="html/MONDO_0019050.html">MONDO:0019050</a> (hemoglobinopathy) [13][65.64%]</li>
<li><a href="html/MONDO_0019052.html">MONDO:0019052</a> (rare inborn errors of metabolism) [428][53.07%]</li>
<li><a href="html/MONDO_0019053.html">MONDO:0019053</a> (peroxisomal disease) [13][63.04%]</li>
<li><a href="html/MONDO_0019054.html">MONDO:0019054</a> (congenital limb malformation) [133][52.63%]</li>
<li><a href="html/MONDO_0019055.html">MONDO:0019055</a> (mitochondrial disease) [54][51.78%]</li>
<li><a href="html/MONDO_0019056.html">MONDO:0019056</a> (neuromuscular disease) [162][62.11%]</li>
<li><a href="html/MONDO_0019057.html">MONDO:0019057</a> (rare constitutional aplastic anemia) [6][70.52%]</li>
<li><a href="html/MONDO_0019058.html">MONDO:0019058</a> (neurometabolic disease) [82][54.99%]</li>
<li><a href="html/MONDO_0019059.html">MONDO:0019059</a> (rare parkinsonian disorder) [8][61.78%]</li>
<li><a href="html/MONDO_0019060.html">MONDO:0019060</a> (rare bone tumor) [7][62.50%]</li>
<li><a href="html/MONDO_0019061.html">MONDO:0019061</a> (rare parathyroid disease and phosphocalcic metabolism anomaly) [31][60.79%]</li>
<li><a href="html/MONDO_0019062.html">MONDO:0019062</a> (rare infectious disease) [56][25.22%]</li>
<li><a href="html/MONDO_0019063.html">MONDO:0019063</a> (vascular anomaly or angioma) [55][33.30%]</li>
<li><a href="html/MONDO_0019064.html">MONDO:0019064</a> (hereditary spastic paraplegia) [15][62.50%]</li>
<li><a href="html/MONDO_0019065.html">MONDO:0019065</a> (amyloidosis (disease)) [8][64.29%]</li>
<li><a href="html/MONDO_0019066.html">MONDO:0019066</a> (syndrome with brachydactyly) [11][51.02%]</li>
<li><a href="html/MONDO_0019069.html">MONDO:0019069</a> (rhabdoid tumor) [1][66.67%]</li>
<li><a href="html/MONDO_0019072.html">MONDO:0019072</a> (intrahepatic cholestasis) [3][77.78%]</li>
<li><a href="html/MONDO_0019079.html">MONDO:0019079</a> (proximal spinal muscular atrophy) [2][62.50%]</li>
<li><a href="html/MONDO_0019096.html">MONDO:0019096</a> (rare pulmonary hypertension) [6][63.64%]</li>
<li><a href="html/MONDO_0019097.html">MONDO:0019097</a> (rare hemorrhagic disorder due to a constitutional platelet anomaly) [22][59.16%]</li>
<li><a href="html/MONDO_0019099.html">MONDO:0019099</a> (rare soft tissue tumor) [19][42.82%]</li>
<li><a href="html/MONDO_0019110.html">MONDO:0019110</a> (rare central nervous system and retinal vascular disease) [29][46.34%]</li>
<li><a href="html/MONDO_0019116.html">MONDO:0019116</a> (catecholamine-producing tumor) [2][81.25%]</li>
<li><a href="html/MONDO_0019117.html">MONDO:0019117</a> (rare genetic neurological disorder) [1008][65.50%]</li>
<li><a href="html/MONDO_0019118.html">MONDO:0019118</a> (retinal dystrophy) [52][55.40%]</li>
<li><a href="html/MONDO_0019119.html">MONDO:0019119</a> (muscular channelopathy) [8][58.68%]</li>
<li><a href="html/MONDO_0019126.html">MONDO:0019126</a> (intractable diarrhea of infancy) [1][66.67%]</li>
<li><a href="html/MONDO_0019128.html">MONDO:0019128</a> (mullerian aplasia) [3][70.00%]</li>
<li><a href="html/MONDO_0019142.html">MONDO:0019142</a> (porphyria) [6][55.80%]</li>
<li><a href="html/MONDO_0019146.html">MONDO:0019146</a> (mendelian susceptibility to mycobacterial diseases) [5][21.62%]</li>
<li><a href="html/MONDO_0019155.html">MONDO:0019155</a> (leydig cell hypoplasia) [1][62.50%]</li>
<li><a href="html/MONDO_0019171.html">MONDO:0019171</a> (familial long QT syndrome) [2][80.56%]</li>
<li><a href="html/MONDO_0019172.html">MONDO:0019172</a> (aniridia) [3][62.50%]</li>
<li><a href="html/MONDO_0019175.html">MONDO:0019175</a> (primary lymphedema) [5][61.99%]</li>
<li><a href="html/MONDO_0019182.html">MONDO:0019182</a> (genetic obesity) [13][54.47%]</li>
<li><a href="html/MONDO_0019183.html">MONDO:0019183</a> (rare genetic odontologic disease) [16][50.92%]</li>
<li><a href="html/MONDO_0019187.html">MONDO:0019187</a> (Axenfeld-Rieger syndrome) [2][66.67%]</li>
<li><a href="html/MONDO_0019189.html">MONDO:0019189</a> (disorder of amino acid and other organic acid metabolism) [68][50.96%]</li>
<li><a href="html/MONDO_0019211.html">MONDO:0019211</a> (isolated congenital anonychia) [1][52.02%]</li>
<li><a href="html/MONDO_0019213.html">MONDO:0019213</a> (cerebral organic aciduria) [5][30.26%]</li>
<li><a href="html/MONDO_0019214.html">MONDO:0019214</a> (carbohydrate metabolic disorder) [91][44.00%]</li>
<li><a href="html/MONDO_0019215.html">MONDO:0019215</a> (classic organic aciduria) [8][65.91%]</li>
<li><a href="html/MONDO_0019216.html">MONDO:0019216</a> (disorder of amino acid absorption and transport) [5][65.38%]</li>
<li><a href="html/MONDO_0019217.html">MONDO:0019217</a> (disorder of urea cycle metabolism and ammonia detoxification) [4][64.29%]</li>
<li><a href="html/MONDO_0019218.html">MONDO:0019218</a> (disorder of bile acid synthesis) [3][55.36%]</li>
<li><a href="html/MONDO_0019219.html">MONDO:0019219</a> (disorder of neurotransmitter metabolism and transport) [4][72.22%]</li>
<li><a href="html/MONDO_0019220.html">MONDO:0019220</a> (disorder of cobalamin metabolism and transport) [5][64.71%]</li>
<li><a href="html/MONDO_0019222.html">MONDO:0019222</a> (disorder of methionine cycle and sulfur amino acid metabolism) [4][58.05%]</li>
<li><a href="html/MONDO_0019223.html">MONDO:0019223</a> (disorder of fatty acid oxidation and ketone body metabolism) [12][58.14%]</li>
<li><a href="html/MONDO_0019224.html">MONDO:0019224</a> (disorder of gamma-aminobutyric acid metabolism) [1][75.00%]</li>
<li><a href="html/MONDO_0019225.html">MONDO:0019225</a> (gluconeogenesis disorder) [2][70.00%]</li>
<li><a href="html/MONDO_0019227.html">MONDO:0019227</a> (disorder of glycerol metabolism) [2][83.33%]</li>
<li><a href="html/MONDO_0019228.html">MONDO:0019228</a> (disorder of histidine metabolism) [1][75.00%]</li>
<li><a href="html/MONDO_0019230.html">MONDO:0019230</a> (disorder of ornithine or proline metabolism) [5][66.67%]</li>
<li><a href="html/MONDO_0019232.html">MONDO:0019232</a> (disorder of peptide metabolism) [1][75.00%]</li>
<li><a href="html/MONDO_0019233.html">MONDO:0019233</a> (peroxisomal beta-oxidation disorder) [2][70.00%]</li>
<li><a href="html/MONDO_0019234.html">MONDO:0019234</a> (peroxisome biogenesis disorder) [3][63.46%]</li>
<li><a href="html/MONDO_0019235.html">MONDO:0019235</a> (disorder of phenylalanin or tyrosine metabolism) [5][70.83%]</li>
<li><a href="html/MONDO_0019236.html">MONDO:0019236</a> (disorder of purine metabolism) [7][63.33%]</li>
<li><a href="html/MONDO_0019237.html">MONDO:0019237</a> (disorder of pyridoxine metabolism) [1][66.67%]</li>
<li><a href="html/MONDO_0019239.html">MONDO:0019239</a> (disorder of serine or glycine metabolism) [4][70.00%]</li>
<li><a href="html/MONDO_0019240.html">MONDO:0019240</a> (sterol biosynthesis disorder) [2][75.00%]</li>
<li><a href="html/MONDO_0019241.html">MONDO:0019241</a> (disorder of the gamma-glutamyl cycle) [1][100.00%]</li>
<li><a href="html/MONDO_0019242.html">MONDO:0019242</a> (disorder of branched-chain amino acid metabolism) [18][53.32%]</li>
<li><a href="html/MONDO_0019243.html">MONDO:0019243</a> (disorder of energy metabolism) [71][51.66%]</li>
<li><a href="html/MONDO_0019244.html">MONDO:0019244</a> (glycogen storage disease) [8][32.25%]</li>
<li><a href="html/MONDO_0019245.html">MONDO:0019245</a> (lipid storage disease) [21][51.40%]</li>
<li><a href="html/MONDO_0019246.html">MONDO:0019246</a> (disorder of lysosomal amino acid transport) [4][70.00%]</li>
<li><a href="html/MONDO_0019248.html">MONDO:0019248</a> (mucolipidosis) [2][62.50%]</li>
<li><a href="html/MONDO_0019249.html">MONDO:0019249</a> (mucopolysaccharidosis) [7][84.29%]</li>
<li><a href="html/MONDO_0019250.html">MONDO:0019250</a> (disorder of biogenic amine metabolism and transport) [11][36.42%]</li>
<li><a href="html/MONDO_0019251.html">MONDO:0019251</a> (Oligosaccharidosis) [5][66.67%]</li>
<li><a href="html/MONDO_0019252.html">MONDO:0019252</a> (other metabolic disease with skin involvement) [1][100.00%]</li>
<li><a href="html/MONDO_0019253.html">MONDO:0019253</a> (metabolic disease involving other neurotransmitter deficiency) [1][87.50%]</li>
<li><a href="html/MONDO_0019254.html">MONDO:0019254</a> (disorder of purine or pyrimidine metabolism) [9][48.42%]</li>
<li><a href="html/MONDO_0019255.html">MONDO:0019255</a> (sphingolipidosis) [12][56.16%]</li>
<li><a href="html/MONDO_0019256.html">MONDO:0019256</a> (sterol metabolism disorder) [7][48.99%]</li>
<li><a href="html/MONDO_0019268.html">MONDO:0019268</a> (rare genetic epidermal disease) [95][57.16%]</li>
<li><a href="html/MONDO_0019269.html">MONDO:0019269</a> (ichthyosis (disease)) [30][67.53%]</li>
<li><a href="html/MONDO_0019270.html">MONDO:0019270</a> (Erythrokeratoderma) [2][70.00%]</li>
<li><a href="html/MONDO_0019271.html">MONDO:0019271</a> (acrokeratoderma) [1][75.00%]</li>
<li><a href="html/MONDO_0019272.html">MONDO:0019272</a> (hereditary palmoplantar keratoderma) [27][62.51%]</li>
<li><a href="html/MONDO_0019274.html">MONDO:0019274</a> (other epidermal disorder) [5][65.38%]</li>
<li><a href="html/MONDO_0019275.html">MONDO:0019275</a> (other genetic epidermal disease) [5][65.38%]</li>
<li><a href="html/MONDO_0019276.html">MONDO:0019276</a> (inherited epidermolysis bullosa) [8][59.53%]</li>
<li><a href="html/MONDO_0019277.html">MONDO:0019277</a> (epidermal appendage anomaly) [48][59.49%]</li>
<li><a href="html/MONDO_0019278.html">MONDO:0019278</a> (hair anomaly) [19][54.75%]</li>
<li><a href="html/MONDO_0019279.html">MONDO:0019279</a> (alopecia) [8][57.82%]</li>
<li><a href="html/MONDO_0019280.html">MONDO:0019280</a> (hypertrichosis (disease)) [1][87.50%]</li>
<li><a href="html/MONDO_0019281.html">MONDO:0019281</a> (isolated hair shaft abnormality) [2][67.79%]</li>
<li><a href="html/MONDO_0019282.html">MONDO:0019282</a> (syndromic hair shaft abnormality) [4][68.37%]</li>
<li><a href="html/MONDO_0019283.html">MONDO:0019283</a> (nail anomaly) [6][57.22%]</li>
<li><a href="html/MONDO_0019284.html">MONDO:0019284</a> (isolated nail anomaly) [2][57.39%]</li>
<li><a href="html/MONDO_0019285.html">MONDO:0019285</a> (syndromic nail anomaly) [2][66.94%]</li>
<li><a href="html/MONDO_0019287.html">MONDO:0019287</a> (ectodermal dysplasia syndrome) [24][51.97%]</li>
<li><a href="html/MONDO_0019288.html">MONDO:0019288</a> (pigmentation anomaly of the skin) [30][61.45%]</li>
<li><a href="html/MONDO_0019289.html">MONDO:0019289</a> (hyperpigmentation of the skin) [17][45.77%]</li>
<li><a href="html/MONDO_0019290.html">MONDO:0019290</a> (hypopigmentation of the skin (disease)) [11][76.86%]</li>
<li><a href="html/MONDO_0019291.html">MONDO:0019291</a> (dermis disorder) [42][59.52%]</li>
<li><a href="html/MONDO_0019292.html">MONDO:0019292</a> (dermis elastic tissue disorder) [20][59.55%]</li>
<li><a href="html/MONDO_0019293.html">MONDO:0019293</a> (skin vascular disease) [7][59.93%]</li>
<li><a href="html/MONDO_0019294.html">MONDO:0019294</a> (mixed dermis disorder) [3][67.86%]</li>
<li><a href="html/MONDO_0019295.html">MONDO:0019295</a> (other dermis disorder) [8][59.01%]</li>
<li><a href="html/MONDO_0019296.html">MONDO:0019296</a> (subcutaneous tissue disease) [8][76.82%]</li>
<li><a href="html/MONDO_0019297.html">MONDO:0019297</a> (lymphedema) [10][47.86%]</li>
<li><a href="html/MONDO_0019298.html">MONDO:0019298</a> (rare urticaria) [3][100.00%]</li>
<li><a href="html/MONDO_0019299.html">MONDO:0019299</a> (unclassified genetic skin disorder) [2][66.67%]</li>
<li><a href="html/MONDO_0019300.html">MONDO:0019300</a> (rare skin tumor or hamartoma) [33][50.51%]</li>
<li><a href="html/MONDO_0019301.html">MONDO:0019301</a> (metabolic disease with skin involvement) [19][39.78%]</li>
<li><a href="html/MONDO_0019302.html">MONDO:0019302</a> (mucopolysaccharidosis with skin involvement) [1][75.00%]</li>
<li><a href="html/MONDO_0019303.html">MONDO:0019303</a> (premature aging) [4][63.64%]</li>
<li><a href="html/MONDO_0019304.html">MONDO:0019304</a> (rare photodermatosis) [12][62.50%]</li>
<li><a href="html/MONDO_0019305.html">MONDO:0019305</a> (immune deficiency with skin involvement) [5][65.61%]</li>
<li><a href="html/MONDO_0019312.html">MONDO:0019312</a> (Hermansky-Pudlak syndrome) [2][71.43%]</li>
<li><a href="html/MONDO_0019337.html">MONDO:0019337</a> (autoimmune bullous skin disease) [3][73.30%]</li>
<li><a href="html/MONDO_0019340.html">MONDO:0019340</a> (scleroderma (disease)) [2][83.33%]</li>
<li><a href="html/MONDO_0019347.html">MONDO:0019347</a> (peeling skin syndrome) [1][65.82%]</li>
<li><a href="html/MONDO_0019351.html">MONDO:0019351</a> (isolated spina bifida) [4][57.49%]</li>
<li><a href="html/MONDO_0019354.html">MONDO:0019354</a> (Stickler syndrome) [3][62.50%]</li>
<li><a href="html/MONDO_0019356.html">MONDO:0019356</a> (urogenital tract malformation) [28][30.08%]</li>
<li><a href="html/MONDO_0019358.html">MONDO:0019358</a> (encephalopathy due to sulfite oxidase deficiency) [1][87.50%]</li>
<li><a href="html/MONDO_0019366.html">MONDO:0019366</a> (Free sialic acid storage disease) [1][83.33%]</li>
<li><a href="html/MONDO_0019399.html">MONDO:0019399</a> (Isaac syndrome) [1][83.33%]</li>
<li><a href="html/MONDO_0019402.html">MONDO:0019402</a> (beta thalassemia) [1][76.73%]</li>
<li><a href="html/MONDO_0019403.html">MONDO:0019403</a> (congenital dyserythropoietic anemia) [1][83.33%]</li>
<li><a href="html/MONDO_0019457.html">MONDO:0019457</a> (Therapy related acute myeloid leukemia and myelodysplastic syndrome) [2][48.87%]</li>
<li><a href="html/MONDO_0019460.html">MONDO:0019460</a> (acute leukemia of ambiguous lineage) [2][48.87%]</li>
<li><a href="html/MONDO_0019491.html">MONDO:0019491</a> (rare intellectual disability) [140][57.66%]</li>
<li><a href="html/MONDO_0019496.html">MONDO:0019496</a> (neuroendocrine tumor) [6][80.00%]</li>
<li><a href="html/MONDO_0019497.html">MONDO:0019497</a> (nonsyndromic deafness) [6][48.08%]</li>
<li><a href="html/MONDO_0019501.html">MONDO:0019501</a> (Usher syndrome) [3][63.64%]</li>
<li><a href="html/MONDO_0019502.html">MONDO:0019502</a> (autosomal recessive non-syndromic intellectual disability) [3][65.00%]</li>
<li><a href="html/MONDO_0019503.html">MONDO:0019503</a> (anterior segment dysgenesis) [9][66.19%]</li>
<li><a href="html/MONDO_0019507.html">MONDO:0019507</a> (amelogenesis imperfecta) [3][76.63%]</li>
<li><a href="html/MONDO_0019512.html">MONDO:0019512</a> (congenital heart malformation) [54][52.90%]</li>
<li><a href="html/MONDO_0019513.html">MONDO:0019513</a> (esophageal malformation) [7][33.10%]</li>
<li><a href="html/MONDO_0019515.html">MONDO:0019515</a> (rare dementia) [83][52.21%]</li>
<li><a href="html/MONDO_0019519.html">MONDO:0019519</a> (rare skin disease) [316][62.33%]</li>
<li><a href="html/MONDO_0019520.html">MONDO:0019520</a> (syndromic lymphedema) [6][52.56%]</li>
<li><a href="html/MONDO_0019523.html">MONDO:0019523</a> (Walker-Warburg syndrome) [1][66.67%]</li>
<li><a href="html/MONDO_0019524.html">MONDO:0019524</a> (infantile Bartter syndrome with sensorineural deafness) [1][66.67%]</li>
<li><a href="html/MONDO_0019530.html">MONDO:0019530</a> (non-syndromic syndactyly) [3][66.67%]</li>
<li><a href="html/MONDO_0019548.html">MONDO:0019548</a> (autosomal dominant intermediate Charcot-Marie-tooth disease) [1][66.67%]</li>
<li><a href="html/MONDO_0019564.html">MONDO:0019564</a> (systemic sclerosis) [1][83.33%]</li>
<li><a href="html/MONDO_0019565.html">MONDO:0019565</a> (von willebrand disease) [1][18.92%]</li>
<li><a href="html/MONDO_0019573.html">MONDO:0019573</a> (autosomal recessive cutis laxa type 2) [1][66.67%]</li>
<li><a href="html/MONDO_0019589.html">MONDO:0019589</a> (syndromic genetic deafness) [48][48.93%]</li>
<li><a href="html/MONDO_0019590.html">MONDO:0019590</a> (rare endocrine growth disease) [63][52.42%]</li>
<li><a href="html/MONDO_0019592.html">MONDO:0019592</a> (disorder of sex development) [34][61.52%]</li>
<li><a href="html/MONDO_0019593.html">MONDO:0019593</a> (46,XX disorder of sex development induced by fetal androgens excess) [1][62.50%]</li>
<li><a href="html/MONDO_0019594.html">MONDO:0019594</a> (46,XY disorder of sex development due to a testosterone synthesis defect) [6][59.97%]</li>
<li><a href="html/MONDO_0019595.html">MONDO:0019595</a> (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect) [3][68.30%]</li>
<li><a href="html/MONDO_0019596.html">MONDO:0019596</a> (46,XY disorder of sex development due to testicular steroidogenesis defect) [1][64.14%]</li>
<li><a href="html/MONDO_0019599.html">MONDO:0019599</a> (primary lipodystrophy) [6][75.98%]</li>
<li><a href="html/MONDO_0019601.html">MONDO:0019601</a> (autosomal recessive axonal hereditary motor and sensory neuropathy) [1][62.50%]</li>
<li><a href="html/MONDO_0019602.html">MONDO:0019602</a> (other metabolic disease) [1][66.67%]</li>
<li><a href="html/MONDO_0019609.html">MONDO:0019609</a> (Zellweger syndrome) [2][65.38%]</li>
<li><a href="html/MONDO_0019623.html">MONDO:0019623</a> (hereditary angioedema) [1][80.80%]</li>
<li><a href="html/MONDO_0019648.html">MONDO:0019648</a> (achondrogenesis) [1][87.50%]</li>
<li><a href="html/MONDO_0019673.html">MONDO:0019673</a> (postaxial polydactyly type a (disease)) [2][66.67%]</li>
<li><a href="html/MONDO_0019684.html">MONDO:0019684</a> (rare bone disease) [305][61.71%]</li>
<li><a href="html/MONDO_0019685.html">MONDO:0019685</a> (FGFR3-related chondrodysplasia) [3][58.30%]</li>
<li><a href="html/MONDO_0019686.html">MONDO:0019686</a> (type 2 collagen-related bone disorder) [3][66.67%]</li>
<li><a href="html/MONDO_0019687.html">MONDO:0019687</a> (type 11 collagen-related bone disorder) [1][66.67%]</li>
<li><a href="html/MONDO_0019690.html">MONDO:0019690</a> (filamin-related bone disorder) [3][71.43%]</li>
<li><a href="html/MONDO_0019691.html">MONDO:0019691</a> (short rib dysplasia) [6][63.64%]</li>
<li><a href="html/MONDO_0019692.html">MONDO:0019692</a> (multiple epiphyseal dysplasia and pseudoachondroplasia) [3][63.64%]</li>
<li><a href="html/MONDO_0019693.html">MONDO:0019693</a> (multiple metaphyseal dysplasia) [2][75.00%]</li>
<li><a href="html/MONDO_0019694.html">MONDO:0019694</a> (Spondylodysplastic dysplasia) [5][60.11%]</li>
<li><a href="html/MONDO_0019695.html">MONDO:0019695</a> (acromelic dysplasia) [7][62.50%]</li>
<li><a href="html/MONDO_0019696.html">MONDO:0019696</a> (acromesomelic dysplasia) [3][71.43%]</li>
<li><a href="html/MONDO_0019697.html">MONDO:0019697</a> (mesomelic and rhizo-mesomelic dysplasia) [7][66.67%]</li>
<li><a href="html/MONDO_0019698.html">MONDO:0019698</a> (bent bone dysplasia) [3][58.30%]</li>
<li><a href="html/MONDO_0019699.html">MONDO:0019699</a> (Slender bone dysplasia) [7][62.86%]</li>
<li><a href="html/MONDO_0019700.html">MONDO:0019700</a> (primary bone dysplasia with multiple joint dislocations) [2][66.67%]</li>
<li><a href="html/MONDO_0019701.html">MONDO:0019701</a> (chondrodysplasia punctata) [4][69.23%]</li>
<li><a href="html/MONDO_0019703.html">MONDO:0019703</a> (primary bone dysplasia with increased bone density) [14][61.29%]</li>
<li><a href="html/MONDO_0019704.html">MONDO:0019704</a> (primary bone dysplasia with decreased bone density) [8][58.30%]</li>
<li><a href="html/MONDO_0019705.html">MONDO:0019705</a> (primary bone dysplasia with defective bone mineralization) [12][60.47%]</li>
<li><a href="html/MONDO_0019706.html">MONDO:0019706</a> (lysosomal storage disease with skeletal involvement) [10][73.52%]</li>
<li><a href="html/MONDO_0019707.html">MONDO:0019707</a> (primary osteolysis) [5][70.00%]</li>
<li><a href="html/MONDO_0019708.html">MONDO:0019708</a> (primary bone dysplasia with disorganized development of skeletal components) [3][66.67%]</li>
<li><a href="html/MONDO_0019709.html">MONDO:0019709</a> (cleidocranial dysplasia and isolated cranial ossification defect) [2][73.29%]</li>
<li><a href="html/MONDO_0019710.html">MONDO:0019710</a> (dysostosis with predominant craniofacial involvement) [4][62.50%]</li>
<li><a href="html/MONDO_0019711.html">MONDO:0019711</a> (dysostosis with predominant vertebral and costal involvement) [4][64.29%]</li>
<li><a href="html/MONDO_0019712.html">MONDO:0019712</a> (patellar dysostosis) [3][62.50%]</li>
<li><a href="html/MONDO_0019713.html">MONDO:0019713</a> (non-syndromic limb reduction defect) [32][19.48%]</li>
<li><a href="html/MONDO_0019714.html">MONDO:0019714</a> (non-syndromic polydactyly, syndactyly and/or hyperphalangy) [20][42.18%]</li>
<li><a href="html/MONDO_0019715.html">MONDO:0019715</a> (syndrome with synostosis or other joint formation defect) [7][51.21%]</li>
<li><a href="html/MONDO_0019716.html">MONDO:0019716</a> (overgrowth syndrome) [15][64.52%]</li>
<li><a href="html/MONDO_0019717.html">MONDO:0019717</a> (chromosomal disease with overgrowth) [1][75.00%]</li>
<li><a href="html/MONDO_0019719.html">MONDO:0019719</a> (renal or urinary tract malformation) [35][44.63%]</li>
<li><a href="html/MONDO_0019720.html">MONDO:0019720</a> (non-syndromic renal or urinary tract malformation) [11][37.50%]</li>
<li><a href="html/MONDO_0019721.html">MONDO:0019721</a> (syndromic renal or urinary tract malformation) [22][47.75%]</li>
<li><a href="html/MONDO_0019722.html">MONDO:0019722</a> (glomerular disease) [34][37.67%]</li>
<li><a href="html/MONDO_0019723.html">MONDO:0019723</a> (basement membrane disease) [2][78.57%]</li>
<li><a href="html/MONDO_0019724.html">MONDO:0019724</a> (secondary glomerular disease) [17][49.01%]</li>
<li><a href="html/MONDO_0019737.html">MONDO:0019737</a> (thrombotic microangiopathy) [5][72.50%]</li>
<li><a href="html/MONDO_0019741.html">MONDO:0019741</a> (familial cystic renal disease) [6][63.46%]</li>
<li><a href="html/MONDO_0019743.html">MONDO:0019743</a> (nephropathy secondary to a storage or other metabolic disease) [25][49.99%]</li>
<li><a href="html/MONDO_0019744.html">MONDO:0019744</a> (rare renal tubular disease) [41][49.05%]</li>
<li><a href="html/MONDO_0019747.html">MONDO:0019747</a> (hematological disorder with renal involvement) [4][79.62%]</li>
<li><a href="html/MONDO_0019748.html">MONDO:0019748</a> (rare cause of hypertension) [11][56.19%]</li>
<li><a href="html/MONDO_0019749.html">MONDO:0019749</a> (rare renal tumor) [7][63.30%]</li>
<li><a href="html/MONDO_0019750.html">MONDO:0019750</a> (rare renal disease) [180][53.24%]</li>
<li><a href="html/MONDO_0019751.html">MONDO:0019751</a> (autoinflammatory syndrome) [21][31.30%]</li>
<li><a href="html/MONDO_0019755.html">MONDO:0019755</a> (rare developmental defect during embryogenesis) [1072][62.20%]</li>
<li><a href="html/MONDO_0019781.html">MONDO:0019781</a> (astrocytoma) [5][64.29%]</li>
<li><a href="html/MONDO_0019792.html">MONDO:0019792</a> (autosomal dominant cerebellar ataxia type i) [2][62.50%]</li>
<li><a href="html/MONDO_0019796.html">MONDO:0019796</a> (acrocephalosyndactyly) [2][70.00%]</li>
<li><a href="html/MONDO_0019800.html">MONDO:0019800</a> (chronic hepatic porphyria) [2][70.00%]</li>
<li><a href="html/MONDO_0019806.html">MONDO:0019806</a> (primary progressive aphasia) [3][70.00%]</li>
<li><a href="html/MONDO_0019817.html">MONDO:0019817</a> (congenital mitral valve insufficiency and/or stenosis) [1][75.00%]</li>
<li><a href="html/MONDO_0019820.html">MONDO:0019820</a> (Univentricular cardiopathy) [3][70.00%]</li>
<li><a href="html/MONDO_0019822.html">MONDO:0019822</a> (arterial duct anomaly) [2][43.21%]</li>
<li><a href="html/MONDO_0019824.html">MONDO:0019824</a> (non-acquired pituitary hormone deficiency) [26][42.39%]</li>
<li><a href="html/MONDO_0019827.html">MONDO:0019827</a> (disease associated with non-acquired combined pituitary hormone deficiency) [10][64.29%]</li>
<li><a href="html/MONDO_0019832.html">MONDO:0019832</a> (acquired pituitary hormone deficiency) [22][29.27%]</li>
<li><a href="html/MONDO_0019833.html">MONDO:0019833</a> (pituitary hormone deficiency from tumoral origin) [11][62.50%]</li>
<li><a href="html/MONDO_0019834.html">MONDO:0019834</a> (pituitary hormone deficiency from meningeal origin) [1][83.33%]</li>
<li><a href="html/MONDO_0019843.html">MONDO:0019843</a> (pituitary hormone deficiency secondary to a granulomatous disease) [2][66.67%]</li>
<li><a href="html/MONDO_0019844.html">MONDO:0019844</a> (pituitary hormone deficiency secondary to storage disease) [2][71.55%]</li>
<li><a href="html/MONDO_0019852.html">MONDO:0019852</a> (non-acquired premature ovarian failure) [10][55.54%]</li>
<li><a href="html/MONDO_0019853.html">MONDO:0019853</a> (congenital hypothyroidism due to developmental anomaly) [3][82.27%]</li>
<li><a href="html/MONDO_0019856.html">MONDO:0019856</a> (primary congenital hypothyroidism without thyroid developmental anomaly) [1][85.71%]</li>
<li><a href="html/MONDO_0019859.html">MONDO:0019859</a> (congenital thyroid malformation without hypothyroidism) [1][100.00%]</li>
<li><a href="html/MONDO_0019927.html">MONDO:0019927</a> (Somatotropic adenoma) [3][71.43%]</li>
<li><a href="html/MONDO_0019936.html">MONDO:0019936</a> (rare otorhinolaryngological malformation) [24][34.29%]</li>
<li><a href="html/MONDO_0019937.html">MONDO:0019937</a> (rare gynecologic or obstetric disease) [102][38.06%]</li>
<li><a href="html/MONDO_0019938.html">MONDO:0019938</a> (anorectal malformation) [19][56.33%]</li>
<li><a href="html/MONDO_0019942.html">MONDO:0019942</a> (distal arthrogryposis) [6][58.05%]</li>
<li><a href="html/MONDO_0019950.html">MONDO:0019950</a> (congenital muscular dystrophy) [17][72.20%]</li>
<li><a href="html/MONDO_0019952.html">MONDO:0019952</a> (congenital myopathy) [21][56.80%]</li>
<li><a href="html/MONDO_0019956.html">MONDO:0019956</a> (encephalitis) [11][15.75%]</li>
<li><a href="html/MONDO_0019978.html">MONDO:0019978</a> (Robinow syndrome) [1][70.00%]</li>
<li><a href="html/MONDO_0019992.html">MONDO:0019992</a> (pseudohypoparathyroidism) [2][75.00%]</li>
<li><a href="html/MONDO_0019996.html">MONDO:0019996</a> (rare cardiac disease) [94][60.31%]</li>
<li><a href="html/MONDO_0019997.html">MONDO:0019997</a> (rare gastroenterologic disease) [84][48.59%]</li>
<li><a href="html/MONDO_0019998.html">MONDO:0019998</a> (gastroduodenal malformation) [3][70.00%]</li>
<li><a href="html/MONDO_0019999.html">MONDO:0019999</a> (intestinal malformation) [5][55.40%]</li>
<li><a href="html/MONDO_0020000.html">MONDO:0020000</a> (rare respiratory disease) [109][36.85%]</li>
<li><a href="html/MONDO_0020001.html">MONDO:0020001</a> (respiratory or thoracic malformation) [17][52.50%]</li>
<li><a href="html/MONDO_0020002.html">MONDO:0020002</a> (rare surgical thoracic disease) [35][49.79%]</li>
<li><a href="html/MONDO_0020003.html">MONDO:0020003</a> (rare surgical cardiac disease) [61][52.59%]</li>
<li><a href="html/MONDO_0020004.html">MONDO:0020004</a> (rare eye disease) [437][62.85%]</li>
<li><a href="html/MONDO_0020005.html">MONDO:0020005</a> (rare endocrine disease) [332][54.23%]</li>
<li><a href="html/MONDO_0020006.html">MONDO:0020006</a> (rare hematologic disease) [218][53.77%]</li>
<li><a href="html/MONDO_0020008.html">MONDO:0020008</a> (rare immune disease) [192][53.96%]</li>
<li><a href="html/MONDO_0020009.html">MONDO:0020009</a> (rare neurologic disease) [1216][64.08%]</li>
<li><a href="html/MONDO_0020010.html">MONDO:0020010</a> (infectious disease of the nervous system) [8][18.52%]</li>
<li><a href="html/MONDO_0020011.html">MONDO:0020011</a> (rare headache) [2][83.33%]</li>
<li><a href="html/MONDO_0020012.html">MONDO:0020012</a> (rare systemic or rheumatologic disease) [95][41.01%]</li>
<li><a href="html/MONDO_0020013.html">MONDO:0020013</a> (rare odontologic disease) [36][52.12%]</li>
<li><a href="html/MONDO_0020014.html">MONDO:0020014</a> (rare disease with odontological manifestation) [15][43.11%]</li>
<li><a href="html/MONDO_0020015.html">MONDO:0020015</a> (rare circulatory system disease) [196][50.93%]</li>
<li><a href="html/MONDO_0020016.html">MONDO:0020016</a> (rare neurologic disease with psychiatric involvement) [97][50.00%]</li>
<li><a href="html/MONDO_0020017.html">MONDO:0020017</a> (rare otorhinolaryngologic disease) [105][50.13%]</li>
<li><a href="html/MONDO_0020018.html">MONDO:0020018</a> (cranial malformation) [14][55.61%]</li>
<li><a href="html/MONDO_0020019.html">MONDO:0020019</a> (digestive tract malformation) [37][46.70%]</li>
<li><a href="html/MONDO_0020020.html">MONDO:0020020</a> (visceral malformation of the liver, biliary tract, pancreas or spleen) [7][58.10%]</li>
<li><a href="html/MONDO_0020021.html">MONDO:0020021</a> (diaphragmatic or abdominal wall malformation) [18][50.70%]</li>
<li><a href="html/MONDO_0020022.html">MONDO:0020022</a> (central nervous system malformation) [109][49.83%]</li>
<li><a href="html/MONDO_0020023.html">MONDO:0020023</a> (respiratory or mediastinal malformation) [12][38.78%]</li>
<li><a href="html/MONDO_0020024.html">MONDO:0020024</a> (rare infertility) [79][52.35%]</li>
<li><a href="html/MONDO_0020025.html">MONDO:0020025</a> (rare male infertility) [59][51.78%]</li>
<li><a href="html/MONDO_0020026.html">MONDO:0020026</a> (rare female infertility) [36][45.76%]</li>
<li><a href="html/MONDO_0020027.html">MONDO:0020027</a> (rare allergic disease) [10][66.67%]</li>
<li><a href="html/MONDO_0020028.html">MONDO:0020028</a> (rare allergic respiratory disease) [3][62.50%]</li>
<li><a href="html/MONDO_0020029.html">MONDO:0020029</a> (rare genetic cardiac disease) [80][56.63%]</li>
<li><a href="html/MONDO_0020030.html">MONDO:0020030</a> (rare genetic renal disease) [153][53.96%]</li>
<li><a href="html/MONDO_0020031.html">MONDO:0020031</a> (rare tumor) [352][49.50%]</li>
<li><a href="html/MONDO_0020033.html">MONDO:0020033</a> (rare digestive tumor) [37][26.25%]</li>
<li><a href="html/MONDO_0020034.html">MONDO:0020034</a> (rare respiratory tumor) [6][60.11%]</li>
<li><a href="html/MONDO_0020035.html">MONDO:0020035</a> (rare otorhinolaryngologic tumor) [1][62.50%]</li>
<li><a href="html/MONDO_0020036.html">MONDO:0020036</a> (rare nervous system tumor) [47][28.90%]</li>
<li><a href="html/MONDO_0020038.html">MONDO:0020038</a> (gonadal dysgenesis of gynecological interest) [4][77.73%]</li>
<li><a href="html/MONDO_0020039.html">MONDO:0020039</a> (46,XX disorder of sex development induced by androgens excess) [4][64.29%]</li>
<li><a href="html/MONDO_0020040.html">MONDO:0020040</a> (46,XY disorder of sex development) [20][59.99%]</li>
<li><a href="html/MONDO_0020042.html">MONDO:0020042</a> (syndrome with 46,XY disorder of sex development) [2][64.29%]</li>
<li><a href="html/MONDO_0020043.html">MONDO:0020043</a> (autosomal recessive congenital cerebellar ataxia) [7][58.46%]</li>
<li><a href="html/MONDO_0020044.html">MONDO:0020044</a> (autosomal recessive metabolic cerebellar ataxia) [3][66.67%]</li>
<li><a href="html/MONDO_0020045.html">MONDO:0020045</a> (autosomal recessive cerebellar ataxia due to a DNA repair defect) [5][63.89%]</li>
<li><a href="html/MONDO_0020046.html">MONDO:0020046</a> (autosomal recessive degenerative and progressive cerebellar ataxia) [1][83.33%]</li>
<li><a href="html/MONDO_0020051.html">MONDO:0020051</a> (total autosomal trisomy) [1][100.00%]</li>
<li><a href="html/MONDO_0020058.html">MONDO:0020058</a> (Gonosome anomaly) [23][17.10%]</li>
<li><a href="html/MONDO_0020060.html">MONDO:0020060</a> (Gonosome structural anomaly) [14][19.72%]</li>
<li><a href="html/MONDO_0020061.html">MONDO:0020061</a> (chromosome Y structural anomaly) [2][62.50%]</li>
<li><a href="html/MONDO_0020062.html">MONDO:0020062</a> (chromosome X structural anomaly) [10][19.67%]</li>
<li><a href="html/MONDO_0020063.html">MONDO:0020063</a> (malformation syndrome with hamartosis) [19][61.41%]</li>
<li><a href="html/MONDO_0020065.html">MONDO:0020065</a> (combined dystonia) [11][48.34%]</li>
<li><a href="html/MONDO_0020066.html">MONDO:0020066</a> (Ehlers-Danlos syndrome) [8][69.57%]</li>
<li><a href="html/MONDO_0020067.html">MONDO:0020067</a> (infectious encephalitis) [3][65.00%]</li>
<li><a href="html/MONDO_0020070.html">MONDO:0020070</a> (neonatal epilepsy syndrome) [8][72.92%]</li>
<li><a href="html/MONDO_0020071.html">MONDO:0020071</a> (infantile epilepsy syndrome) [11][64.72%]</li>
<li><a href="html/MONDO_0020072.html">MONDO:0020072</a> (childhood-onset epilepsy syndrome) [28][50.20%]</li>
<li><a href="html/MONDO_0020073.html">MONDO:0020073</a> (adolescent-onset epilepsy syndrome) [23][49.65%]</li>
<li><a href="html/MONDO_0020074.html">MONDO:0020074</a> (progressive myoclonic epilepsy) [5][70.45%]</li>
<li><a href="html/MONDO_0020076.html">MONDO:0020076</a> (myeloproliferative neoplasm) [10][64.29%]</li>
<li><a href="html/MONDO_0020077.html">MONDO:0020077</a> (myelodysplastic/myeloproliferative disease) [3][62.50%]</li>
<li><a href="html/MONDO_0020078.html">MONDO:0020078</a> (acute myeloid leukemia with recurrent genetic anomaly) [2][48.87%]</li>
<li><a href="html/MONDO_0020079.html">MONDO:0020079</a> (plasma cell tumor) [5][64.29%]</li>
<li><a href="html/MONDO_0020082.html">MONDO:0020082</a> (dendritic cell tumor) [2][66.67%]</li>
<li><a href="html/MONDO_0020086.html">MONDO:0020086</a> (idiopathic interstitial pneumonia) [9][50.43%]</li>
<li><a href="html/MONDO_0020087.html">MONDO:0020087</a> (genetic lipodystrophy) [3][80.12%]</li>
<li><a href="html/MONDO_0020089.html">MONDO:0020089</a> (acquired lipodystrophy) [1][100.00%]</li>
<li><a href="html/MONDO_0020090.html">MONDO:0020090</a> (male infertility due to gonadal dysgenesis) [2][77.92%]</li>
<li><a href="html/MONDO_0020091.html">MONDO:0020091</a> (male infertility due to obstructive azoospermia) [5][25.52%]</li>
<li><a href="html/MONDO_0020094.html">MONDO:0020094</a> (autosomal dominant disease with diffuse palmoplantar keratoderma as a major feature) [3][62.50%]</li>
<li><a href="html/MONDO_0020095.html">MONDO:0020095</a> (autosomal dominant disease associated with focal palmoplantar keratoderma as a major feature) [1][78.05%]</li>
<li><a href="html/MONDO_0020097.html">MONDO:0020097</a> (autosomal recessive disease with focal palmoplantar keratoderma as a major feature) [1][100.00%]</li>
<li><a href="html/MONDO_0020099.html">MONDO:0020099</a> (constitutional sideroblastic anemia) [4][58.30%]</li>
<li><a href="html/MONDO_0020100.html">MONDO:0020100</a> (rare hemolytic anemia) [39][55.98%]</li>
<li><a href="html/MONDO_0020101.html">MONDO:0020101</a> (rare constitutional hemolytic anemia due to a red cell membrane anomaly) [6][64.71%]</li>
<li><a href="html/MONDO_0020102.html">MONDO:0020102</a> (hereditary stomatocytosis) [2][70.00%]</li>
<li><a href="html/MONDO_0020104.html">MONDO:0020104</a> (rare constitutional hemolytic anemia due to an enzyme disorder) [4][75.00%]</li>
<li><a href="html/MONDO_0020105.html">MONDO:0020105</a> (hemolytic anemia due to hexose monophosphate shunt and glutathione metabolism anomalies) [1][100.00%]</li>
<li><a href="html/MONDO_0020108.html">MONDO:0020108</a> (autoimmune hemolytic anemia) [1][56.30%]</li>
<li><a href="html/MONDO_0020109.html">MONDO:0020109</a> (constitutional megaloblastic anemia due to vitamin B12 metabolism disorder) [4][67.43%]</li>
<li><a href="html/MONDO_0020112.html">MONDO:0020112</a> (vitamin B12- and folate-independent constitutional megaloblastic anemia) [2][75.00%]</li>
<li><a href="html/MONDO_0020115.html">MONDO:0020115</a> (secondary polycythemia) [3][70.00%]</li>
<li><a href="html/MONDO_0020116.html">MONDO:0020116</a> (inherited blood coagulation disease) [61][53.25%]</li>
<li><a href="html/MONDO_0020117.html">MONDO:0020117</a> (alpha granule disease) [1][66.67%]</li>
<li><a href="html/MONDO_0020118.html">MONDO:0020118</a> (dense granule disease) [5][65.22%]</li>
<li><a href="html/MONDO_0020119.html">MONDO:0020119</a> (X-linked syndromic intellectual disability) [42][52.01%]</li>
<li><a href="html/MONDO_0020120.html">MONDO:0020120</a> (skeletal muscle disease) [113][60.93%]</li>
<li><a href="html/MONDO_0020121.html">MONDO:0020121</a> (muscular dystrophy) [38][64.66%]</li>
<li><a href="html/MONDO_0020122.html">MONDO:0020122</a> (idiopathic inflammatory myopathy) [5][70.00%]</li>
<li><a href="html/MONDO_0020123.html">MONDO:0020123</a> (metabolic myopathy) [17][35.09%]</li>
<li><a href="html/MONDO_0020124.html">MONDO:0020124</a> (neuromuscular junction disease) [11][65.38%]</li>
<li><a href="html/MONDO_0020125.html">MONDO:0020125</a> (acquired neuromuscular junction disease) [5][62.50%]</li>
<li><a href="html/MONDO_0020126.html">MONDO:0020126</a> (rare peripheral neuropathy) [127][43.43%]</li>
<li><a href="html/MONDO_0020127.html">MONDO:0020127</a> (genetic peripheral neuropathy) [83][42.62%]</li>
<li><a href="html/MONDO_0020128.html">MONDO:0020128</a> (motor neuron disease) [30][59.32%]</li>
<li><a href="html/MONDO_0020129.html">MONDO:0020129</a> (acquired motor neuron disease) [1][75.00%]</li>
<li><a href="html/MONDO_0020130.html">MONDO:0020130</a> (malformation of the cerebellar vermis) [4][55.22%]</li>
<li><a href="html/MONDO_0020132.html">MONDO:0020132</a> (cranial nerve and nuclear aplasia) [2][62.50%]</li>
<li><a href="html/MONDO_0020133.html">MONDO:0020133</a> (posterior fossa malformation) [13][43.89%]</li>
<li><a href="html/MONDO_0020134.html">MONDO:0020134</a> (cystic malformation of the posterior fossa) [1][75.00%]</li>
<li><a href="html/MONDO_0020135.html">MONDO:0020135</a> (non-syndromic pontocerebellar hypoplasia) [2][65.00%]</li>
<li><a href="html/MONDO_0020136.html">MONDO:0020136</a> (neurodegenerative disease with dementia) [60][46.50%]</li>
<li><a href="html/MONDO_0020137.html">MONDO:0020137</a> (frontotemporal degeneration with dementia) [10][52.85%]</li>
<li><a href="html/MONDO_0020138.html">MONDO:0020138</a> (ataxia with dementia) [34][50.07%]</li>
<li><a href="html/MONDO_0020139.html">MONDO:0020139</a> (early-onset ataxia with dementia) [24][51.13%]</li>
<li><a href="html/MONDO_0020140.html">MONDO:0020140</a> (late-onset ataxia with dementia) [8][63.64%]</li>
<li><a href="html/MONDO_0020141.html">MONDO:0020141</a> (infectious disease with dementia) [1][75.00%]</li>
<li><a href="html/MONDO_0020142.html">MONDO:0020142</a> (metabolic disease with dementia) [11][54.34%]</li>
<li><a href="html/MONDO_0020143.html">MONDO:0020143</a> (cerebral lipidosis with dementia) [6][64.00%]</li>
<li><a href="html/MONDO_0020144.html">MONDO:0020144</a> (cerebrovascular dementia) [3][73.08%]</li>
<li><a href="html/MONDO_0020145.html">MONDO:0020145</a> (developmental defect of the eye) [67][49.85%]</li>
<li><a href="html/MONDO_0020146.html">MONDO:0020146</a> (major induction processes eye anomaly) [17][59.40%]</li>
<li><a href="html/MONDO_0020147.html">MONDO:0020147</a> (anophthalmia-microphthalmia syndrome) [12][61.25%]</li>
<li><a href="html/MONDO_0020148.html">MONDO:0020148</a> (syndromic aniridia) [1][66.67%]</li>
<li><a href="html/MONDO_0020149.html">MONDO:0020149</a> (rare eye disease due to a differentiation anomaly) [12][60.47%]</li>
<li><a href="html/MONDO_0020150.html">MONDO:0020150</a> (rare palpebral, lacrimal system and conjunctival disease) [111][45.23%]</li>
<li><a href="html/MONDO_0020151.html">MONDO:0020151</a> (rare palpebral disease) [83][45.32%]</li>
<li><a href="html/MONDO_0020152.html">MONDO:0020152</a> (eyelid malformation) [7][56.94%]</li>
<li><a href="html/MONDO_0020153.html">MONDO:0020153</a> (cryptophthalmia) [1][75.00%]</li>
<li><a href="html/MONDO_0020155.html">MONDO:0020155</a> (eyelid border anomaly) [3][66.67%]</li>
<li><a href="html/MONDO_0020157.html">MONDO:0020157</a> (syndromic palpebral coloboma) [1][62.50%]</li>
<li><a href="html/MONDO_0020158.html">MONDO:0020158</a> (eyelids malposition disorder) [15][61.99%]</li>
<li><a href="html/MONDO_0020159.html">MONDO:0020159</a> (congenital entropion) [9][69.37%]</li>
<li><a href="html/MONDO_0020160.html">MONDO:0020160</a> (secondary entropion) [1][70.00%]</li>
<li><a href="html/MONDO_0020161.html">MONDO:0020161</a> (congenital ectropion) [1][66.67%]</li>
<li><a href="html/MONDO_0020162.html">MONDO:0020162</a> (secondary ectropion) [3][59.01%]</li>
<li><a href="html/MONDO_0020163.html">MONDO:0020163</a> (Canthal anomaly) [9][48.82%]</li>
<li><a href="html/MONDO_0020164.html">MONDO:0020164</a> (Epicanthal fold) [2][75.00%]</li>
<li><a href="html/MONDO_0020165.html">MONDO:0020165</a> (syndromic epicanthus) [1][100.00%]</li>
<li><a href="html/MONDO_0020167.html">MONDO:0020167</a> (malposition of external canthus) [2][63.33%]</li>
<li><a href="html/MONDO_0020168.html">MONDO:0020168</a> (Kinetic eyelid anomaly) [20][55.77%]</li>
<li><a href="html/MONDO_0020169.html">MONDO:0020169</a> (rare disorder with ptosis) [18][56.47%]</li>
<li><a href="html/MONDO_0020171.html">MONDO:0020171</a> (palpebral tumor) [19][32.04%]</li>
<li><a href="html/MONDO_0020172.html">MONDO:0020172</a> (palpebral epidermal tumor) [5][64.29%]</li>
<li><a href="html/MONDO_0020173.html">MONDO:0020173</a> (benign tumor of palpebral epidermis) [1][33.84%]</li>
<li><a href="html/MONDO_0020175.html">MONDO:0020175</a> (malignant tumor of palpebral epidermis) [1][100.00%]</li>
<li><a href="html/MONDO_0020177.html">MONDO:0020177</a> (pigmented palpebral tumor) [6][47.60%]</li>
<li><a href="html/MONDO_0020178.html">MONDO:0020178</a> (palpebral lentiginosis) [3][70.00%]</li>
<li><a href="html/MONDO_0020180.html">MONDO:0020180</a> (palpebral piliary tumor) [2][45.53%]</li>
<li><a href="html/MONDO_0020181.html">MONDO:0020181</a> (Mesenchymatous palpebral tumor) [1][62.50%]</li>
<li><a href="html/MONDO_0020184.html">MONDO:0020184</a> (rare eyebrow/eyelashes anomaly) [15][45.69%]</li>
<li><a href="html/MONDO_0020185.html">MONDO:0020185</a> (eyebrow/eyelashes hypertrichosis) [1][87.50%]</li>
<li><a href="html/MONDO_0020186.html">MONDO:0020186</a> (eyebrow hypertrophy) [3][63.64%]</li>
<li><a href="html/MONDO_0020188.html">MONDO:0020188</a> (congenital absence of the eyebrow/eyelashes) [1][100.00%]</li>
<li><a href="html/MONDO_0020190.html">MONDO:0020190</a> (eyebrow/eyelashes distichiasis) [2][70.00%]</li>
<li><a href="html/MONDO_0020191.html">MONDO:0020191</a> (eyebrow/eyelashes pigmentation anomaly) [3][66.67%]</li>
<li><a href="html/MONDO_0020192.html">MONDO:0020192</a> (rare lacrimal system disease) [16][51.46%]</li>
<li><a href="html/MONDO_0020193.html">MONDO:0020193</a> (secretory apparatus of the lacrimal system anomaly) [7][55.11%]</li>
<li><a href="html/MONDO_0020194.html">MONDO:0020194</a> (congenital alacrima) [6][56.13%]</li>
<li><a href="html/MONDO_0020195.html">MONDO:0020195</a> (excretory apparatus of the lacrimal system anomaly) [4][76.16%]</li>
<li><a href="html/MONDO_0020196.html">MONDO:0020196</a> (anomaly of the secretory and excretory apparatus of the lacrimal system) [2][66.67%]</li>
<li><a href="html/MONDO_0020197.html">MONDO:0020197</a> (EEC syndrome and related syndrome) [1][70.00%]</li>
<li><a href="html/MONDO_0020198.html">MONDO:0020198</a> (rare conjunctival disease) [14][61.19%]</li>
<li><a href="html/MONDO_0020199.html">MONDO:0020199</a> (conjunctival vascular anomaly) [6][63.16%]</li>
<li><a href="html/MONDO_0020201.html">MONDO:0020201</a> (conjunctival telangiectasia (disease)) [2][72.22%]</li>
<li><a href="html/MONDO_0020202.html">MONDO:0020202</a> (conjunctival lymphangiectasia) [1][67.86%]</li>
<li><a href="html/MONDO_0020203.html">MONDO:0020203</a> (pigmented conjunctival lesion) [1][75.00%]</li>
<li><a href="html/MONDO_0020204.html">MONDO:0020204</a> (conjunctival tumor) [4][76.16%]</li>
<li><a href="html/MONDO_0020206.html">MONDO:0020206</a> (rare refraction anomaly) [13][46.37%]</li>
<li><a href="html/MONDO_0020208.html">MONDO:0020208</a> (syndromic myopia) [7][63.64%]</li>
<li><a href="html/MONDO_0020209.html">MONDO:0020209</a> (rare hyperopia and astigmatism) [3][70.00%]</li>
<li><a href="html/MONDO_0020210.html">MONDO:0020210</a> (syndromic hyperopia) [1][100.00%]</li>
<li><a href="html/MONDO_0020211.html">MONDO:0020211</a> (syndromic keratoconus) [2][80.00%]</li>
<li><a href="html/MONDO_0020213.html">MONDO:0020213</a> (stromal corneal dystrophy) [1][83.33%]</li>
<li><a href="html/MONDO_0020214.html">MONDO:0020214</a> (posterior corneal dystrophy) [2][58.76%]</li>
<li><a href="html/MONDO_0020215.html">MONDO:0020215</a> (syndromic corneal dystrophy) [4][51.23%]</li>
<li><a href="html/MONDO_0020216.html">MONDO:0020216</a> (secondary dysgenetic glaucoma) [17][31.55%]</li>
<li><a href="html/MONDO_0020217.html">MONDO:0020217</a> (glaucoma associated with neural crest cell migration anomaly) [13][62.53%]</li>
<li><a href="html/MONDO_0020219.html">MONDO:0020219</a> (Corneogoniodysgenesis) [1][60.36%]</li>
<li><a href="html/MONDO_0020220.html">MONDO:0020220</a> (Corneoiridogoniodysgenesis) [1][52.02%]</li>
<li><a href="html/MONDO_0020221.html">MONDO:0020221</a> (secondary glaucoma due to a proliferation and differentiation anomaly) [2][45.00%]</li>
<li><a href="html/MONDO_0020222.html">MONDO:0020222</a> (rare disease with glaucoma as a major feature) [22][49.83%]</li>
<li><a href="html/MONDO_0020223.html">MONDO:0020223</a> (lens and zonula anomaly) [56][59.30%]</li>
<li><a href="html/MONDO_0020224.html">MONDO:0020224</a> (rare cataract) [45][58.71%]</li>
<li><a href="html/MONDO_0020225.html">MONDO:0020225</a> (syndromic cataract) [39][50.78%]</li>
<li><a href="html/MONDO_0020226.html">MONDO:0020226</a> (chromosomal anomaly with cataract) [3][62.50%]</li>
<li><a href="html/MONDO_0020227.html">MONDO:0020227</a> (systemic disease with cataract) [29][52.72%]</li>
<li><a href="html/MONDO_0020228.html">MONDO:0020228</a> (cataract associated with a metabolic disease) [6][55.56%]</li>
<li><a href="html/MONDO_0020229.html">MONDO:0020229</a> (cerebral disease with cataract) [2][65.62%]</li>
<li><a href="html/MONDO_0020230.html">MONDO:0020230</a> (renal disease with cataract) [1][62.50%]</li>
<li><a href="html/MONDO_0020231.html">MONDO:0020231</a> (cardiac disease with cataract) [1][66.67%]</li>
<li><a href="html/MONDO_0020232.html">MONDO:0020232</a> (musculoskeletal disease with cataract) [8][63.64%]</li>
<li><a href="html/MONDO_0020233.html">MONDO:0020233</a> (Dentocutaneous disease with cataract) [1][100.00%]</li>
<li><a href="html/MONDO_0020234.html">MONDO:0020234</a> (craniofacial anomaly with cataract) [3][63.46%]</li>
<li><a href="html/MONDO_0020235.html">MONDO:0020235</a> (lens size anomaly) [1][70.00%]</li>
<li><a href="html/MONDO_0020236.html">MONDO:0020236</a> (lens position anomaly) [4][64.29%]</li>
<li><a href="html/MONDO_0020237.html">MONDO:0020237</a> (lens shape anomaly) [4][59.33%]</li>
<li><a href="html/MONDO_0020238.html">MONDO:0020238</a> (genetic vitreous-retinal disease) [71][59.46%]</li>
<li><a href="html/MONDO_0020239.html">MONDO:0020239</a> (color-vision disease) [1][78.57%]</li>
<li><a href="html/MONDO_0020240.html">MONDO:0020240</a> (syndromic retinitis pigmentosa) [12][50.42%]</li>
<li><a href="html/MONDO_0020241.html">MONDO:0020241</a> (unclassified familial retinal dystrophy) [1][86.63%]</li>
<li><a href="html/MONDO_0020242.html">MONDO:0020242</a> (genetic macular dystrophy) [33][50.29%]</li>
<li><a href="html/MONDO_0020243.html">MONDO:0020243</a> (colobomatous and areolar dystrophy) [1][62.50%]</li>
<li><a href="html/MONDO_0020244.html">MONDO:0020244</a> (unclassified primitive or secondary maculopathy) [21][52.57%]</li>
<li><a href="html/MONDO_0020245.html">MONDO:0020245</a> (disease predisposing to age-related macular degeneration) [1][66.67%]</li>
<li><a href="html/MONDO_0020246.html">MONDO:0020246</a> (vitreoretinopathy) [12][55.11%]</li>
<li><a href="html/MONDO_0020247.html">MONDO:0020247</a> (congenital vitreoretinal dysplasia) [4][61.29%]</li>
<li><a href="html/MONDO_0020248.html">MONDO:0020248</a> (vitreoretinal degeneration) [6][67.50%]</li>
<li><a href="html/MONDO_0020249.html">MONDO:0020249</a> (hereditary optic neuropathy) [15][48.59%]</li>
<li><a href="html/MONDO_0020250.html">MONDO:0020250</a> (autosomal dominant optic atrophy) [2][62.50%]</li>
<li><a href="html/MONDO_0020251.html">MONDO:0020251</a> (rare strabismus and restriction syndrome) [17][48.93%]</li>
<li><a href="html/MONDO_0020253.html">MONDO:0020253</a> (syndrome with a symptomatic strabismus) [16][49.69%]</li>
<li><a href="html/MONDO_0020254.html">MONDO:0020254</a> (craniostenosis associated with a strabismus) [2][70.00%]</li>
<li><a href="html/MONDO_0020255.html">MONDO:0020255</a> (oculomotor palsy) [11][38.11%]</li>
<li><a href="html/MONDO_0020257.html">MONDO:0020257</a> (supranuclear oculomotor palsy) [8][38.22%]</li>
<li><a href="html/MONDO_0020258.html">MONDO:0020258</a> (oculomotor apraxia or related oculomotor disease) [6][54.02%]</li>
<li><a href="html/MONDO_0020259.html">MONDO:0020259</a> (myopathy with eye involvement) [6][69.52%]</li>
<li><a href="html/MONDO_0020260.html">MONDO:0020260</a> (myasthenic syndrome with eye involvement) [5][70.18%]</li>
<li><a href="html/MONDO_0020261.html">MONDO:0020261</a> (abnormal eye movements) [3][62.50%]</li>
<li><a href="html/MONDO_0020262.html">MONDO:0020262</a> (nervous system anomaly with eye involvement) [38][51.90%]</li>
<li><a href="html/MONDO_0020263.html">MONDO:0020263</a> (spinocerebellar ataxia with oculomotor anomaly) [32][50.52%]</li>
<li><a href="html/MONDO_0020264.html">MONDO:0020264</a> (spinocerebellar degenerescence and spastic paraparesis with an oculomotor anomaly) [1][83.33%]</li>
<li><a href="html/MONDO_0020265.html">MONDO:0020265</a> (mitochondrial disease with eye involvement) [6][46.67%]</li>
<li><a href="html/MONDO_0020266.html">MONDO:0020266</a> (genodermatosis with ocular features) [36][57.60%]</li>
<li><a href="html/MONDO_0020267.html">MONDO:0020267</a> (genetic keratinization disorder associated with ocular features) [8][59.00%]</li>
<li><a href="html/MONDO_0020268.html">MONDO:0020268</a> (ichthyosis associated with ocular features) [3][67.84%]</li>
<li><a href="html/MONDO_0020269.html">MONDO:0020269</a> (syndromic ichthyosis associated with ocular features) [4][63.64%]</li>
<li><a href="html/MONDO_0020270.html">MONDO:0020270</a> (pigmentation disorder with eye involvement) [14][74.68%]</li>
<li><a href="html/MONDO_0020271.html">MONDO:0020271</a> (phakomatosis with eye involvement) [5][67.36%]</li>
<li><a href="html/MONDO_0020272.html">MONDO:0020272</a> (connective tissue disease with eye involvement) [3][65.00%]</li>
<li><a href="html/MONDO_0020275.html">MONDO:0020275</a> (oculocutaneous or ocular albinism) [9][71.88%]</li>
<li><a href="html/MONDO_0020276.html">MONDO:0020276</a> (pigmentation disorder with eye involvement, excluding albinism) [3][76.92%]</li>
<li><a href="html/MONDO_0020277.html">MONDO:0020277</a> (ectodermal malformation syndrome associated with ocular features) [2][70.00%]</li>
<li><a href="html/MONDO_0020278.html">MONDO:0020278</a> (metabolic disease associated with ocular features) [38][51.65%]</li>
<li><a href="html/MONDO_0020279.html">MONDO:0020279</a> (metabolic disease with corneal opacity) [8][63.79%]</li>
<li><a href="html/MONDO_0020280.html">MONDO:0020280</a> (metabolic disease with cataract) [13][58.34%]</li>
<li><a href="html/MONDO_0020281.html">MONDO:0020281</a> (metabolic disease with pigmentary retinitis) [7][66.22%]</li>
<li><a href="html/MONDO_0020282.html">MONDO:0020282</a> (metabolic disease with macular cherry-red spot) [3][73.56%]</li>
<li><a href="html/MONDO_0020283.html">MONDO:0020283</a> (uveitis (disease)) [14][62.50%]</li>
<li><a href="html/MONDO_0020284.html">MONDO:0020284</a> (heart position anomaly) [1][70.00%]</li>
<li><a href="html/MONDO_0020285.html">MONDO:0020285</a> (transposition of the great arteries and conotruncal cardiac anomaly) [15][35.65%]</li>
<li><a href="html/MONDO_0020286.html">MONDO:0020286</a> (aortic malformation) [7][60.11%]</li>
<li><a href="html/MONDO_0020287.html">MONDO:0020287</a> (pulmonary artery or pulmonary branch anomaly) [2][66.67%]</li>
<li><a href="html/MONDO_0020288.html">MONDO:0020288</a> (atrioventricular valve anomaly) [9][50.43%]</li>
<li><a href="html/MONDO_0020289.html">MONDO:0020289</a> (congenital tricuspid malformation) [2][66.67%]</li>
<li><a href="html/MONDO_0020290.html">MONDO:0020290</a> (atrioventricular septal defect) [1][53.97%]</li>
<li><a href="html/MONDO_0020292.html">MONDO:0020292</a> (congenital anomaly of the great arteries) [17][41.37%]</li>
<li><a href="html/MONDO_0020293.html">MONDO:0020293</a> (ascending aorta anomaly) [2][75.00%]</li>
<li><a href="html/MONDO_0020294.html">MONDO:0020294</a> (atrial defect and interatrial communication) [3][63.90%]</li>
<li><a href="html/MONDO_0020295.html">MONDO:0020295</a> (congenital pulmonary veins anomaly) [1][100.00%]</li>
<li><a href="html/MONDO_0020297.html">MONDO:0020297</a> (Noonan syndrome and Noonan-related syndrome) [3][67.50%]</li>
<li><a href="html/MONDO_0020310.html">MONDO:0020310</a> (familial focal epilepsy with variable foci) [1][75.00%]</li>
<li><a href="html/MONDO_0020312.html">MONDO:0020312</a> (atypical chronic myeloid leukemia) [1][75.00%]</li>
<li><a href="html/MONDO_0020347.html">MONDO:0020347</a> (acute inflammatory demyelinating polyradiculoneuropathy) [1][66.67%]</li>
<li><a href="html/MONDO_0020366.html">MONDO:0020366</a> (congenital glaucoma) [2][34.62%]</li>
<li><a href="html/MONDO_0020377.html">MONDO:0020377</a> (early-onset partial cataract) [3][40.24%]</li>
<li><a href="html/MONDO_0020380.html">MONDO:0020380</a> (autosomal dominant cerebellar ataxia) [7][24.20%]</li>
<li><a href="html/MONDO_0020471.html">MONDO:0020471</a> (pituitary adenoma) [7][65.00%]</li>
<li><a href="html/MONDO_0020484.html">MONDO:0020484</a> (rare familial disorder with hypertrophic cardiomyopathy) [19][45.43%]</li>
<li><a href="html/MONDO_0020511.html">MONDO:0020511</a> (precursor b-cell acute lymphoblastic leukemia) [1][75.00%]</li>
<li><a href="html/MONDO_0020529.html">MONDO:0020529</a> (ACTH-independent Cushing syndrome) [3][68.75%]</li>
<li><a href="html/MONDO_0020537.html">MONDO:0020537</a> (occupational allergic alveolitis) [1][75.00%]</li>
<li><a href="html/MONDO_0020551.html">MONDO:0020551</a> (hydatidiform mole) [1][35.48%]</li>
<li><a href="html/MONDO_0020561.html">MONDO:0020561</a> (myxoid/round cell liposarcoma) [1][66.67%]</li>
<li><a href="html/MONDO_0021002.html">MONDO:0021002</a> (syndactyly (disease)) [4][65.00%]</li>
<li><a href="html/MONDO_0021003.html">MONDO:0021003</a> (polydactyly (disease)) [15][46.66%]</li>
<li><p><a href="html/MONDO_0021004.html">MONDO:0021004</a> (brachydactyly (disease)) [4][62.50%]</p></li>
</ol>
</body>
</html>
